(lp1
(dp2
S'CDSRfilename'
p3
VCD009987 v. 2.4 Decentralising HIV treatment in lower- and middle-income countries.rm5
p4
sS'refs'
p5
(lp6
(dp7
S'PMfilename'
p8
V23078768.xml
p9
sS'CDSRrefcode'
p10
VSTD-Hansudewechakul--2012
p11
sS'PMCid'
p12
S'PMC3494174'
p13
sa(dp14
g8
V20687955.xml
p15
sg10
VSTD-Humphreys-2010
p16
sg12
S'PMC2924332'
p17
sa(dp18
g8
V20877631.xml
p19
sg10
VSTD-Fatti-2010
p20
sg12
S'PMC2943483'
p21
sa(dp22
g8
V19939445.xml
p23
sg10
VSTD-Jaffar-2009
p24
sg12
S'PMC2806484'
p25
sa(dp26
g8
V23272094.xml
p27
sg10
VSTD-Odafe-2012
p28
sg12
S'PMC3521762'
p29
sasa(dp30
g3
VCD000284 v. 13.5 Chlorpromazine versus placebo for schizophrenia.rm5
p31
sg5
(lp32
(dp33
g8
V23388243.xml
p34
sg10
VSTD-Payne-1960
p35
sg12
S'PMC3577661'
p36
sasa(dp37
g3
VCD007146 v. 8.0 Interventions for preventing falls in older people living in the community.rm5
p38
sg5
(lp39
(dp40
g8
V17355644.xml
p41
sg10
VSTD-Lannin-2007
p42
sg12
S'PMC1832184'
p43
sa(dp44
g8
V21680622.xml
p45
sg10
VSTD-Spink-2011
p46
sg12
S'PMC3116775'
p47
sa(dp48
g8
V20501583.xml
p49
sg10
VSTD-Haran-2010
p50
sg12
S'PMC2876235'
p51
sa(dp52
g8
V20823124.xml
p53
sg10
VSTD-Conroy-2010
p54
sg12
S'PMC2956530'
p55
sa(dp56
g8
V21526229.xml
p57
sg10
VSTD-Dangour-2011
p58
sg12
S'PMC3079648'
p59
sa(dp60
g8
V20460331.xml
p61
sg10
VSTD-Logan-2010
p62
sg12
S'PMC2868162'
p63
sasa(dp64
g3
VCD005067 v. 6.0 Interventions for Old World cutaneous leishmaniasis.rm5
p65
sg5
(lp66
(dp67
g8
V17466071.xml
p68
sg10
VSTD-Nilforoushzadeh-2007
p69
sg12
S'PMC1891315'
p70
sasa(dp71
g3
VCD005482 v. 4.0 Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults.rm5
p72
sg5
(lp73
(dp74
g8
V15630469.xml
p75
sg10
VSTD-Papasavvas-2004
p76
sg12
S'PMC539050'
p77
sasa(dp78
g3
VCD005458 v. 6.0 Antibiotics for mastitis in breastfeeding women.rm5
p79
sg5
(lp80
(dp81
g8
V18476075.xml
p82
sg10
VSTD-Hager-1996
p83
sg12
S'PMC2364471'
p84
sasa(dp85
g3
VCD006726 v. 4.0 Psychological therapies for the treatment of post-traumatic stress disorder in children and adolesce.rm5
p86
sg5
(lp87
(dp88
g8
V19439099.xml
p89
sg10
VSTD-Catani-2009
p90
sg12
S'PMC2685130'
p91
sasa(dp92
g3
VCD008728 v. 2.0 Interventions for preventing falls in people after stroke.rm5
p93
sg5
(lp94
(dp95
g8
V20501583.xml
p96
sg10
VSTD-Haran-2010
p97
sg12
S'PMC2876235'
p98
sasa(dp99
g3
VCD005547 v. 5.0 Effect of administration of antihelminthics for soil transmitted helminths during pregnancy.rm5
p100
sg5
(lp101
(dp102
g8
V16371154.xml
p103
sg10
VSTD-Elliott-2005
p104
sg12
S'PMC1352364'
p105
sasa(dp106
g3
VCD006706 v. 2.0 Interventions for the prevention and treatment of herpes simplex virus in patients being treated for.rm5
p107
sg5
(lp108
(dp109
g8
V2539180.xml
p110
sg10
VSTD-Selby-1989
p111
sg12
S'PMC2247066'
p112
sa(dp113
g8
V6378236.xml
p114
sg10
VSTD-Anderson-1984
p115
sg12
S'PMC1976928'
p116
sasa(dp117
g3
VCD008726 v. 1.0 Different classes of antibiotics given to women routinely for preventing infection at caesarean sect.rm5
p118
sg5
(lp119
(dp120
g8
V9894177.xml
p121
sg10
VSTD-Noyes-1998
p122
sg12
S'PMC1784814'
p123
sasa(dp124
g3
VMR000008 v. 7.0 Methods to increase response to postal and electronic questionnaires.rm5
p125
sg5
(lp126
(dp127
g8
V18710487.xml
p128
sg10
VSTD-Jamtvedt-2008
p129
sg12
S'PMC2518288'
p130
sa(dp131
g8
V16646970.xml
p132
sg10
VSTD-Finsen-2006
p133
sg12
S'PMC1459867'
p134
sa(dp135
g8
V16250910.xml
p136
sg10
VSTD-Cockayne-2005
p137
sg12
S'PMC1280926'
p138
sa(dp139
g8
V15631963.xml
p140
sg10
VSTD-Leece-2006a
p141
sg12
S'PMC1550620'
p142
sa(dp143
g8
V15533256.xml
p144
sg10
VSTD-Roberts-2004
p145
sg12
S'PMC534094'
p146
sa(dp147
g8
V16091137.xml
p148
sg10
VSTD-McKenzie_x002d_McHarg-2005
p149
sg12
S'PMC1190172'
p150
sa(dp151
g8
V16109160.xml
p152
sg10
VSTD-Kenyon-2005
p153
sg12
S'PMC1201139'
p154
sa(dp155
g8
V15631963.xml
p156
sg10
VSTD-Leece-2006b
p157
sg12
S'PMC1550620'
p158
sa(dp159
g8
V18174120.xml
p160
sg10
VSTD-Br_x00f8_gger-2007
p161
sg12
S'PMC2270416'
p162
sa(dp163
g8
V18507819.xml
p164
sg10
VSTD-Lavelle-2008
p165
sg12
S'PMC2427026'
p166
sa(dp167
g8
V15537429.xml
p168
sg10
VSTD-Harrison-2004
p169
sg12
S'PMC534787'
p170
sa(dp171
g8
V15222889.xml
p172
sg10
VSTD-Moses-2004
p173
sg12
S'PMC449720'
p174
sa(dp175
g8
V11782286.xml
p176
sg10
VSTD-Clark-TJ-2001
p177
sg12
S'PMC64502'
p178
sasa(dp179
g3
VCD003474 v. 15.3 Bisphosphonates and other bone agents for breast cancer.rm5
p180
sg5
(lp181
(dp182
g8
V15026791.xml
p183
sg10
VSTD-Body-2004
p184
sg12
S'PMC2409647'
p185
sasa(dp186
g3
VCD005989 v. 4.0 Herbal interventions for chronic asthma in adults and children.rm5
p187
sg5
(lp188
(dp189
g8
V15154607.xml
p190
sg10
VSTD-Ziboh-2004
p191
sg12
S'PMC2275406'
p192
sasa(dp193
g3
VCD003543 v. 10.0 Interventions to improve antibiotic prescribing practices for hospital inpatients.rm5
p194
sg5
(lp195
(dp196
g8
V12095438.xml
p197
sg10
VSTD-Fridkin-2002
p198
sg12
S'PMC3369588'
p199
sasa(dp200
g3
VCD003650 v. 8.0 Micronutrient supplementation in children and adults with HIV infection.rm5
p201
sg5
(lp202
(dp203
g8
V17593956.xml
p204
sg10
VSTD-Luabeya-2007
p205
sg12
S'PMC1891438'
p206
sasa(dp207
g3
VCD009153 v. 5.0 Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples.rm5
p208
sg5
(lp209
(dp210
g8
V20472675.xml
p211
sg10
VSTD-Del-Romero-2010
p212
sg12
S'PMC2871073'
p213
sasa(dp214
g3
VCD006504 v. 4.0 Cholinesterase inhibitors for dementia with Lewy bodies Parkinson's disease dementia and cognitive .rm5
p215
sg5
(lp216
(dp217
g8
V23951200.xml
p218
sg10
VSTD-McKeith-2000
p219
sg12
S'PMC3739737'
p220
sasa(dp221
g3
VCD003672 v. 7.0 Cholinesterase inhibitors for dementia with Lewy bodies.rm5
p222
sg5
(lp223
(dp224
g8
V23951200.xml
p225
sg10
VSTD-McKeith-2000
p226
sg12
S'PMC3739737'
p227
sasa(dp228
g3
VCD008510 v. 3.7 Chinese herbal medicines for threatened miscarriage.rm5
p229
sg5
(lp230
(dp231
g8
V22904831.xml
p232
sg10
VSTD-Yang-2001
p233
sg12
S'PMC3414298'
p234
sa(dp235
g8
V23634098.xml
p236
sg10
VSTD-Liu-2008
p237
sg12
S'PMC3629611'
p238
sasa(dp239
g3
VCD008145 v. 2.2 Interventions for improving coverage of child immunization in low- and middle-income countries.rm5
p240
sg5
(lp241
(dp242
g8
V19828055.xml
p243
sg10
VSTD-Djibuti-2009
p244
sg12
S'PMC3226230'
p245
sa(dp246
g8
V19828066.xml
p247
sg10
VSTD-Andersson-2009
p248
sg12
S'PMC3226240'
p249
sasa(dp250
g3
VCD008440 v. 2.0 Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.rm5
p251
sg5
(lp252
(dp253
g8
V17713983.xml
p254
sg10
VSTD-Tonwe_x002d_Gold-2007
p255
sg12
S'PMC1949842'
p256
sasa(dp257
g3
VCD006386 v. 4.0 Interventions for the treatment of oral cavity and oropharyngeal cancer chemotherapy.rm5
p258
sg5
(lp259
(dp260
g8
V11189100.xml
p261
sg10
VSTD-Domenge-2000
p262
sg12
S'PMC2363468'
p263
sa(dp264
g8
V19875337.xml
p265
sg10
VSTD-UKHAN-2010
p266
sg12
S'PMC2806549'
p267
sasa(dp268
g3
VCD008207 v. 2.0 Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty.rm5
p269
sg5
(lp270
(dp271
g8
V18442423.xml
p272
sg10
VSTD-Lenssen-2008
p273
sg12
S'PMC2386789'
p274
sasa(dp275
g3
VCD002124 v. 5.0 Herbal and dietary therapies for primary and secondary dysmenorrhoea.rm5
p276
sg5
(lp277
(dp278
g8
V21961521.xml
p279
sg10
VSTD-Davis-1988
p280
sg12
S'PMC3195724'
p281
sasa(dp282
g3
VCD005465 v. 7.10 Interventions for preventing falls in older people in care facilities and hospitals.rm5
p283
sg5
(lp284
(dp285
g8
V18845605.xml
p286
sg10
VSTD-Kerse-2008
p287
sg12
S'PMC2565754'
p288
sa(dp289
g8
V15066200.xml
p290
sg10
VSTD-Crotty-2004b
p291
sg12
S'PMC415557'
p292
sa(dp293
g8
V17061151.xml
p294
sg10
VSTD-Stenvall-2007
p295
sg12
S'PMC1766476'
p296
sasa(dp297
g3
VCD007854 v. 3.0 Acupuncture for dysmenorrhoea.rm5
p298
sg5
(lp299
(dp300
g8
V21799683.xml
p301
sg10
VSTD-Smith-2010
p302
sg12
S'PMC3140031'
p303
sasa(dp304
g3
VCD004143 v. 6.0 Long term hormone therapy for perimenopausal and postmenopausal women.rm5
p305
sg5
(lp306
(dp307
g8
V18366766.xml
p308
sg10
VSTD-EPHT-2006
p309
sg12
S'PMC2330032'
p310
sasa(dp311
g3
VCD003868 v. 11.0 Oral morphine for cancer pain.rm5
p312
sg5
(lp313
(dp314
g8
V14647133.xml
p315
sg10
VSTD-Lauretti-2003
p316
sg12
S'PMC2376845'
p317
sasa(dp318
g3
VCD000255 v. 8.0 Antithrombotic drugs for carotid artery dissection.rm5
p319
sg5
(lp320
(dp321
g8
V17563840.xml
p322
sg10
VSTD-Campos-2007
p323
sg12
S'PMC3476141'
p324
sasa(dp325
g3
VCD006103 v. 12.0 Nicotine receptor partial agonists for smoking cessation.rm5
p326
sg5
(lp327
(dp328
g8
V18263663.xml
p329
sg10
VSTD-Aubin-2008
p330
sg12
S'PMC2569194'
p331
sa(dp332
g8
V22080588.xml
p333
sg10
VSTD-Rennard-2011
p334
sg12
S'PMC3281242'
p335
sasa(dp336
g3
VCD001359 v. 12.0 Olanzapine for schizophrenia.rm5
p337
sg5
(lp338
(dp339
g8
V21407865.xml
p340
sg10
VSTD-Avasthi-2001
p341
sg12
S'PMC2956152'
p342
sasa(dp343
g3
VCD001027 v. 14.0 Cognitive behaviour therapy for chronic fatigue syndrome in adults.rm5
p344
sg5
(lp345
(dp346
g8
V19594903.xml
p347
sg10
VSTD-King-1999
p348
sg12
S'PMC2722588'
p349
sasa(dp350
g3
VCD008653 v. 2.0 Febuxostat for treating chronic gout.rm5
p351
sg5
(lp352
(dp353
g8
V20370912.xml
p354
sg10
VSTD-Becker-2010
p355
sg12
S'PMC2888216'
p356
sasa(dp357
g3
VCD006275 v. 11.0 Non-pharmacological management of infant and young child procedural pain.rm5
p358
sg5
(lp359
(dp360
g8
V17640375.xml
p361
sg10
VSTD-Curtis-2007
p362
sg12
S'PMC1950500'
p363
sa(dp364
g8
V19448377.xml
p365
sg10
VSTD-Elserafy-2009
p366
sg12
S'PMC2813645'
p367
sasa(dp368
g3
VCD002817 v. 10.2 Physiotherapy versus placebo or no intervention in Parkinson's disease.rm5
p369
sg5
(lp370
(dp371
g8
V20976096.xml
p372
sg10
VSTD-Schilling-2008
p373
sg12
S'PMC2957327'
p374
sa(dp375
g8
V20976086.xml
p376
sg10
VSTD-de-Bruin-2010a
p377
sg12
S'PMC2957229'
p378
sa(dp379
g8
V20976086.xml
p380
sg10
VSTD-de-Bruin-2010b
p381
sg12
S'PMC2957229'
p382
sasa(dp383
g3
VCD009401 v. 3.3 Interventions to improve the use of systematic reviews in decision-making by health system managers.rm5
p384
sg5
(lp385
(dp386
g8
V19775439.xml
p387
sg10
VSTD-Dobbins-2009
p388
sg12
S'PMC2936828'
p389
sasa(dp390
g3
VCD006170 v. 4.2 Methods of milk expression for lactating women.rm5
p391
sg5
(lp392
(dp393
g8
V23991112.xml
p394
sg10
VSTD-Francis-2008
p395
sg12
S'PMC3749169'
p396
sasa(dp397
g3
VCD007070 v. 3.5 Acupuncture for treating fibromyalgia.rm5
p398
sg5
(lp399
(dp400
g8
V20331844.xml
p401
sg10
VSTD-Itoh-2010
p402
sg12
S'PMC2852376'
p403
sasa(dp404
g3
VCD009157 v. 4.0 Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.rm5
p405
sg5
(lp406
(dp407
g8
V21935312.xml
p408
sg10
VSTD-Naik-2010
p409
sg12
S'PMC3169962'
p410
sa(dp411
g8
V17370096.xml
p412
sg10
VSTD-Rutten_x002d_van-Molken-2007
p413
sg12
S'PMC1913175'
p414
sasa(dp415
g3
VMR000030 v. 3.0 Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised.rm5
p416
sg5
(lp417
(dp418
g8
V19358717.xml
p419
sg10
VSTD-Ethgen-2009
p420
sg12
S'PMC2679061'
p421
sa(dp422
g8
V20482769.xml
p423
sg10
VSTD-Yu-2010
p424
sg12
S'PMC2886040'
p425
sa(dp426
g8
V20332510.xml
p427
sg10
VSTD-Hopewell-2010
p428
sg12
S'PMC2844941'
p429
sa(dp430
g8
V19930576.xml
p431
sg10
VSTD-Partsinevelou-2009
p432
sg12
S'PMC2788535'
p433
sa(dp434
g8
V18270568.xml
p435
sg10
VSTD-Prady-2008
p436
sg12
S'PMC2216683'
p437
sa(dp438
g8
V20067642.xml
p439
sg10
VSTD-Montan_x00e9_-2010
p440
sg12
S'PMC2822812'
p441
sasa(dp442
g3
VCD002143 v. 12.0 Palliative radiotherapy regimens for non-small cell lung cancer.rm5
p443
sg5
(lp444
(dp445
g8
V15770205.xml
p446
sg10
VSTD-Senkus_x002d_Konefka-2005
p447
sg12
S'PMC2361948'
p448
sa(dp449
g8
V1705140.xml
p450
sg10
VSTD-MRC-1991
p451
sg12
S'PMC1971762'
p452
sa(dp453
g8
V1377484.xml
p454
sg10
VSTD-MRC-1992
p455
sg12
S'PMC1977779'
p456
sasa(dp457
g3
VCD008511 v. 3.0 Social skills groups for people aged 6 to 21 with autism spectrum disorders (ASD).rm5
p458
sg5
(lp459
(dp460
g8
V20058059.xml
p461
sg10
VSTD-Frankel-2010
p462
sg12
S'PMC2890979'
p463
sasa(dp464
g3
VCD003267 v. 6.2 Interventions for providers to promote a patient-centred approach in clinical consultations.rm5
p465
sg5
(lp466
(dp467
g8
V11720460.xml
p468
sg10
VSTD-Brown-2001
p469
sg12
S'PMC2375236'
p470
sasa(dp471
g3
VCD007825 v. 8.0 Collaboration between local health and local government agencies for health improvement.rm5
p472
sg5
(lp473
(dp474
g8
V23863613.xml
p475
sg10
VSTD-Rosen-2006
p476
sg12
S'PMC3734469'
p477
sa(dp478
g8
V14629776.xml
p479
sg10
VSTD-Lumley-2006
p480
sg12
S'PMC305350'
p481
sa(dp482
g8
V21680632.xml
p483
sg10
VSTD-Florence-2011
p484
sg12
S'PMC3116927'
p485
sasa(dp486
g3
VCD009577 v. 2.0 Long-acting FSH versus daily FSH for women undergoing assisted reproduction.rm5
p487
sg5
(lp488
(dp489
g8
V19684043.xml
p490
sg10
VSTD-ENGAGE-2009
p491
sg12
S'PMC2777786'
p492
sasa(dp493
g3
VCD003993 v. 4.0 Thymic peptides for treatment of cancer patients.rm5
p494
sg5
(lp495
(dp496
g8
V23618554.xml
p497
sg10
VSTD-Pavesi-1993
p498
sg12
S'PMC3640956'
p499
sasa(dp500
g3
VCD008657 v. 3.0 Housing improvements for health and associated socio-economic outcomes.rm5
p501
sg5
(lp502
(dp503
g8
V18812366.xml
p504
sg10
VSTD-Howden_x002d_Chapman-2008
p505
sg12
S'PMC2658826'
p506
sasa(dp507
g3
VCD008331 v. 2.0 Tocilizumab for rheumatoid arthritis.rm5
p508
sg5
(lp509
(dp510
g8
V18979150.xml
p511
sg10
VSTD-Nishimoto-2009-_x0028_SATORI_x0029_
p512
sg12
S'PMC2638601'
p513
sasa(dp514
g3
VCD008454 v. 2.0 Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease evidence .rm5
p515
sg5
(lp516
(dp517
g8
V21252104.xml
p518
sg10
VSTD-Driver-2011-age-matched
p519
sg12
S'PMC3023971'
p520
sa(dp521
g8
V21252104.xml
p522
sg10
VSTD-Driver-2011-age_x002b_-matched
p523
sg12
S'PMC3023971'
p524
sasa(dp525
g3
VCD002900 v. 6.0 Surgical methods for first trimester termination of pregnancy.rm5
p526
sg5
(lp527
(dp528
g8
V23040108.xml
p529
sg10
VSTD-Yin-2005
p530
sg12
S'PMC3523975'
p531
sasa(dp532
g3
VCD003189 v. 13.2 Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.rm5
p533
sg5
(lp534
(dp535
g8
V16508640.xml
p536
sg10
VSTD-Burton-2006
p537
sg12
S'PMC3216418'
p538
sasa(dp539
g3
VCD009118 v. 2.0 Osmotic and stimulant laxatives for the management of childhood constipation.rm5
p540
sg5
(lp541
(dp542
g8
V22615652.xml
p543
sg10
VSTD-Rafati-2011
p544
sg12
S'PMC3232099'
p545
sasa(dp546
g3
VCD009593 v. 3.3 Xpert MTBRIF assay for pulmonary tuberculosis and rifampicin resistance in adults.rm5
p547
sg5
(lp548
(dp549
g8
V21738575.xml
p550
sg10
VSTD-Rachow-2011
p551
sg12
S'PMC3126807'
p552
sa(dp553
g8
V21814495.xml
p554
sg10
VSTD-Scott-2011
p555
sg12
S'PMC3144192'
p556
sa(dp557
g8
V21507477.xml
p558
sg10
VSTD-Boehme-2011f
p559
sg12
S'PMC3085933'
p560
sa(dp561
g8
V21507477.xml
p562
sg10
VSTD-Boehme-2011e
p563
sg12
S'PMC3085933'
p564
sa(dp565
g8
V21507477.xml
p566
sg10
VSTD-Boehme-2011d
p567
sg12
S'PMC3085933'
p568
sa(dp569
g8
V21507477.xml
p570
sg10
VSTD-Boehme-2011c
p571
sg12
S'PMC3085933'
p572
sa(dp573
g8
V21507477.xml
p574
sg10
VSTD-Boehme-2011b
p575
sg12
S'PMC3085933'
p576
sa(dp577
g8
V21507477.xml
p578
sg10
VSTD-Boehme-2011a
p579
sg12
S'PMC3085933'
p580
sa(dp581
g8
V21818180.xml
p582
sg10
VSTD-Lawn-2011
p583
sg12
S'PMC3144215'
p584
sasa(dp585
g3
VCD008012 v. 3.0 Psychological and pharmacological interventions for depression in patients with coronary artery dise.rm5
p586
sg5
(lp587
(dp588
g8
V19742062.xml
p589
sg10
VSTD-Barth-2005
p590
sg12
S'PMC2736492'
p591
sasa(dp592
g3
VCD006086 v. 4.2 Nutritional supplements for people being treated for active tuberculosis.rm5
p593
sg5
(lp594
(dp595
g8
V20920186.xml
p596
sg10
VSTD-Pakasi-2010
p597
sg12
S'PMC2957385'
p598
sa(dp599
g8
V19858174.xml
p600
sg10
VSTD-Martins-2009
p601
sg12
S'PMC2767482'
p602
sasa(dp603
g3
VCD007064 v. 4.6 Psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed.rm5
p604
sg5
(lp605
(dp606
g8
V19018255.xml
p607
sg10
VSTD-Johansson-2008
p608
sg12
S'PMC2607225'
p609
sasa(dp610
g3
VCD008834 v. 3.0 Antiplatelet agents for chronic kidney disease.rm5
p611
sg5
(lp612
(dp613
g8
V20368925.xml
p614
sg10
VSTD-Ghorbani-2009
p615
sg12
S'PMC2847809'
p616
sasa(dp617
g3
VCD004070 v. 8.0 Vaginal chlorhexidine during labour for preventing maternal and neonatal infections (excluding Group.rm5
p618
sg5
(lp619
(dp620
g8
V18476153.xml
p621
sg10
VSTD-Eriksen-1997
p622
sg12
S'PMC2364551'
p623
sasa(dp624
g3
VCD008370 v. 5.0 Somatostatin analogues for pancreatic surgery.rm5
p625
sg5
(lp626
(dp627
g8
V21694864.xml
p628
sg10
VSTD-Katsourakis-2010
p629
sg12
S'PMC3108665'
p630
sasa(dp631
g3
VCD007072 v. 4.0 Nicotine vaccines for smoking cessation.rm5
p632
sg5
(lp633
(dp634
g8
V18575629.xml
p635
sg10
VSTD-Cornuz-2008
p636
sg12
S'PMC2432028'
p637
sasa(dp638
g3
VCD003183 v. 6.0 Medicinal herbs for hepatitis C virus infection.rm5
p639
sg5
(lp640
(dp641
g8
V23573108.xml
p642
sg10
VSTD-Yu-1995
p643
sg12
S'PMC3616209'
p644
sasa(dp645
g3
VCD008960 v. 2.0 Phyllanthus species for chronic hepatitis B virus infection.rm5
p646
sg5
(lp647
(dp648
g8
V21672207.xml
p649
sg10
VSTD-He-2008
p650
sg12
S'PMC3142497'
p651
sasa(dp652
g3
VCD003181 v. 6.0 Bile acids for viral hepatitis.rm5
p653
sg5
(lp654
(dp655
g8
V11286466.xml
p656
sg10
VSTD-Kawata-1994
p657
sg12
S'PMC2363838'
p658
sasa(dp659
g3
VCD001546 v. 7.0 Laparoscopic versus open surgery for suspected appendicitis.rm5
p660
sg5
(lp661
(dp662
g8
V17663093.xml
p663
sg10
VSTD-Ricca-2007
p664
sg12
S'PMC3015793'
p665
sasa(dp666
g3
VCD005331 v. 4.0 Psychosocial interventions for conversion disorder.rm5
p667
sg5
(lp668
(dp669
g8
V12923337.xml
p670
sg10
VSTD-Ataoglu-2003
p671
sg12
S'PMC3055095'
p672
sasa(dp673
g3
VCD007079 v. 2.0 Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy.rm5
p674
sg5
(lp675
(dp676
g8
V19165383.xml
p677
sg10
VSTD-Ettinger-2009
p678
sg12
S'PMC2627861'
p679
sasa(dp680
g3
VCD001396 v. 7.3 Selective serotonin reuptake inhibitors for premenstrual syndrome.rm5
p681
sg5
(lp682
(dp683
g8
V23675477.xml
p684
sg10
VSTD-Freeman-2010
p685
sg12
S'PMC3651198'
p686
sasa(dp687
g3
VCD009527 v. 2.0 Home- or community-based programmes for treating malaria.rm5
p688
sg5
(lp689
(dp690
g8
V20877714.xml
p691
sg10
VSTD-Yeboah_x002d_Antwi-2010
p692
sg12
S'PMC2943441'
p693
sa(dp694
g8
V18364043.xml
p695
sg10
VSTD-Kouyate-2008
p696
sg12
S'PMC2287184'
p697
sa(dp698
g8
V21750697.xml
p699
sg10
VSTD-Mubi-2011
p700
sg12
S'PMC3130036'
p701
sa(dp702
g8
V21655317.xml
p703
sg10
VSTD-Kangwana-2011
p704
sg12
S'PMC3104978'
p705
sasa(dp706
g3
VCD009350 v. 2.0 Dietary flavonoid for preventing colorectal neoplasms.rm5
p707
sg5
(lp708
(dp709
g8
V19417743.xml
p710
sg10
VSTD-Akhter-2009
p711
sg12
S'PMC2695684'
p712
sasa(dp713
g3
VCD004127 v. 7.0 Noninvasive positive pressure ventilation as a weaning strategy for intubated adults with respirator.rm5
p714
sg5
(lp715
(dp716
g8
V18439326.xml
p717
sg10
VSTD-Trevisan-2008
p718
sg12
S'PMC2447590'
p719
sasa(dp720
g3
VCD002923 v. 11.0 Penfluridol for schizophrenia.rm5
p721
sg5
(lp722
(dp723
g8
V21927264.xml
p724
sg10
VSTD-Channabasavanna-1987
p725
sg12
S'PMC3172444'
p726
sasa(dp727
g3
VCD008137 v. 1.0 The impact of conditional cash transfers on health outcomes and use of health services in low and mi.rm5
p728
sg5
(lp729
(dp730
g8
V23393551.xml
p731
sg10
VSTD-Thornton-2006
p732
sg12
S'PMC3564866'
p733
sasa(dp734
g3
VCD006894 v. 4.0 Interventions for preventing infectious complications in haemodialysis patients with central venous .rm5
p735
sg5
(lp736
(dp737
g8
V23977660.xml
p738
sg10
VSTD-Atapour-2006
p739
sg12
S'PMC3748638'
p740
sasa(dp741
g3
VCD003123 v. 11.0 Epinephrine for bronchiolitis.rm5
p742
sg5
(lp743
(dp744
g8
V17543129.xml
p745
sg10
VSTD-Beck-2007
p746
sg12
S'PMC1896161'
p747
sasa(dp748
g3
VCD001865 v. 8.4 Personalised risk communication for informed decision making about taking screening tests.rm5
p749
sg5
(lp750
(dp751
g8
V20978060.xml
p752
sg10
VSTD-Smith-2010
p753
sg12
S'PMC2965151'
p754
sa(dp755
g8
V21636633.xml
p756
sg10
VSTD-Steckelberg-2011
p757
sg12
S'PMC3106362'
p758
sasa(dp759
g3
VCD004905 v. 7.3 Multiple-micronutrient supplementation for women during pregnancy.rm5
p760
sg5
(lp761
(dp762
g8
V21596735.xml
p763
sg10
VSTD-Vadillo_x002d_Ortega-2011
p764
sg12
S'PMC3100912'
p765
sa(dp766
g8
V18996930.xml
p767
sg10
VSTD-Zeng-2008
p768
sg12
S'PMC2577799'
p769
sasa(dp770
g3
VCD003721 v. 7.2 Cancer genetic risk assessment for individuals at risk of familial breast cancer.rm5
p771
sg5
(lp772
(dp773
g8
V12915873.xml
p774
sg10
VSTD-Fry-2003
p775
sg12
S'PMC2376929'
p776
sa(dp777
g8
V17047645.xml
p778
sg10
VSTD-Young-2006
p779
sg12
S'PMC2360713'
p780
sasa(dp781
g3
VCD007862 v. 4.2 Active cycle of breathing technique for cystic fibrosis.rm5
p782
sg5
(lp783
(dp784
g8
V19703826.xml
p785
sg10
VSTD-Osman-2008
p786
sg12
S'PMC2922723'
p787
sasa(dp788
g3
VCD006370 v. 5.0 Behavioural treatments for non-epileptic attack disorder.rm5
p789
sg5
(lp790
(dp791
g8
V12923337.xml
p792
sg10
VSTD-Ataoglu-2003
p793
sg12
S'PMC3055095'
p794
sasa(dp795
g3
VCD006201 v. 5.0 Chemotherapy for second-stage Human African trypanosomiasis.rm5
p796
sg5
(lp797
(dp798
g8
V17160135.xml
p799
sg10
VSTD-Priotto-2006
p800
sg12
S'PMC1687208'
p801
sasa(dp802
g3
VCD006980 v. 5.0 Neonatal vitamin A supplementation for the prevention of mortality and morbidity in term neonates in.rm5
p803
sg5
(lp804
(dp805
g8
V20215360.xml
p806
sg10
VSTD-Benn-2010
p807
sg12
S'PMC2835853'
p808
sasa(dp809
g3
VCD005321 v. 3.0 Viscosupplementation for the treatment of osteoarthritis of the knee.rm5
p810
sg5
(lp811
(dp812
g8
V23209545.xml
p813
sg10
VSTD-Auerbach-2002a
p814
sg12
S'PMC3507824'
p815
sasa(dp816
g3
VCD001141 v. 9.4 Support for healthy breastfeeding mothers with healthy term babies.rm5
p817
sg5
(lp818
(dp819
g8
V22733107.xml
p820
sg10
VSTD-Sinclair-2007
p821
sg12
S'PMC3471286'
p822
sa(dp823
g8
V19181729.xml
p824
sg10
VSTD-Hoddinott-2009
p825
sg12
S'PMC2635594'
p826
sasa(dp827
g3
VCD005274 v. 5.2 Interventions to reduce risky sexual behaviour for preventing HIV infection in workers in occupation.rm5
p828
sg5
(lp829
(dp830
g8
V16796402.xml
p831
sg10
VSTD-Corbett-2006
p832
sg12
S'PMC1483908'
p833
sasa(dp834
g3
VCD004829 v. 5.2 Pain relief for women undergoing oocyte retrieval for assisted reproduction.rm5
p835
sg5
(lp836
(dp837
g8
V21789385.xml
p838
sg10
VSTD-Coskun-2011
p839
sg12
S'PMC3109380'
p840
sasa(dp841
g3
VCD001269 v. 13.0 Vaccines for preventing influenza in healthy adults.rm5
p842
sg5
(lp843
(dp844
g8
V19149900.xml
p845
sg10
VSTD-Beran-2009a
p846
sg12
S'PMC2639595'
p847
sasa(dp848
g3
VCD010610 v. 1.2 Topiramate for the prophylaxis of episodic migraine in adults.rm5
p849
sg5
(lp850
(dp851
g8
V21890526.xml
p852
sg10
VSTD-Varkey-2011
p853
sg12
S'PMC3236524'
p854
sasa(dp855
g3
VCD007426 v. 3.0 Relaxation therapy for preventing and treating preterm labour.rm5
p856
sg5
(lp857
(dp858
g8
V22069407.xml
p859
sg10
VSTD-Bahadoran-2010
p860
sg12
S'PMC3208940'
p861
sasa(dp862
g3
VCD008033 v. 3.2 Reduction versus abrupt cessation in smokers who want to quit.rm5
p863
sg5
(lp864
(dp865
g8
V22852768.xml
p866
sg10
VSTD-Riley-2005
p867
sg12
S'PMC3479413'
p868
sasa(dp869
g3
VCD004778 v. 7.0 Laparoscopic repair for perforated peptic ulcer disease.rm5
p870
sg5
(lp871
(dp872
g8
V19430829.xml
p873
sg10
VSTD-Bertleff-2009
p874
sg12
S'PMC2691927'
p875
sasa(dp876
g3
VCD006207 v. 9.1 Physical interventions to interrupt or reduce the spread of respiratory viruses.rm5
p877
sg5
(lp878
(dp879
g8
V19284644.xml
p880
sg10
VSTD-Chen-2009
p881
sg12
S'PMC2666722'
p882
sa(dp883
g8
V18461182.xml
p884
sg10
VSTD-Cowling-2008
p885
sg12
S'PMC2364646'
p886
sa(dp887
g8
V15030685.xml
p888
sg10
VSTD-Wu-2004
p889
sg12
S'PMC3322931'
p890
sa(dp891
g8
V19193267.xml
p892
sg10
VSTD-MacIntyre-2009
p893
sg12
S'PMC2662657'
p894
sa(dp895
g8
V15200846.xml
p896
sg10
VSTD-Lau-2004a
p897
sg12
S'PMC3323085'
p898
sa(dp899
g8
V20353566.xml
p900
sg10
VSTD-Cowling-2010
p901
sg12
S'PMC3152767'
p902
sasa(dp903
g3
VCD006095 v. 3.0 Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.rm5
p904
sg5
(lp905
(dp906
g8
V22371721.xml
p907
sg10
VSTD-Psaradellis-2010
p908
sg12
S'PMC3278944'
p909
sasa(dp910
g3
VCD005413 v. 4.0 Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma.rm5
p911
sg5
(lp912
(dp913
g8
V11870502.xml
p914
sg10
VSTD-Atzpodien-2002
p915
sg12
S'PMC2375173'
p916
sa(dp917
g8
V9579834.xml
p918
sg10
VSTD-Johnston-1998
p919
sg12
S'PMC2150174'
p920
sasa(dp921
g3
VCD003195 v. 6.4 Urodynamic studies for management of urinary incontinence in children and adults.rm5
p922
sg5
(lp923
(dp924
g8
V22833787.xml
p925
sg10
VSTD-Kristjansson-1999
p926
sg12
S'PMC3402187'
p927
sasa(dp928
g3
VCD004699 v. 7.0 Surgery for local and locally advanced non-small cell lung cancer.rm5
p929
sg5
(lp930
(dp931
g8
V9744511.xml
p932
sg10
VSTD-Shepherd-1998
p933
sg12
S'PMC2063048'
p934
sasa(dp935
g3
VCD007978 v. 3.0 Email for clinical communication between patientscaregivers and healthcare professionals.rm5
p936
sg5
(lp937
(dp938
g8
V16236699.xml
p939
sg10
VSTD-Lin-2005
p940
sg12
S'PMC1550679'
p941
sa(dp942
g8
V15249261.xml
p943
sg10
VSTD-Ross-2004
p944
sg12
S'PMC1550594'
p945
sasa(dp946
g3
VCD001871 v. 13.12 Interventions for preventing obesity in children.rm5
p947
sg5
(lp948
(dp949
g8
V19765270.xml
p950
sg10
VSTD-Gentile-2009
p951
sg12
S'PMC2758893'
p952
sa(dp953
g8
V17718785.xml
p954
sg10
VSTD-Lazaar-2007
p955
sg12
S'PMC2040215'
p956
sasa(dp957
g3
VCD006188 v. 3.0 Surgical interventions for the rheumatoid shoulder.rm5
p958
sg5
(lp959
(dp960
g8
V17683577.xml
p961
sg10
VSTD-Rosenberg-2007
p962
sg12
S'PMC1964758'
p963
sasa(dp964
g3
VCD000409 v. 7.0 Educational outreach visits effects on professional practice and health care outcomes.rm5
p965
sg5
(lp966
(dp967
g8
V15066200.xml
p968
sg10
VSTD-Crotty-2004
p969
sg12
S'PMC415557'
p970
sa(dp971
g8
V16737349.xml
p972
sg10
VSTD-Fretheim-2006
p973
sg12
S'PMC1472698'
p974
sasa(dp975
g3
VCD004826 v. 5.0 Probiotics for maintenance of remission in Crohn's disease.rm5
p976
sg5
(lp977
(dp978
g8
V15113451.xml
p979
sg10
VSTD-Schultz-2004
p980
sg12
S'PMC394324'
p981
sasa(dp982
g3
VCD009021 v. 2.0 Exercise for pregnant women for preventing gestational diabetes mellitus.rm5
p983
sg5
(lp984
(dp985
g8
V20357374.xml
p986
sg10
VSTD-Callaway-2010
p987
sg12
S'PMC2890340'
p988
sasa(dp989
g3
VMR000009 v. 8.2 Outcomes of patients who participate in randomized controlled trials compared to similar patients re.rm5
p990
sg5
(lp991
(dp992
g8
V12237770.xml
p993
sg10
VSTD-Bijker-2000b
p994
sg12
S'PMC2364244'
p995
sa(dp996
g8
V12237770.xml
p997
sg10
VSTD-Bijker-2000a
p998
sg12
S'PMC2364244'
p999
sasa(dp1000
g3
VCD007145 v. 2.0 Interventions for preventing excessive weight gain during pregnancy.rm5
p1001
sg5
(lp1002
(dp1003
g8
V20357374.xml
p1004
sg10
VSTD-Callaway-2010
p1005
sg12
S'PMC2890340'
p1006
sa(dp1007
g8
V21429234.xml
p1008
sg10
VSTD-Korpi_x002d_Hyovalti-2011
p1009
sg12
S'PMC3078095'
p1010
sa(dp1011
g8
V19279301.xml
p1012
sg10
VSTD-Moses-2009
p1013
sg12
S'PMC2681032'
p1014
sa(dp1015
g8
V21610860.xml
p1016
sg10
VSTD-Luoto-2011
p1017
sg12
S'PMC3096610'
p1018
sasa(dp1019
g3
VCD007821 v. 2.0 Heated CO2 with or without humidification for minimally invasive abdominal surgery.rm5
p1020
sg5
(lp1021
(dp1022
g8
V10036122.xml
p1023
sg10
VSTD-Ott-1998
p1024
sg12
S'PMC3015252'
p1025
sasa(dp1026
g3
VCD004946 v. 4.0 Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) rec.rm5
p1027
sg5
(lp1028
(dp1029
g8
V12530483.xml
p1030
sg10
VSTD-Scott-2002
p1031
sg12
S'PMC1784606'
p1032
sasa(dp1033
g3
VCD007303 v. 3.2 Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient d.rm5
p1034
sg5
(lp1035
(dp1036
g8
V12671693.xml
p1037
sg10
VSTD-Boogaerts-2003
p1038
sg12
S'PMC2376376'
p1039
sa(dp1040
g8
V16570051.xml
p1041
sg10
VSTD-Wilkinson-2006
p1042
sg12
S'PMC2361228'
p1043
sasa(dp1044
g3
VCD007362 v. 2.11 Sugammadex a selective reversal medication for preventing postoperative residual neuromuscular bloc.rm5
p1045
sg5
(lp1046
(dp1047
g8
V20809967.xml
p1048
sg10
VSTD-Lemmens-2007
p1049
sg12
S'PMC2944304'
p1050
sasa(dp1051
g3
VCD007355 v. 6.0 Single dose oral ketoprofen and dexketoprofen for acute postoperative pain in adults.rm5
p1052
sg5
(lp1053
(dp1054
g8
V22558179.xml
p1055
sg10
VSTD-Harrison-1996
p1056
sg12
S'PMC3340390'
p1057
sasa(dp1058
g3
VCD007480 v. 2.0 Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age.rm5
p1059
sg5
(lp1060
(dp1061
g8
V20215360.xml
p1062
sg10
VSTD-Benn-2010
p1063
sg12
S'PMC2835853'
p1064
sasa(dp1065
g3
VCD004416 v. 6.0 Oral evening primrose oil and borage oil for eczema.rm5
p1066
sg5
(lp1067
(dp1068
g8
V22905031.xml
p1069
sg10
VSTD-MacKie-Child-1990
p1070
sg12
S'PMC3417576'
p1071
sa(dp1072
g8
V22905031.xml
p1073
sg10
VSTD-MacKie-Adult-1990
p1074
sg12
S'PMC3417576'
p1075
sasa(dp1076
g3
VCD006198 v. 3.0 Vaccines for preventing malaria (pre-erythrocytic).rm5
p1077
sg5
(lp1078
(dp1079
g8
V15526058.xml
p1080
sg10
VSTD-Moorthy-2004b
p1081
sg12
S'PMC524376'
p1082
sasa(dp1083
g3
VCD000033 v. 9.12 Barbiturates for acute traumatic brain injury.rm5
p1084
sg5
(lp1085
(dp1086
g8
V18759980.xml
p1087
sg10
VSTD-P_x00e9_rez_x002d_B_x00e1_rcena-2008
p1088
sg12
S'PMC2575601'
p1089
sasa(dp1090
g3
VCD009557 v. 2.0 Fibrin glue instillation under skin flaps to prevent seroma-related morbidity following breast and a.rm5
p1091
sg5
(lp1092
(dp1093
g8
V19270819.xml
p1094
sg10
VSTD-Ko-2009
p1095
sg12
S'PMC2650992'
p1096
sasa(dp1097
g3
VCD004492 v. 9.0 Stage-based interventions for smoking cessation.rm5
p1098
sg5
(lp1099
(dp1100
g8
V17995993.xml
p1101
sg10
VSTD-Meyer-2008
p1102
sg12
S'PMC2253708'
p1103
sa(dp1104
g8
V18304363.xml
p1105
sg10
VSTD-Young-2008
p1106
sg12
S'PMC2268921'
p1107
sasa(dp1108
g3
VCD000371 v. 15.4 Deworming drugs for soil-transmitted intestinal worms in children effects on nutritional indicators.rm5
p1109
sg5
(lp1110
(dp1111
g8
V18414647.xml
p1112
sg10
VSTD-Awasthi-2008-_x0028_Cluster_x0029_
p1113
sg12
S'PMC2291568'
p1114
sa(dp1115
g8
V20858280.xml
p1116
sg10
VSTD-Kirwan-2010
p1117
sg12
S'PMC3161357'
p1118
sasa(dp1119
g3
VCD009517 v. 2.6 Endometrial injury in women undergoing assisted reproductive techniques.rm5
p1120
sg5
(lp1121
(dp1122
g8
V20607003.xml
p1123
sg10
VSTD-Narvekar-2010
p1124
sg12
S'PMC2890904'
p1125
sasa(dp1126
g3
VCD007253 v. 5.13 Interventions for smoking cessation and reduction in individuals with schizophrenia.rm5
p1127
sg5
(lp1128
(dp1129
g8
V18568115.xml
p1130
sg10
VSTD-_x005e_Horst-2005
p1131
sg12
S'PMC2424122'
p1132
sa(dp1133
g8
V21407853.xml
p1134
sg10
VSTD-_x002a_Williams-2012
p1135
sg12
S'PMC2955947'
p1136
sasa(dp1137
g3
VCD009318 v. 2.0 Lacosamide for neuropathic pain and fibromyalgia in adults.rm5
p1138
sg5
(lp1139
(dp1140
g8
V20067958.xml
p1141
sg10
VSTD-Ziegler-2010
p1142
sg12
S'PMC2845038'
p1143
sasa(dp1144
g3
VCD009232 v. 2.0 Acupuncture or acupressure for pain management in labour.rm5
p1145
sg5
(lp1146
(dp1147
g8
V17342250.xml
p1148
sg10
VSTD-Qu-2007
p1149
sg12
S'PMC1810361'
p1150
sasa(dp1151
g3
VCD009997 v. 1.0 Intermittent oral iron supplementation during pregnancy.rm5
p1152
sg5
(lp1153
(dp1154
g8
V22026956.xml
p1155
sg10
VSTD-Bouzari-2011
p1156
sg12
S'PMC3217057'
p1157
sa(dp1158
g8
V22162919.xml
p1159
sg10
VSTD-Yekta-2011
p1160
sg12
S'PMC3233526'
p1161
sasa(dp1162
g3
VCD005463 v. 3.2 Individual and group-based parenting programmes for the treatment of physical child abuse and neglec.rm5
p1163
sg5
(lp1164
(dp1165
g8
V23476865.xml
p1166
sg10
VSTD-Egan-1983
p1167
sg12
S'PMC3582081'
p1168
sasa(dp1169
g3
VCD005566 v. 4.0 Prophylactic corticosteroids for cardiopulmonary bypass in adults.rm5
p1170
sg5
(lp1171
(dp1172
g8
V17547746.xml
p1173
sg10
VSTD-Starobin-2007
p1174
sg12
S'PMC1892551'
p1175
sasa(dp1176
g3
VCD006761 v. 5.0 Conventional versus LigaSure hemorrhoidectomy for patients with symptomatic Hemorrhoids.rm5
p1177
sg5
(lp1178
(dp1179
g8
V18545884.xml
p1180
sg10
VSTD-Tan-2008
p1181
sg12
S'PMC2780654'
p1182
sasa(dp1183
g3
VCD009513 v. 1.0 Interventions to improve adherence to antiretroviral therapy in children with HIV infection.rm5
p1184
sg5
(lp1185
(dp1186
g8
V19549342.xml
p1187
sg10
VSTD-Wamalwa-2009
p1188
sg12
S'PMC2708138'
p1189
sasa(dp1190
g3
VCD005436 v. 5.0 Oral zinc for treating diarrhoea in children.rm5
p1191
sg5
(lp1192
(dp1193
g8
V19416499.xml
p1194
sg10
VSTD-Patel-2009
p1195
sg12
S'PMC2684117'
p1196
sa(dp1197
g8
V19416499.xml
p1198
sg10
VSTD-Patel-2009a-_x0028_zinc_x0029_
p1199
sg12
S'PMC2684117'
p1200
sa(dp1201
g8
V19416499.xml
p1202
sg10
VSTD-Patel-2009b-_x0028_zinc_x002b_copper_x0029_
p1203
sg12
S'PMC2684117'
p1204
sasa(dp1205
g3
VCD001418 v. 8.0 Chemotherapy for advanced ovarian cancer.rm5
p1206
sg5
(lp1207
(dp1208
g8
V1739629.xml
p1209
sg10
VSTD-d-SGCTG-1986
p1210
sg12
S'PMC1977737'
p1211
sasa(dp1212
g3
VCD000165 v. 14.0 Physician advice for smoking cessation.rm5
p1213
sg5
(lp1214
(dp1215
g8
V17995993.xml
p1216
sg10
VSTD-Meyer-2008
p1217
sg12
S'PMC2253708'
p1218
sa(dp1219
g8
V17372796.xml
p1220
sg10
VSTD-Unrod-2007
p1221
sg12
S'PMC1829425'
p1222
sasa(dp1223
g3
VCD006534 v. 4.0 Citalopram versus other anti-depressive agents for depression.rm5
p1224
sg5
(lp1225
(dp1226
g8
V21206792.xml
p1227
sg10
VSTD-Lalit-2004
p1228
sg12
S'PMC2950952'
p1229
sasa(dp1230
g3
VCD009620 v. 2.0 Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer.rm5
p1231
sg5
(lp1232
(dp1233
g8
V10735496.xml
p1234
sg10
VSTD-Windbichler-2000
p1235
sg12
S'PMC2363351'
p1236
sa(dp1237
g8
V15305182.xml
p1238
sg10
VSTD-Hall-2004
p1239
sg12
S'PMC2364769'
p1240
sasa(dp1241
g3
VCD004912 v. 5.0 Drugs for treating uncomplicated malaria in pregnant women.rm5
p1242
sg5
(lp1243
(dp1244
g8
V18000538.xml
p1245
sg10
VSTD-Kalilani-2007
p1246
sg12
S'PMC2048661'
p1247
sa(dp1248
g8
V16776817.xml
p1249
sg10
VSTD-Coulibaly-2006
p1250
sg12
S'PMC1533839'
p1251
sasa(dp1252
g3
VCD000448 v. 10.0 St John's wort for major depression.rm5
p1253
sg5
(lp1254
(dp1255
g8
V16796730.xml
p1256
sg10
VSTD-Kasper-2006
p1257
sg12
S'PMC1538611'
p1258
sasa(dp1259
g3
VCD005007 v. 5.3 Hyperbaric oxygenation for tumour sensitisation to radiotherapy.rm5
p1260
sg5
(lp1261
(dp1262
g8
V4854060.xml
p1263
sg10
VSTD-Van-Den-Brenk-1968
p1264
sg12
S'PMC2009013'
p1265
sasa(dp1266
g3
VCD001841 v. 7.0 First-line drugs for hypertension.rm5
p1267
sg5
(lp1268
(dp1269
g8
V23704171.xml
p1270
sg10
VSTD-Carter
p1271
sg12
S'PMC3662830'
p1272
sasa(dp1273
g3
VCD003514 v. 7.0 Bed rest with or without hospitalisation for hypertension during pregnancy.rm5
p1274
sg5
(lp1275
(dp1276
g8
V23642125.xml
p1277
sg10
VSTD-Crowther-1986
p1278
sg12
S'PMC3655914'
p1279
sasa(dp1280
g3
VCD003289 v. 8.0 Tobacco cessation interventions for young people.rm5
p1281
sg5
(lp1282
(dp1283
g8
V17173716.xml
p1284
sg10
VSTD-Horn-2007
p1285
sg12
S'PMC1832131'
p1286
sasa(dp1287
g3
VCD006317 v. 4.0 Radiofrequency ablation in the treatment of liver metastases from colorectal cancer.rm5
p1288
sg5
(lp1289
(dp1290
g8
V20148084.xml
p1291
sg10
VSTD-McKay-2009
p1292
sg12
S'PMC2817867'
p1293
sa(dp1294
g8
V22066097.xml
p1295
sg10
VSTD-Kim-2011
p1296
sg12
S'PMC3204557'
p1297
sasa(dp1298
g3
VCD004873 v. 9.0 Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old.rm5
p1299
sg5
(lp1300
(dp1301
g8
V20927359.xml
p1302
sg10
VSTD-Gajdos-2010
p1303
sg12
S'PMC2946956'
p1304
sasa(dp1305
g3
VCD004736 v. 7.0 Daily oral iron supplementation during pregnancy.rm5
p1306
sg5
(lp1307
(dp1308
g8
V18996930.xml
p1309
sg10
VSTD-Zeng-2008-_x0028_C_x0029_
p1310
sg12
S'PMC2577799'
p1311
sasa(dp1312
g3
VCD003648 v. 8.0 Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection.rm5
p1313
sg5
(lp1314
(dp1315
g8
V21177735.xml
p1316
sg10
VSTD-Humphrey-2006
p1317
sg12
S'PMC3007097'
p1318
sasa(dp1319
g3
VCD002302 v. 5.0 Pressure-relieving interventions for treating diabetic foot ulcers.rm5
p1320
sg5
(lp1321
(dp1322
g8
V20357377.xml
p1323
sg10
VSTD-Faglia-2010
p1324
sg12
S'PMC2890332'
p1325
sasa(dp1326
g3
VCD003688 v. 7.0 Patient education for adults with rheumatoid arthritis.rm5
p1327
sg5
(lp1328
(dp1329
g8
V21540202.xml
p1330
sg10
VSTD-Hewlett-1999
p1331
sg12
S'PMC3086034'
p1332
sasa(dp1333
g3
VCD002142 v. 13.0 Postoperative radiotherapy for non-small cell lung cancer.rm5
p1334
sg5
(lp1335
(dp1336
g8
V8761382.xml
p1337
sg10
VSTD-MRC-LU11
p1338
sg12
S'PMC2074683'
p1339
sasa(dp1340
g3
VCD006953 v. 3.6 Psychosocial interventions for reducing fatigue during cancer treatment in adults.rm5
p1341
sg5
(lp1342
(dp1343
g8
V11747326.xml
p1344
sg10
VSTD-Faithfull-2001
p1345
sg12
S'PMC2364007'
p1346
sasa(dp1347
g3
VCD006438 v. 4.0 Open surgical procedures for incisional hernias.rm5
p1348
sg5
(lp1349
(dp1350
g8
V17372669.xml
p1351
sg10
VSTD-de-Vries-2007a
p1352
sg12
S'PMC1913177'
p1353
sasa(dp1354
g3
VCD009243 v. 3.0 Antispasmodics for labour.rm5
p1355
sg5
(lp1356
(dp1357
g8
V21495198.xml
p1358
sg10
VSTD-Makvandi-2010
p1359
sg12
S'PMC3081214'
p1360
sasa(dp1361
g3
VCD003962 v. 6.0 Non-immunosuppressive treatment for IgA nephropathy.rm5
p1362
sg5
(lp1363
(dp1364
g8
V17497466.xml
p1365
sg10
VSTD-Horita-2007
p1366
sg12
S'PMC2409178'
p1367
sasa(dp1368
g3
VCD010538 v. 2.0 Topical herbal therapies for treating osteoarthritis.rm5
p1369
sg5
(lp1370
(dp1371
g8
V22427772.xml
p1372
sg10
VSTD-Soltanian-2010
p1373
sg12
S'PMC3302710'
p1374
sa(dp1375
g8
V22454655.xml
p1376
sg10
VSTD-Wang-2012
p1377
sg12
S'PMC3292236'
p1378
sasa(dp1379
g3
VCD005654 v. 4.0 Pelvic floor muscle training versus no treatment or inactive control treatments for urinary incont.rm5
p1380
sg5
(lp1381
(dp1382
g8
V18719756.xml
p1383
sg10
VSTD-Castro-2008
p1384
sg12
S'PMC2664121'
p1385
sasa(dp1386
g3
VCD008285 v. 2.0 Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer individual patien.rm5
p1387
sg5
(lp1388
(dp1389
g8
V22815624.xml
p1390
sg10
VSTD-Pras-1995
p1391
sg12
S'PMC3399783'
p1392
sasa(dp1393
g3
VCD005195 v. 9.0 Selenium for preventing cancer.rm5
p1394
sg5
(lp1395
(dp1396
g8
V16175184.xml
p1397
sg10
VSTD-Michaud-2005
p1398
sg12
S'PMC2361644'
p1399
sasa(dp1400
g3
VCD004879 v. 9.0 Vaccines for preventing influenza in healthy children.rm5
p1401
sg5
(lp1402
(dp1403
g8
V22110695.xml
p1404
sg10
VSTD-ba-Kissling-2011
p1405
sg12
S'PMC3216983'
p1406
sa(dp1407
g8
V21379316.xml
p1408
sg10
VSTD-ba-Valenciano-2011
p1409
sg12
S'PMC3019108'
p1410
sa(dp1411
g8
V21060780.xml
p1412
sg10
VSTD-ab-Mallory-2010
p1413
sg12
S'PMC2966412'
p1414
sasa(dp1415
g3
VCD003193 v. 6.2 Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrom.rm5
p1416
sg5
(lp1417
(dp1418
g8
V17179687.xml
p1419
sg10
VSTD-Song-2006
p1420
sg12
S'PMC2721929'
p1421
sa(dp1422
g8
V18324952.xml
p1423
sg10
VSTD-Chancellor-2008
p1424
sg12
S'PMC2325270'
p1425
sasa(dp1426
g3
VCD004294 v. 6.3 Physical rehabilitation for older people in long-term care.rm5
p1427
sg5
(lp1428
(dp1429
g8
V16372905.xml
p1430
sg10
VSTD-Bautmans-2005
p1431
sg12
S'PMC1368976'
p1432
sa(dp1433
g8
V18845605.xml
p1434
sg10
VSTD-Kerse-2008
p1435
sg12
S'PMC2565754'
p1436
sa(dp1437
g8
V19723707.xml
p1438
sg10
VSTD-Sackley-2009
p1439
sg12
S'PMC2736373'
p1440
sa(dp1441
g8
V15233841.xml
p1442
sg10
VSTD-Chin-A-Paw-2004
p1443
sg12
S'PMC471553'
p1444
sasa(dp1445
g3
VCD001190 v. 14.0 Donepezil for dementia due to Alzheimer's disease.rm5
p1446
sg5
(lp1447
(dp1448
g8
V21455360.xml
p1449
sg10
VSTD-Study-315
p1450
sg12
S'PMC2962290'
p1451
sasa(dp1452
g3
VCD004310 v. 8.0 Megestrol acetate for treatment of anorexia-cachexia syndrome.rm5
p1453
sg5
(lp1454
(dp1455
g8
V8664133.xml
p1456
sg10
VSTD-Gebbia-1996
p1457
sg12
S'PMC2074540'
p1458
sasa(dp1459
g3
VCD005083 v. 7.0 Honey as a topical treatment for wounds.rm5
p1460
sg5
(lp1461
(dp1462
g8
V21189872.xml
p1463
sg10
VSTD-Subrahmanyam-1996a
p1464
sg12
S'PMC2991644'
p1465
sa(dp1466
g8
V20640210.xml
p1467
sg10
VSTD-Subrahmanyam-1996c
p1468
sg12
S'PMC2894501'
p1469
sa(dp1470
g8
V17466071.xml
p1471
sg10
VSTD-Nilforoushzadeh-2007
p1472
sg12
S'PMC1891315'
p1473
sa(dp1474
g8
V20368852.xml
p1475
sg10
VSTD-Baghel-2009
p1476
sg12
S'PMC2845359'
p1477
sa(dp1478
g8
V20640210.xml
p1479
sg10
VSTD-Subrahmanyam-1993b
p1480
sg12
S'PMC2894501'
p1481
sasa(dp1482
g3
VCD002139 v. 10.0 Chemotherapy for non-small cell lung cancer.rm5
p1483
sg5
(lp1484
(dp1485
g8
V3907687.xml
p1486
sg10
VSTD-a01-MRC-LU02
p1487
sg12
S'PMC1977284'
p1488
sa(dp1489
g8
V1691921.xml
p1490
sg10
VSTD-d04-RLW-8351
p1491
sg12
S'PMC1971367'
p1492
sa(dp1493
g8
V1691921.xml
p1494
sg10
VSTD-d06-Southampton
p1495
sg12
S'PMC1971367'
p1496
sasa(dp1497
g3
VCD006017 v. 4.4 Targeted therapy for advanced renal cell carcinoma.rm5
p1498
sg5
(lp1499
(dp1500
g8
V14562010.xml
p1501
sg10
VSTD-Madhusudan-2004
p1502
sg12
S'PMC2394342'
p1503
sasa(dp1504
g3
VCD006625 v. 3.0 Quetiapine versus other atypical antipsychotics for schizophrenia.rm5
p1505
sg5
(lp1506
(dp1507
g8
V23869281.xml
p1508
sg10
VSTD-Li-2003
p1509
sg12
S'PMC3707322'
p1510
sasa(dp1511
g3
VCD010118 v. 2.0 Preoperative physical therapy for elective cardiac surgery patients.rm5
p1512
sg5
(lp1513
(dp1514
g8
V21385466.xml
p1515
sg10
VSTD-Rosenfeldt-2011
p1516
sg12
S'PMC3063826'
p1517
sasa(dp1518
g3
VCD002068 v. 9.0 Bisphosphonates for the relief of pain secondary to bone metastases.rm5
p1519
sg5
(lp1520
(dp1521
g8
V9328156.xml
p1522
sg10
VSTD-Kylmala-1997
p1523
sg12
S'PMC2228066'
p1524
sasa(dp1525
g3
VCD006924 v. 4.0 Regular treatment with formoterol and inhaled steroids for chronic asthma serious adverse events.rm5
p1526
sg5
(lp1527
(dp1528
g8
V17887990.xml
p1529
sg10
VSTD-Morice-2007
p1530
sg12
S'PMC2228375'
p1531
sasa(dp1532
g3
VCD006094 v. 3.0 Interventions for improving the appropriate use of imaging in people with musculoskeletal conditions.rm5
p1533
sg5
(lp1534
(dp1535
g8
V17356969.xml
p1536
sg10
VSTD-Solomon-2007a
p1537
sg12
S'PMC1824772'
p1538
sa(dp1539
g8
V17356966.xml
p1540
sg10
VSTD-Lafata-2007
p1541
sg12
S'PMC1824751'
p1542
sasa(dp1543
g3
VCD003137 v. 10.0 Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chron.rm5
p1544
sg5
(lp1545
(dp1546
g8
V17897478.xml
p1547
sg10
VSTD-Pavord-2007
p1548
sg12
S'PMC2174463'
p1549
sasa(dp1550
g3
VCD002225 v. 7.0 Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix.rm5
p1551
sg5
(lp1552
(dp1553
g8
V22815624.xml
p1554
sg10
VSTD-Pras-2000
p1555
sg12
S'PMC3399783'
p1556
sasa(dp1557
g3
VMR000005 v. 6.0 Full publication of results initially presented in abstracts.rm5
p1558
sg5
(lp1559
(dp1560
g8
V21324139.xml
p1561
sg10
VSTD-Todd-1997
p1562
sg12
S'PMC3055815'
p1563
sa(dp1564
g8
V11978183.xml
p1565
sg10
VSTD-Timmer-2002
p1566
sg12
S'PMC115863'
p1567
sasa(dp1568
g3
VCD007470 v. 4.2 Vitamin D supplementation for prevention of mortality in adults.rm5
p1569
sg5
(lp1570
(dp1571
g8
V17874029.xml
p1572
sg10
VSTD-Chel-2008
p1573
sg12
S'PMC2277446'
p1574
sasa(dp1575
g3
VCD000543 v. 11.18 Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.rm5
p1576
sg5
(lp1577
(dp1578
g8
V20049950.xml
p1579
sg10
VSTD-Ito-2010
p1580
sg12
S'PMC2972638'
p1581
sa(dp1582
g8
V18832520.xml
p1583
sg10
VSTD-Kruis-2009
p1584
sg12
S'PMC3269751'
p1585
sasa(dp1586
g3
VCD002117 v. 7.0 Tricyclic and related drugs for nocturnal enuresis in children.rm5
p1587
sg5
(lp1588
(dp1589
g8
V22058522.xml
p1590
sg10
VSTD-Khorana-1972
p1591
sg12
S'PMC3013192'
p1592
sasa(dp1593
g3
VCD000057 v. 7.0 Clomiphene citrate for unexplained subfertility in women.rm5
p1594
sg5
(lp1595
(dp1596
g8
V18687718.xml
p1597
sg10
VSTD-Battacharya-2008
p1598
sg12
S'PMC2505091'
p1599
sasa(dp1600
g3
VCD006536 v. 5.0 Stem cell treatment for acute myocardial infarction.rm5
p1601
sg5
(lp1602
(dp1603
g8
V19508995.xml
p1604
sg10
VSTD-Cao-2009
p1605
sg12
S'PMC2726958'
p1606
sasa(dp1607
g3
VCD000330 v. 12.0 Enemas during labour.rm5
p1608
sg5
(lp1609
(dp1610
g8
V16545140.xml
p1611
sg10
VSTD-Cuervo-2006
p1612
sg12
S'PMC1468428'
p1613
sasa(dp1614
g3
VCD010119 v. 2.0 Integration of HIVAIDS services with maternal neonatal and child health nutrition and family pla.rm5
p1615
sg5
(lp1616
(dp1617
g8
V18671876.xml
p1618
sg10
VSTD-Bahwere-2008
p1619
sg12
S'PMC2536666'
p1620
sasa(dp1621
g3
VCD008602 v. 3.2 Interventions for congenital talipes equinovarus (clubfoot).rm5
p1622
sg5
(lp1623
(dp1624
g8
V20419009.xml
p1625
sg10
VSTD-Rijal-2010
p1626
sg12
S'PMC2856397'
p1627
sasa(dp1628
g3
VCD005315 v. 3.3 Sensory environment on health-related outcomes of hospital patients.rm5
p1629
sg5
(lp1630
(dp1631
g8
V18493472.xml
p1632
sg10
VSTD-Kotwal-1998
p1633
sg12
S'PMC2362603'
p1634
sasa(dp1635
g3
VCD004827 v. 6.3 Probiotics for the prevention of pediatric antibiotic-associated diarrhea.rm5
p1636
sg5
(lp1637
(dp1638
g8
V15546485.xml
p1639
sg10
VSTD-Destura-unpublished
p1640
sg12
S'PMC543444'
p1641
sasa(dp1642
g3
VCD009163 v. 2.5 Antibiotics for otitis media with effusion in children.rm5
p1643
sg5
(lp1644
(dp1645
g8
V18513453.xml
p1646
sg10
VSTD-Leach-2008
p1647
sg12
S'PMC2443129'
p1648
sa(dp1649
g8
V19434268.xml
p1650
sg10
VSTD-Choung-2008
p1651
sg12
S'PMC2671765'
p1652
sasa(dp1653
g3
VCD009098 v. 3.0 High versus low positive end-expiratory pressure (PEEP) levels for mechanically ventilated adult pat.rm5
p1654
sg5
(lp1655
(dp1656
g8
V19239703.xml
p1657
sg10
VSTD-Huh-2009
p1658
sg12
S'PMC2688140'
p1659
sasa(dp1660
g3
VCD004085 v. 5.2 High-frequency ventilation versus conventional ventilation for treatment of acute lung injury and ac.rm5
p1661
sg5
(lp1662
(dp1663
g8
V16137357.xml
p1664
sg10
VSTD-Bollen-2005
p1665
sg12
S'PMC1269459'
p1666
sasa(dp1667
g3
VCD006667 v. 5.0 Recruitment manoeuvres for adults with acute lung injury receiving mechanical ventilation.rm5
p1668
sg5
(lp1669
(dp1670
g8
V12617741.xml
p1671
sg10
VSTD-Dyhr-2003
p1672
sg12
S'PMC154111'
p1673
sasa(dp1674
g3
VCD009223 v. 3.0 Non-opioid drugs for pain management in labour.rm5
p1675
sg5
(lp1676
(dp1677
g8
V21495198.xml
p1678
sg10
VSTD-Makvandi-2011
p1679
sg12
S'PMC3081214'
p1680
sasa(dp1681
g3
VCD007477 v. 5.0 Deferasirox for managing transfusional iron overload in people with sickle cell disease.rm5
p1682
sg5
(lp1683
(dp1684
g8
V17233848.xml
p1685
sg10
VSTD-Vichinsky-2007
p1686
sg12
S'PMC1974786'
p1687
sasa(dp1688
g3
VCD004087 v. 4.8 Pharmacological agents for preventing morbidity associated with the haemodynamic response to trachea.rm5
p1689
sg5
(lp1690
(dp1691
g8
V21804705.xml
p1692
sg10
VSTD-Bafna-2011
p1693
sg12
S'PMC3146157'
p1694
sa(dp1695
g8
V22247722.xml
p1696
sg10
VSTD-Montazeri-2011
p1697
sg12
S'PMC3252769'
p1698
sasa(dp1699
g3
VCD003407 v. 13.2 Erythropoietin or darbepoetin for patients with cancer.rm5
p1700
sg5
(lp1701
(dp1702
g8
V21959870.xml
p1703
sg10
VSTD-Fujisaka-2011
p1704
sg12
S'PMC3241560'
p1705
sa(dp1706
g8
V10408844.xml
p1707
sg10
VSTD-Thatcher-1999b
p1708
sg12
S'PMC2362337'
p1709
sa(dp1710
g8
V10408844.xml
p1711
sg10
VSTD-Thatcher-1999a
p1712
sg12
S'PMC2362337'
p1713
sa(dp1714
g8
V12671693.xml
p1715
sg10
VSTD-Boogaerts-2003
p1716
sg12
S'PMC2376376'
p1717
sa(dp1718
g8
V12799626.xml
p1719
sg10
VSTD-Smith-2003b
p1720
sg12
S'PMC2741110'
p1721
sa(dp1722
g8
V12799626.xml
p1723
sg10
VSTD-Smith-2003c
p1724
sg12
S'PMC2741110'
p1725
sa(dp1726
g8
V12799626.xml
p1727
sg10
VSTD-Smith-2003a
p1728
sg12
S'PMC2741110'
p1729
sa(dp1730
g8
V16570051.xml
p1731
sg10
VSTD-Wilkinson-2006
p1732
sg12
S'PMC2361228'
p1733
sa(dp1734
g8
V20798194.xml
p1735
sg10
VSTD-Pronzato-2010
p1736
sg12
S'PMC3228044'
p1737
sa(dp1738
g8
V9667681.xml
p1739
sg10
VSTD-Sweeney-1998
p1740
sg12
S'PMC2150364'
p1741
sa(dp1742
g8
V10408844.xml
p1743
sg10
VSTD-Thatcher-1999
p1744
sg12
S'PMC2362337'
p1745
sa(dp1746
g8
V12799626.xml
p1747
sg10
VSTD-Smith-2003
p1748
sg12
S'PMC2741110'
p1749
sa(dp1750
g8
V12671693.xml
p1751
sg10
VSTD-Boogaerts-Coiffier-2001
p1752
sg12
S'PMC2376376'
p1753
sasa(dp1754
g3
VCD007239 v. 4.0 Interventions for preventing mastitis after childbirth.rm5
p1755
sg5
(lp1756
(dp1757
g8
V17032458.xml
p1758
sg10
VSTD-Amir-2004
p1759
sg12
S'PMC1630426'
p1760
sasa(dp1761
g3
VCD006140 v. 5.0 Sustained-Release Naltrexone For Opioid Dependence.rm5
p1762
sg5
(lp1763
(dp1764
g8
V15804355.xml
p1765
sg10
VSTD-Galloway-2005
p1766
sg12
S'PMC1087493'
p1767
sasa(dp1768
g3
VCD008341 v. 2.0 Golimumab for rheumatoid arthritis.rm5
p1769
sg5
(lp1770
(dp1771
g8
V19066176.xml
p1772
sg10
VSTD-Keystone-2009
p1773
sg12
S'PMC2674549'
p1774
sasa(dp1775
g3
VCD002907 v. 8.2 Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding.rm5
p1776
sg5
(lp1777
(dp1778
g8
V17043424.xml
p1779
sg10
VSTD-Jun-2006
p1780
sg12
S'PMC2722000'
p1781
sasa(dp1782
g3
VCD005575 v. 6.2 Organisational travel plans for improving health.rm5
p1783
sg5
(lp1784
(dp1785
g8
V19413910.xml
p1786
sg10
VSTD-Mendoza-2009
p1787
sg12
S'PMC2680829'
p1788
sa(dp1789
g8
V23894666.xml
p1790
sg10
VSTD-TAPESTRY-Dublin-2003
p1791
sg12
S'PMC3720922'
p1792
sasa(dp1793
g3
VCD001319 v. 13.0 Colloid solutions for fluid resuscitation.rm5
p1794
sg5
(lp1795
(dp1796
g8
V17697359.xml
p1797
sg10
VSTD-Gombocz-2007
p1798
sg12
S'PMC2206488'
p1799
sa(dp1800
g8
V16998584.xml
p1801
sg10
VSTD-Akech-2006
p1802
sg12
S'PMC1569382'
p1803
sasa(dp1804
g3
VCD007992 v. 3.0 Omega-3 fatty acids supplementation for autism spectrum disorders (ASD).rm5
p1805
sg5
(lp1806
(dp1807
g8
V20683766.xml
p1808
sg10
VSTD-Bent-2011
p1809
sg12
S'PMC3076562'
p1810
sasa(dp1811
g3
VCD001324 v. 10.0 Interventions for emergency contraception.rm5
p1812
sg5
(lp1813
(dp1814
g8
V23300530.xml
p1815
sg10
VSTD-Lou-C-2002
p1816
sg12
S'PMC3530567'
p1817
sasa(dp1818
g3
VCD008326 v. 5.0 Total disc replacement for chronic back pain in the presence of disc degeneration.rm5
p1819
sg5
(lp1820
(dp1821
g8
V21596740.xml
p1822
sg10
VSTD-Hellum-2011
p1823
sg12
S'PMC3100911'
p1824
sasa(dp1825
g3
VCD000544 v. 11.0 Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.rm5
p1826
sg5
(lp1827
(dp1828
g8
V20049949.xml
p1829
sg10
VSTD-Ito-2010
p1830
sg12
S'PMC2972641'
p1831
sa(dp1832
g8
V19920971.xml
p1833
sg10
VSTD-Kane-2008a
p1834
sg12
S'PMC2770408'
p1835
sa(dp1836
g8
V18272546.xml
p1837
sg10
VSTD-Kamm-2008
p1838
sg12
S'PMC2564831'
p1839
sa(dp1840
g8
V22081522.xml
p1841
sg10
VSTD-Hawthorne-2011
p1842
sg12
S'PMC3746130'
p1843
sasa(dp1844
g3
VCD009774 v. 2.0 Parent-mediated early intervention for young children with autism spectrum disorders (ASD).rm5
p1845
sg5
(lp1846
(dp1847
g8
V20494434.xml
p1848
sg10
VSTD-Green-2010
p1849
sg12
S'PMC2890859'
p1850
sa(dp1851
g8
V20145986.xml
p1852
sg10
VSTD-Kasari-2010
p1853
sg12
S'PMC2922697'
p1854
sasa(dp1855
g3
VCD006641 v. 3.0 Separate care for new mother and infant versus rooming-in for increasing the duration of breastfeedi.rm5
p1856
sg5
(lp1857
(dp1858
g8
V17488524.xml
p1859
sg10
VSTD-Bystrova-2008
p1860
sg12
S'PMC1878468'
p1861
sasa(dp1862
g3
VCD003756 v. 6.2 Intermittent preventive treatment for malaria in children living in areas with seasonal transmission.rm5
p1863
sg5
(lp1864
(dp1865
g8
V21214940.xml
p1866
sg10
VSTD-Sesay-2011
p1867
sg12
S'PMC3024263'
p1868
sa(dp1869
g8
V21304925.xml
p1870
sg10
VSTD-Konate-2011
p1871
sg12
S'PMC3032552'
p1872
sa(dp1873
g8
V19098989.xml
p1874
sg10
VSTD-Kweku-2008
p1875
sg12
S'PMC2602973'
p1876
sa(dp1877
g8
V21304923.xml
p1878
sg10
VSTD-Dicko-2011
p1879
sg12
S'PMC3032550'
p1880
sa(dp1881
g8
V18611271.xml
p1882
sg10
VSTD-Dicko-2008
p1883
sg12
S'PMC2500037'
p1884
sasa(dp1885
g3
VCD008615 v. 3.2 Sumatriptan (oral route of administration) for acute migraine attacks in adults.rm5
p1886
sg5
(lp1887
(dp1888
g8
V17627707.xml
p1889
sg10
VSTD-Sandrini-2007
p1890
sg12
S'PMC1974802'
p1891
sa(dp1892
g8
V17164991.xml
p1893
sg10
VSTD-Tfelt_x002d_Hansen-2006
p1894
sg12
S'PMC3452229'
p1895
sasa(dp1896
g3
VCD000265 v. 15.0 Compression for venous leg ulcers.rm5
p1897
sg5
(lp1898
(dp1899
g8
V22419941.xml
p1900
sg10
VSTD-Szewczyk-2010
p1901
sg12
S'PMC3298351'
p1902
sasa(dp1903
g3
VCD002063 v. 10.0 Intravenous immunoglobulin for Guillain-Barr syndrome.rm5
p1904
sg5
(lp1905
(dp1906
g8
V21745374.xml
p1907
sg10
VSTD-El_x002d_Bayoumi-2011
p1908
sg12
S'PMC3387601'
p1909
sasa(dp1910
g3
VCD008937 v. 2.4 Psychological therapies for pathological and problem gambling.rm5
p1911
sg5
(lp1912
(dp1913
g8
V19967577.xml
p1914
sg10
VSTD-Carlbring-2010
p1915
sg12
S'PMC2882846'
p1916
sasa(dp1917
g3
VCD007587 v. 3.0 Acupuncture for tension-type headache.rm5
p1918
sg5
(lp1919
(dp1920
g8
V17955168.xml
p1921
sg10
VSTD-Endres-2007
p1922
sg12
S'PMC3476149'
p1923
sasa(dp1924
g3
VCD000246 v. 8.0 Prophylactic antibiotics for inhibiting preterm labour with intact membranes.rm5
p1925
sg5
(lp1926
(dp1927
g8
V18472878.xml
p1928
sg10
VSTD-Watts-1994
p1929
sg12
S'PMC2366143'
p1930
sasa(dp1931
g3
VCD001233 v. 8.0 Mechanical methods for induction of labour.rm5
p1932
sg5
(lp1933
(dp1934
g8
V9678143.xml
p1935
sg10
VSTD-Hibbard-1998
p1936
sg12
S'PMC1784771'
p1937
sasa(dp1938
g3
VCD007393 v. 4.0 Topical capsaicin (high concentration) for chronic neuropathic pain in adults.rm5
p1939
sg5
(lp1940
(dp1941
g8
V20937130.xml
p1942
sg10
VSTD-Webster-2010a
p1943
sg12
S'PMC2958861'
p1944
sasa(dp1945
g3
VCD002898 v. 10.0 Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratiti.rm5
p1946
sg5
(lp1947
(dp1948
g8
V19668521.xml
p1949
sg10
VSTD-Colin-2007a
p1950
sg12
S'PMC2704535'
p1951
sa(dp1952
g8
V19668521.xml
p1953
sg10
VSTD-Colin-2007b
p1954
sg12
S'PMC2704535'
p1955
sa(dp1956
g8
V23801989.xml
p1957
sg10
VSTD-Yamazaki-1984b
p1958
sg12
S'PMC3689032'
p1959
sa(dp1960
g8
V23671647.xml
p1961
sg10
VSTD-Kitano-1985
p1962
sg12
S'PMC3650034'
p1963
sa(dp1964
g8
V23801989.xml
p1965
sg10
VSTD-Yamazaki-1984c
p1966
sg12
S'PMC3689032'
p1967
sasa(dp1968
g3
VCD005247 v. 4.0 Chemotherapy for hormone-refractory prostate cancer.rm5
p1969
sg5
(lp1970
(dp1971
g8
V14710214.xml
p1972
sg10
VSTD-Albrecht-2004
p1973
sg12
S'PMC2395315'
p1974
sa(dp1975
g8
V8512828.xml
p1976
sg10
VSTD-Francini-1993
p1977
sg12
S'PMC1968505'
p1978
sasa(dp1979
g3
VCD006023 v. 6.0 Phosphate binders for preventing and treating bone disease in chronic kidney disease patients.rm5
p1980
sg5
(lp1981
(dp1982
g8
V19666658.xml
p1983
sg10
VSTD-Fan-2009
p1984
sg12
S'PMC2781155'
p1985
sa(dp1986
g8
V18193489.xml
p1987
sg10
VSTD-Tzanakis-2008
p1988
sg12
S'PMC2268719'
p1989
sasa(dp1990
g3
VCD006634 v. 2.0 Probiotics for induction of remission in Crohn's disease.rm5
p1991
sg5
(lp1992
(dp1993
g8
V15113451.xml
p1994
sg10
VSTD-Schultz-2004
p1995
sg12
S'PMC394324'
p1996
sasa(dp1997
g3
VCD000218 v. 8.0 Interventions for treating trichomoniasis in women.rm5
p1998
sg5
(lp1999
(dp2000
g8
V23761847.xml
p2001
sg10
VSTD-Block-1972
p2002
sg12
S'PMC3675863'
p2003
sasa(dp2004
g3
VCD004014 v. 8.0 Surgical management of pelvic organ prolapse in women.rm5
p2005
sg5
(lp2006
(dp2007
g8
V19834635.xml
p2008
sg10
VSTD-Dietz-2010
p2009
sg12
S'PMC2808513'
p2010
sa(dp2011
g8
V19583714.xml
p2012
sg10
VSTD-Carey-2009
p2013
sg12
S'PMC2774153'
p2014
sasa(dp2015
g3
VCD009238 v. 3.0 Helminth therapy (worms) for allergic rhinitis.rm5
p2016
sg5
(lp2017
(dp2018
g8
V19400893.xml
p2019
sg10
VSTD-Feary-2009a
p2020
sg12
S'PMC2728895'
p2021
sasa(dp2022
g3
VCD004398 v. 10.0 Printed educational materials effects on professional practice and healthcare outcomes.rm5
p2023
sg5
(lp2024
(dp2025
g8
V17547760.xml
p2026
sg10
VSTD-Perria-2007
p2027
sg12
S'PMC1904445'
p2028
sasa(dp2029
g3
VCD008141 v. 2.3 Second-generation antipsychotics for obsessive compulsive disorder.rm5
p2030
sg5
(lp2031
(dp2032
g8
V15667657.xml
p2033
sg10
VSTD-Carey-2005
p2034
sg12
S'PMC547907'
p2035
sasa(dp2036
g3
VCD004720 v. 8.0 Screening for prostate cancer.rm5
p2037
sg5
(lp2038
(dp2039
g8
V21454449.xml
p2040
sg10
VSTD-Norrkoping
p2041
sg12
S'PMC3069219'
p2042
sasa(dp2043
g3
VCD006546 v. 4.0 Kinship care for the safety permanency and well-being of children removed from the home for maltre.rm5
p2044
sg5
(lp2045
(dp2046
g8
V23517028.xml
p2047
sg10
VSTD-Christopher-1998
p2048
sg12
S'PMC3654563'
p2049
sasa(dp2050
g3
VCD003348 v. 9.0 Patient controlled opioid analgesia versus conventional opioid analgesia for postoperative pain.rm5
p2051
sg5
(lp2052
(dp2053
g8
V9876706.xml
p2054
sg10
VSTD-Rosen-1998
p2055
sg12
S'PMC3015270'
p2056
sasa(dp2057
g3
VCD007717 v. 3.0 Telehealthcare for asthma.rm5
p2058
sg5
(lp2059
(dp2060
g8
V17662113.xml
p2061
sg10
VSTD-Willems-2007a
p2062
sg12
S'PMC2000864'
p2063
sasa(dp2064
g3
VCD004064 v. 10.0 Chemotherapy for advanced gastric cancer.rm5
p2065
sg5
(lp2066
(dp2067
g8
V17147808.xml
p2068
sg10
VSTD-Sadighi-2006
p2069
sg12
S'PMC1693922'
p2070
sa(dp2071
g8
V15942629.xml
p2072
sg10
VSTD-Moehler-2005
p2073
sg12
S'PMC2361806'
p2074
sa(dp2075
g8
V7533517.xml
p2076
sg10
VSTD-Pyrh_x00f6_nen-1995
p2077
sg12
S'PMC2033628'
p2078
sasa(dp2079
g3
VCD002731 v. 6.0 Nedocromil sodium versus sodium cromoglycate for preventing exercise-induced bronchoconstriction.rm5
p2080
sg5
(lp2081
(dp2082
g8
V18475602.xml
p2083
sg10
VSTD-de-Benedictis-1994b
p2084
sg12
S'PMC2365597'
p2085
sasa(dp2086
g3
VCD000320 v. 14.0 Interventions for treating scabies.rm5
p2087
sg5
(lp2088
(dp2089
g8
V20177574.xml
p2090
sg10
VSTD-Bachewar-2009
p2091
sg12
S'PMC2825021'
p2092
sasa(dp2093
g3
VMR000033 v. 3.0 Industry sponsorship and research outcome.rm5
p2094
sg5
(lp2095
(dp2096
g8
V20422000.xml
p2097
sg10
VSTD-Popelut-2010
p2098
sg12
S'PMC2858083'
p2099
sa(dp2100
g8
V17550302.xml
p2101
sg10
VSTD-Bero-2007
p2102
sg12
S'PMC1885451'
p2103
sa(dp2104
g8
V12213183.xml
p2105
sg10
VSTD-Clifford-2002
p2106
sg12
S'PMC126226'
p2107
sa(dp2108
g8
V19213766.xml
p2109
sg10
VSTD-Jefferson-2009
p2110
sg12
S'PMC2643439'
p2111
sa(dp2112
g8
V20015404.xml
p2113
sg10
VSTD-Rasmussen-2009
p2114
sg12
S'PMC2811705'
p2115
sa(dp2116
g8
V19503811.xml
p2117
sg10
VSTD-Rattinger-2009
p2118
sg12
S'PMC2688752'
p2119
sasa(dp2120
g3
VCD009147 v. 2.0 Image-guided versus blind glucocorticoid injection for shoulder pain.rm5
p2121
sg5
(lp2122
(dp2123
g8
V19168537.xml
p2124
sg10
VSTD-Ekeberg-2009
p2125
sg12
S'PMC2769057'
p2126
sasa(dp2127
g3
VCD008409 v. 3.3 Progesterone for acute traumatic brain injury.rm5
p2128
sg5
(lp2129
(dp2130
g8
V18447940.xml
p2131
sg10
VSTD-Xiao-2008
p2132
sg12
S'PMC2447617'
p2133
sasa(dp2134
g3
VCD006175 v. 4.0 Progesterone for preventing pre-eclampsia and its complications.rm5
p2135
sg5
(lp2136
(dp2137
g8
V23171812.xml
p2138
sg10
VSTD-Dalton-1962
p2139
sg12
S'PMC3557890'
p2140
sasa(dp2141
g3
VCD007938 v. 4.0 Gabapentin for chronic neuropathic pain and fibromyalgia in adults.rm5
p2142
sg5
(lp2143
(dp2144
g8
V15453912.xml
p2145
sg10
VSTD-van-de-Vusse-2004
p2146
sg12
S'PMC523854'
p2147
sasa(dp2148
g3
VCD009415 v. 2.0 Zinc supplements for treating thalassaemia and sickle cell disease.rm5
p2149
sg5
(lp2150
(dp2151
g8
V23056757.xml
p2152
sg10
VSTD-Rashidi-2011
p2153
sg12
S'PMC3446117'
p2154
sasa(dp2155
g3
VCD001183 v. 10.0 Nedocromil sodium for preventing exercise-induced bronchoconstriction.rm5
p2156
sg5
(lp2157
(dp2158
g8
V18475602.xml
p2159
sg10
VSTD-De-Benedictis-1994b
p2160
sg12
S'PMC2365597'
p2161
sasa(dp2162
g3
VCD006424 v. 2.0 Culturally appropriate health education for type 2 diabetes mellitus in ethnic minority groups.rm5
p2163
sg5
(lp2164
(dp2165
g8
V16709243.xml
p2166
sg10
VSTD-Baradaran-2006
p2167
sg12
S'PMC1489930'
p2168
sasa(dp2169
g3
VCD005390 v. 4.0 Adjuvant Therapy for completely resected Stage II Colon Cancer.rm5
p2170
sg5
(lp2171
(dp2172
g8
V2069842.xml
p2173
sg10
VSTD-Gray-1991
p2174
sg12
S'PMC1972556'
p2175
sa(dp2176
g8
V11720425.xml
p2177
sg10
VSTD-Taal-2001
p2178
sg12
S'PMC2363941'
p2179
sasa(dp2180
g3
VCD009269 v. 2.2 Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit d.rm5
p2181
sg5
(lp2182
(dp2183
g8
V21849027.xml
p2184
sg10
VSTD-Feldman-2011
p2185
sg12
S'PMC3191344'
p2186
sasa(dp2187
g3
VCD002845 v. 6.0 Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal.rm5
p2188
sg5
(lp2189
(dp2190
g8
V18475414.xml
p2191
sg10
VSTD-Mikamo-_x0028_1_x0029_-1995
p2192
sg12
S'PMC2364408'
p2193
sa(dp2194
g8
V16338779.xml
p2195
sg10
VSTD-Seidman-2005
p2196
sg12
S'PMC1784583'
p2197
sa(dp2198
g8
V18475414.xml
p2199
sg10
VSTD-Mikamo-_x0028_2_x0029_-1995
p2200
sg12
S'PMC2364408'
p2201
sasa(dp2202
g3
VCD001430 v. 10.0 Corticosteroids for treating optic neuritis.rm5
p2203
sg5
(lp2204
(dp2205
g8
V17699944.xml
p2206
sg10
VSTD-Menon-2007
p2207
sg12
S'PMC2636008'
p2208
sasa(dp2209
g3
VCD008563 v. 2.0 Prevention of diarrhoea in children with HIV infection or exposure to maternal HIV infection.rm5
p2210
sg5
(lp2211
(dp2212
g8
V17593956.xml
p2213
sg10
VSTD-Luabeya-2007
p2214
sg12
S'PMC1891438'
p2215
sasa(dp2216
g3
VCD000259 v. 11.2 Audit and feedback effects on professional practice and healthcare outcomes.rm5
p2217
sg5
(lp2218
(dp2219
g8
V19366977.xml
p2220
sg10
VSTD-O_x0027_Connor-2009
p2221
sg12
S'PMC2699722'
p2222
sa(dp2223
g8
V18093108.xml
p2224
sg10
VSTD-Schneider-2008
p2225
sg12
S'PMC2440309'
p2226
sa(dp2227
g8
V17456241.xml
p2228
sg10
VSTD-Foster-2007
p2229
sg12
S'PMC1868738'
p2230
sasa(dp2231
g3
VCD005528 v. 4.0 Non-clinical interventions for reducing unnecessary caesarean section.rm5
p2232
sg5
(lp2233
(dp2234
g8
V18547413.xml
p2235
sg10
VSTD-Hemminki-2008
p2236
sg12
S'PMC2442595'
p2237
sasa(dp2238
g3
VCD004661 v. 7.0 Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.rm5
p2239
sg5
(lp2240
(dp2241
g8
V17166221.xml
p2242
sg10
VSTD-Magpie-2006
p2243
sg12
S'PMC2063969'
p2244
sasa(dp2245
g3
VCD006915 v. 5.0 Heliox inhalation therapy for bronchiolitis in infants.rm5
p2246
sg5
(lp2247
(dp2248
g8
V19450268.xml
p2249
sg10
VSTD-Kneyber-2009
p2250
sg12
S'PMC2717432'
p2251
sasa(dp2252
g3
VCD003751 v. 5.0 Communication skills training for healthcare professionals working with people who have cancer.rm5
p2253
sg5
(lp2254
(dp2255
g8
V12085247.xml
p2256
sg10
VSTD-Razavi-2002
p2257
sg12
S'PMC2364281'
p2258
sa(dp2259
g8
V20628395.xml
p2260
sg10
VSTD-Lienard-2010
p2261
sg12
S'PMC2906741'
p2262
sasa(dp2263
g3
VCD007536 v. 2.0 Routine pre-pregnancy health promotion for improving pregnancy outcomes.rm5
p2264
sg5
(lp2265
(dp2266
g8
V16824233.xml
p2267
sg10
VSTD-Elsinga-2006
p2268
sg12
S'PMC1552064'
p2269
sa(dp2270
g8
V17156466.xml
p2271
sg10
VSTD-Lumley-2006
p2272
sg12
S'PMC1712341'
p2273
sasa(dp2274
g3
VCD005200 v. 3.0 Laparoscopic versus open total mesorectal excision for rectal cancer.rm5
p2275
sg5
(lp2276
(dp2277
g8
V12113422.xml
p2278
sg10
VSTD-Reis-Neto-2002
p2279
sg12
S'PMC3043413'
p2280
sa(dp2281
g8
V12500834.xml
p2282
sg10
VSTD-Chen-2002
p2283
sg12
S'PMC3043440'
p2284
sasa(dp2285
g3
VCD006686 v. 7.0 Bradykinin beta-2 receptor antagonists for acute traumatic brain injury.rm5
p2286
sg5
(lp2287
(dp2288
g8
V19958521.xml
p2289
sg10
VSTD-BRAIN-2009
p2290
sg12
S'PMC2794266'
p2291
sasa(dp2292
g3
VCD004023 v. 8.0 Early versus deferred treatment for early stage multiple myeloma.rm5
p2293
sg5
(lp2294
(dp2295
g8
V7981078.xml
p2296
sg10
VSTD-Riccardi-1994
p2297
sg12
S'PMC2033710'
p2298
sa(dp2299
g8
V10755397.xml
p2300
sg10
VSTD-Riccardi-2000
p2301
sg12
S'PMC2374495'
p2302
sasa(dp2303
g3
VCD010245 v. 3.0 Tranexamic acid for reducing mortality in emergency and urgent surgery.rm5
p2304
sg5
(lp2305
(dp2306
g8
V21455360.xml
p2307
sg10
VSTD-Pfizer-2011
p2308
sg12
S'PMC2962290'
p2309
sasa(dp2310
g3
VCD003372 v. 8.0 Single agent versus combination chemotherapy for metastatic breast cancer.rm5
p2311
sg5
(lp2312
(dp2313
g8
V15726120.xml
p2314
sg10
VSTD-Icli-F-2005
p2315
sg12
S'PMC2361864'
p2316
sa(dp2317
g8
V8431375.xml
p2318
sg10
VSTD-Fraser-S-1993
p2319
sg12
S'PMC1968186'
p2320
sa(dp2321
g8
V12439707.xml
p2322
sg10
VSTD-Bonneterre--J-2002
p2323
sg12
S'PMC2408916'
p2324
sa(dp2325
g8
V766800.xml
p2326
sg10
VSTD-Rubens-RD-1975
p2327
sg12
S'PMC2025018'
p2328
sasa(dp2329
g3
VCD009008 v. 2.6 Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.rm5
p2330
sg5
(lp2331
(dp2332
g8
V21205128.xml
p2333
sg10
VSTD-LEAD_x002d_3-2006
p2334
sg12
S'PMC3084519'
p2335
sa(dp2336
g8
V23943707.xml
p2337
sg10
VSTD-Kanda-1998
p2338
sg12
S'PMC3699156'
p2339
sasa(dp2340
g3
VCD003091 v. 5.2 Dressings for the prevention of surgical site infection.rm5
p2341
sg5
(lp2342
(dp2343
g8
V22096550.xml
p2344
sg10
VSTD-Hewlett-1996
p2345
sg12
S'PMC3214045'
p2346
sasa(dp2347
g3
VCD002991 v. 7.0 Inhaled corticosteroids for stable chronic obstructive pulmonary disease.rm5
p2348
sg5
(lp2349
(dp2350
g8
V19014549.xml
p2351
sg10
VSTD-Calverley-2008
p2352
sg12
S'PMC2644301'
p2353
sa(dp2354
g8
V20037682.xml
p2355
sg10
VSTD-Schermer-2009
p2356
sg12
S'PMC2793071'
p2357
sasa(dp2358
g3
VCD005199 v. 7.0 Transverse verses midline incisions for abdominal surgery.rm5
p2359
sg5
(lp2360
(dp2361
g8
V19259615.xml
p2362
sg10
VSTD-Halm-2009
p2363
sg12
S'PMC2690844'
p2364
sasa(dp2365
g3
VCD002151 v. 7.0 Antipyretic measures for treating fever in malaria.rm5
p2366
sg5
(lp2367
(dp2368
g8
V18503714.xml
p2369
sg10
VSTD-Matsegui-2008
p2370
sg12
S'PMC2409363'
p2371
sa(dp2372
g8
V21631932.xml
p2373
sg10
VSTD-Kofoed-2011
p2374
sg12
S'PMC3123603'
p2375
sasa(dp2376
g3
VCD001118 v. 10.0 Self-help interventions for smoking cessation.rm5
p2377
sg5
(lp2378
(dp2379
g8
V17995993.xml
p2380
sg10
VSTD-Meyer-2008
p2381
sg12
S'PMC2253708'
p2382
sasa(dp2383
g3
VCD001425 v. 6.0 Immunotherapy for advanced renal cell cancer.rm5
p2384
sg5
(lp2385
(dp2386
g8
V16136045.xml
p2387
sg10
VSTD-Donskov_x0028_ii_x0029_-2005
p2388
sg12
S'PMC2361635'
p2389
sa(dp2390
g8
V9703284.xml
p2391
sg10
VSTD-Jayson-1998
p2392
sg12
S'PMC2063040'
p2393
sa(dp2394
g8
V7841054.xml
p2395
sg10
VSTD-DeMulder-1995
p2396
sg12
S'PMC2033601'
p2397
sa(dp2398
g8
V16136045.xml
p2399
sg10
VSTD-Donskov_x0028_i_x0029_-2005
p2400
sg12
S'PMC2361635'
p2401
sa(dp2402
g8
V9579838.xml
p2403
sg10
VSTD-Henriksson-1998
p2404
sg12
S'PMC2150170'
p2405
sa(dp2406
g8
V11710825.xml
p2407
sg10
VSTD-Atzpodien-2001
p2408
sg12
S'PMC2375150'
p2409
sasa(dp2410
g3
VCD006611 v. 4.4 Mobile phone-based interventions for smoking cessation.rm5
p2411
sg5
(lp2412
(dp2413
g8
V21371991.xml
p2414
sg10
VSTD-Whittaker-2011
p2415
sg12
S'PMC3221331'
p2416
sa(dp2417
g8
V21722952.xml
p2418
sg10
VSTD-Free-2011
p2419
sg12
S'PMC3143315'
p2420
sasa(dp2421
g3
VCD004106 v. 9.0 Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for c.rm5
p2422
sg5
(lp2423
(dp2424
g8
V17362472.xml
p2425
sg10
VSTD-COMPASS
p2426
sg12
S'PMC1920547'
p2427
sasa(dp2428
g3
VCD001321 v. 17.0 Cranberries for preventing urinary tract infections.rm5
p2429
sg5
(lp2430
(dp2431
g8
V19042940.xml
p2432
sg10
VSTD-McMurdo-2009
p2433
sg12
S'PMC2639265'
p2434
sasa(dp2435
g3
VCD002850 v. 9.0 Telephone counselling for smoking cessation.rm5
p2436
sg5
(lp2437
(dp2438
g8
V18304363.xml
p2439
sg10
VSTD-Young-2008
p2440
sg12
S'PMC2268921'
p2441
sasa(dp2442
g3
VCD008654 v. 1.0 Pharmaceutical policies effects of restrictions on reimbursement.rm5
p2443
sg5
(lp2444
(dp2445
g8
V17622192.xml
p2446
sg10
VSTD-Fretheim-2007
p2447
sg12
S'PMC1904466'
p2448
sasa(dp2449
g3
VCD001000 v. 12.0 Corticosteroids for the prevention and treatment of post-extubation stridor in neonates children an.rm5
p2450
sg5
(lp2451
(dp2452
g8
V17705879.xml
p2453
sg10
VSTD-Lee-2007
p2454
sg12
S'PMC2206510'
p2455
sasa(dp2456
g3
VCD004306 v. 9.0 Interventions for smokeless tobacco use cessation.rm5
p2457
sg5
(lp2458
(dp2459
g8
V21134997.xml
p2460
sg10
VSTD-Fagerstrom-2010
p2461
sg12
S'PMC2997603'
p2462
sasa(dp2463
g3
VCD000009 v. 11.0 Acupuncture and related interventions for smoking cessation.rm5
p2464
sg5
(lp2465
(dp2466
g8
V17359519.xml
p2467
sg10
VSTD-White-2007
p2468
sg12
S'PMC1831486'
p2469
sasa(dp2470
g3
VCD005978 v. 9.0 Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months.rm5
p2471
sg5
(lp2472
(dp2473
g8
V17593956.xml
p2474
sg10
VSTD-Luabeya-2007
p2475
sg12
S'PMC1891438'
p2476
sasa(dp2477
g3
VCD008273 v. 3.0 Information interventions for orienting patients and their carers to cancer care facilities.rm5
p2478
sg5
(lp2479
(dp2480
g8
V8664135.xml
p2481
sg10
VSTD-Mohide-1996
p2482
sg12
S'PMC2074537'
p2483
sasa(dp2484
g3
VCD005987 v. 5.0 Scalpel versus electrosurgery for abdominal incisions.rm5
p2485
sg5
(lp2486
(dp2487
g8
V18476202.xml
p2488
sg10
VSTD-Hemsell-1993
p2489
sg12
S'PMC2364680'
p2490
sasa(dp2491
g3
VCD007126 v. 5.0 Single dose intravenous propacetamol or intravenous paracetamol for postoperative pain.rm5
p2492
sg5
(lp2493
(dp2494
g8
V18581586.xml
p2495
sg10
VSTD-Leykin-2008
p2496
sg12
S'PMC2615351'
p2497
sasa(dp2498
g3
VCD001266 v. 7.0 Bronchodilators for bronchiolitis.rm5
p2499
sg5
(lp2500
(dp2501
g8
V11983043.xml
p2502
sg10
VSTD-Totapally-2002
p2503
sg12
S'PMC111183'
p2504
sasa(dp2505
g3
VMR000024 v. 5.0 New treatments compared to established treatments in randomized trials.rm5
p2506
sg5
(lp2507
(dp2508
g8
V21542934.xml
p2509
sg10
VSTD-Dent-2011
p2510
sg12
S'PMC3113983'
p2511
sasa(dp2512
g3
VCD006704 v. 7.2 Drug therapy for the management of cancer-related fatigue.rm5
p2513
sg5
(lp2514
(dp2515
g8
V8494706.xml
p2516
sg10
VSTD-Downer-1993
p2517
sg12
S'PMC1968469'
p2518
sa(dp2519
g8
V12799626.xml
p2520
sg10
VSTD-Smith-2003
p2521
sg12
S'PMC2741110'
p2522
sa(dp2523
g8
V12671693.xml
p2524
sg10
VSTD-Boogaerts-2003
p2525
sg12
S'PMC2376376'
p2526
sa(dp2527
g8
V10408844.xml
p2528
sg10
VSTD-Thatcher-1999
p2529
sg12
S'PMC2362337'
p2530
sa(dp2531
g8
V16570051.xml
p2532
sg10
VSTD-Wilkinson-2006
p2533
sg12
S'PMC2361228'
p2534
sasa(dp2535
g3
VCD003409 v. 19.0 Methadone at tapered doses for the management of opioid withdrawal.rm5
p2536
sg5
(lp2537
(dp2538
g8
V19686525.xml
p2539
sg10
VSTD-Madlung_x002d_Kratzer-2009
p2540
sg12
S'PMC2773536'
p2541
sasa(dp2542
g3
VCD006776 v. 6.0 Using alternative statistical formats for presenting risks and risk reductions.rm5
p2543
sg5
(lp2544
(dp2545
g8
V19707575.xml
p2546
sg10
VSTD-Carling-2009
p2547
sg12
S'PMC2724738'
p2548
sa(dp2549
g8
V19030110.xml
p2550
sg10
VSTD-Carling-2008
p2551
sg12
S'PMC2585274'
p2552
sasa(dp2553
g3
VCD009017 v. 2.0 Clofibrate in combination with phototherapy for unconjugated neonatal hyperbilirubinaemia.rm5
p2554
sg5
(lp2555
(dp2556
g8
V23056681.xml
p2557
sg10
VSTD-Sharafi-2010
p2558
sg12
S'PMC3446002'
p2559
sasa(dp2560
g3
VCD004711 v. 6.0 Heated humidification versus heat and moisture exchangers for ventilated adults and children.rm5
p2561
sg5
(lp2562
(dp2563
g8
V16884530.xml
p2564
sg10
VSTD-Lorente-2006
p2565
sg12
S'PMC1750976'
p2566
sa(dp2567
g8
V11178222.xml
p2568
sg10
VSTD-Thomachot-2001
p2569
sg12
S'PMC29053'
p2570
sasa(dp2571
g3
VCD007847 v. 2.0 Postoperative tamoxifen for ductal carcinoma in situ.rm5
p2572
sg5
(lp2573
(dp2574
g8
V21145284.xml
p2575
sg10
VSTD-UK-ANZ-Trial-2011
p2576
sg12
S'PMC3018565'
p2577
sasa(dp2578
g3
VCD001431 v. 9.0 Decision aids for people facing health treatment or screening decisions.rm5
p2579
sg5
(lp2580
(dp2581
g8
V19209172.xml
p2582
sg10
VSTD-Vodermaier-2009
p2583
sg12
S'PMC2653746'
p2584
sa(dp2585
g8
V17005051.xml
p2586
sg10
VSTD-Sheridan-2006
p2587
sg12
S'PMC1626460'
p2588
sa(dp2589
g8
V17214891.xml
p2590
sg10
VSTD-Thomson-2007
p2591
sg12
S'PMC1781432'
p2592
sasa(dp2593
g3
VMR000013 v. 10.0 Strategies to improve recruitment to randomised controlled trials.rm5
p2594
sg5
(lp2595
(dp2596
g8
V17848908.xml
p2597
sg10
VSTD-Hutchison-2007
p2598
sg12
S'PMC2360384'
p2599
sasa(dp2600
g3
VCD007419 v. 4.0 Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular .rm5
p2601
sg5
(lp2602
(dp2603
g8
V20980427.xml
p2604
sg10
VSTD-RESOLVE
p2605
sg12
S'PMC2963502'
p2606
sasa(dp2607
g3
VCD002747 v. 11.0 Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer.rm5
p2608
sg5
(lp2609
(dp2610
g8
V1503915.xml
p2611
sg10
VSTD-Dixon-1992
p2612
sg12
S'PMC1977824'
p2613
sasa(dp2614
g3
VCD007945 v. 3.0 Centralisation of services for gynaecological cancer.rm5
p2615
sg5
(lp2616
(dp2617
g8
V19125205.xml
p2618
sg10
VSTD-Brookfield-2009
p2619
sg12
S'PMC2612742'
p2620
sa(dp2621
g8
V10638991.xml
p2622
sg10
VSTD-Stockton-2000
p2623
sg12
S'PMC2363169'
p2624
sasa(dp2625
g3
VCD006777 v. 3.0 Framing of health information messages.rm5
p2626
sg5
(lp2627
(dp2628
g8
V20209127.xml
p2629
sg10
VSTD-Carling-2010
p2630
sg12
S'PMC2830888'
p2631
sasa(dp2632
g3
VCD006425 v. 5.3 Antenatal breastfeeding education for increasing breastfeeding duration.rm5
p2633
sg5
(lp2634
(dp2635
g8
V19181730.xml
p2636
sg10
VSTD-MacArthur-2009
p2637
sg12
S'PMC2636685'
p2638
sasa(dp2639
g3
VCD004530 v. 8.0 Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever).rm5
p2640
sg5
(lp2641
(dp2642
g8
V21531174.xml
p2643
sg10
VSTD-Arjyal-2011
p2644
sg12
S'PMC3108101'
p2645
sa(dp2646
g8
V17593957.xml
p2647
sg10
VSTD-Pandit-2007-NPL
p2648
sg12
S'PMC1891439'
p2649
sa(dp2650
g8
V18493312.xml
p2651
sg10
VSTD-Dolecek-2008-VNM
p2652
sg12
S'PMC2374894'
p2653
sasa(dp2654
g3
VCD006165 v. 5.0 Interventions for latent autoimmune diabetes (LADA) in adults.rm5
p2655
sg5
(lp2656
(dp2657
g8
V21088056.xml
p2658
sg10
VSTD-Thunander-2010
p2659
sg12
S'PMC3022338'
p2660
sasa(dp2661
g3
VCD005135 v. 5.2 Laser-assisted in-situ keratomileusis (LASIK) versus photorefractive keratectomy (PRK) for myopia.rm5
p2662
sg5
(lp2663
(dp2664
g8
V21573091.xml
p2665
sg10
VSTD-Hatch-2011
p2666
sg12
S'PMC3090298'
p2667
sasa(dp2668
g3
VCD005085 v. 4.0 Oximes for acute organophosphate pesticide poisoning.rm5
p2669
sg5
(lp2670
(dp2671
g8
V19564902.xml
p2672
sg10
VSTD-Eddleston-2009
p2673
sg12
S'PMC2696321'
p2674
sasa(dp2675
g3
VCD008893 v. 3.1 Effect of cocoa on blood pressure.rm5
p2676
sg5
(lp2677
(dp2678
g8
V19583878.xml
p2679
sg10
VSTD-Ried-2009
p2680
sg12
S'PMC2712451'
p2681
sa(dp2682
g8
V15712594.xml
p2683
sg10
VSTD-Fraga-2005
p2684
sg12
S'PMC2270716'
p2685
sasa(dp2686
g3
VCD005354 v. 7.0 Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology.rm5
p2687
sg5
(lp2688
(dp2689
g8
V14609434.xml
p2690
sg10
VSTD-Dickey-2003
p2691
sg12
S'PMC270000'
p2692
sasa(dp2693
g3
VCD007228 v. 4.0 Structured telephone support or telemonitoring programmes for patients with chronic heart failure.rm5
p2694
sg5
(lp2695
(dp2696
g8
V16533388.xml
p2697
sg10
VSTD-DeWalt-2006
p2698
sg12
S'PMC1475568'
p2699
sasa(dp2700
g3
VCD007952 v. 2.6 Material incentives and enablers in the management of tuberculosis.rm5
p2701
sg5
(lp2702
(dp2703
g8
V19858174.xml
p2704
sg10
VSTD-Martins-2009
p2705
sg12
S'PMC2767482'
p2706
sasa(dp2707
g3
VCD001781 v. 10.0 Topical treatments for cutaneous warts.rm5
p2708
sg5
(lp2709
(dp2710
g8
V21652750.xml
p2711
sg10
VSTD-Cockayne-2011
p2712
sg12
S'PMC3109952'
p2713
sa(dp2714
g8
V19675691.xml
p2715
sg10
VSTD-Fuchs-2004
p2716
sg12
S'PMC2703213'
p2717
sasa(dp2718
g3
VCD003366 v. 9.0 Taxane containing regimens for metastatic breast cancer.rm5
p2719
sg5
(lp2720
(dp2721
g8
V12439707.xml
p2722
sg10
VSTD-TXT-Group
p2723
sg12
S'PMC2408916'
p2724
sa(dp2725
g8
V11986765.xml
p2726
sg10
VSTD-Talbot
p2727
sg12
S'PMC2375384'
p2728
sasa(dp2729
g3
VCD007407 v. 4.2 Psychological therapies for the management of chronic pain (excluding headache) in adults.rm5
p2730
sg5
(lp2731
(dp2732
g8
V19116007.xml
p2733
sg10
VSTD-Lindell-2008
p2734
sg12
S'PMC2649916'
p2735
sasa(dp2736
g3
VCD004843 v. 10.2 Music for pain relief.rm5
p2737
sg5
(lp2738
(dp2739
g8
V18493472.xml
p2740
sg10
VSTD-Kotwal-1998
p2741
sg12
S'PMC2362603'
p2742
sasa(dp2743
g3
VCD005623 v. 7.0 Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-maligna.rm5
p2744
sg5
(lp2745
(dp2746
g8
V16109163.xml
p2747
sg10
VSTD-Vickers-2005
p2748
sg12
S'PMC1208905'
p2749
sasa(dp2750
g3
VCD006829 v. 8.0 Combined corticosteroid and long-acting beta2-agonist in one inhaler versus long-acting beta2-agonis.rm5
p2751
sg5
(lp2752
(dp2753
g8
V19368417.xml
p2754
sg10
VSTD-Rennard-2009
p2755
sg12
S'PMC3580134'
p2756
sasa(dp2757
g3
VCD004253 v. 10.0 Psychological interventions for women with metastatic breast cancer.rm5
p2758
sg5
(lp2759
(dp2760
g8
V16967054.xml
p2761
sg10
VSTD-Aranda-2006
p2762
sg12
S'PMC2360523'
p2763
sasa(dp2764
g3
VCD007651 v. 3.0 School-based physical activity programs for promoting physical activity and fitness in children and .rm5
p2765
sg5
(lp2766
(dp2767
g8
V18718012.xml
p2768
sg10
VSTD-Jones-2008
p2769
sg12
S'PMC2556688'
p2770
sa(dp2771
g8
V20179126.xml
p2772
sg10
VSTD-Kriemler-2010
p2773
sg12
S'PMC2827713'
p2774
sa(dp2775
g8
V19765270.xml
p2776
sg10
VSTD-Gentile-2009
p2777
sg12
S'PMC2758893'
p2778
sasa(dp2779
g3
VCD008358 v. 3.0 Magnesium for alcohol withdrawal.rm5
p2780
sg5
(lp2781
(dp2782
g8
V18218147.xml
p2783
sg10
VSTD-Poikolainen-2008
p2784
sg12
S'PMC2265283'
p2785
sasa(dp2786
g3
VCD005470 v. 5.0 Tailored interventions to overcome identified barriers to change effects on professional practice a.rm5
p2787
sg5
(lp2788
(dp2789
g8
V16737346.xml
p2790
sg10
VSTD-Fretheim-2006
p2791
sg12
S'PMC1472695'
p2792
sasa(dp2793
g3
VCD008955 v. 2.2 Interferon alpha for the adjuvant treatment of cutaneous melanoma.rm5
p2794
sg5
(lp2795
(dp2796
g8
V11379605.xml
p2797
sg10
VSTD-Cameron-2001
p2798
sg12
S'PMC2363881'
p2799
sasa(dp2800
g3
VCD008270 v. 2.5 Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.rm5
p2801
sg5
(lp2802
(dp2803
g8
V15647105.xml
p2804
sg10
VSTD-Keiser-2005
p2805
sg12
S'PMC548524'
p2806
sasa(dp2807
g3
VCD005096 v. 8.2 Chinese herbal medicines for induction of remission in advanced or late gastric cancer.rm5
p2808
sg5
(lp2809
(dp2810
g8
V23882420.xml
p2811
sg10
VSTD-Wang-2010
p2812
sg12
S'PMC3719192'
p2813
sa(dp2814
g8
V23983775.xml
p2815
sg10
VSTD-Xie-2006
p2816
sg12
S'PMC3747414'
p2817
sasa(dp2818
g3
VCD005527 v. 5.4 Ribavirin monotherapy for chronic hepatitis C.rm5
p2819
sg5
(lp2820
(dp2821
g8
V12948399.xml
p2822
sg10
VSTD-Veldt-2003
p2823
sg12
S'PMC222984'
p2824
sasa(dp2825
g3
VCD003930 v. 8.0 Restricting oral fluid and food intake during labour.rm5
p2826
sg5
(lp2827
(dp2828
g8
V19318702.xml
p2829
sg10
VSTD-O_x0027_Sullivan-2009
p2830
sg12
S'PMC2660391'
p2831
sasa(dp2832
g3
VCD004659 v. 5.0 Antiplatelet agents for preventing pre-eclampsia and its complications.rm5
p2833
sg5
(lp2834
(dp2835
g8
V22815699.xml
p2836
sg10
VSTD-Netherlands-1989
p2837
sg12
S'PMC3398037'
p2838
sasa(dp2839
g3
VCD002922 v. 9.2 Treatment for lupus nephritis.rm5
p2840
sg5
(lp2841
(dp2842
g8
V20833738.xml
p2843
sg10
VSTD-MAINTAIN-Nephritis-Study
p2844
sg12
S'PMC3002764'
p2845
sasa(dp2846
g3
VMR000031 v. 2.3 Comparison of protocols and registry entries to published reports for randomised controlled trials.rm5
p2847
sg5
(lp2848
(dp2849
g8
V19435763.xml
p2850
sg10
VSTD-Charles-2009
p2851
sg12
S'PMC2680945'
p2852
sasa(dp2853
g3
VCD007464 v. 3.2 Chemotherapy for brain metastases from small cell lung cancer.rm5
p2854
sg5
(lp2855
(dp2856
g8
V19127261.xml
p2857
sg10
VSTD-Neuhaus-2009
p2858
sg12
S'PMC2634726'
p2859
sasa(dp2860
g3
VCD004562 v. 7.0 LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.rm5
p2861
sg5
(lp2862
(dp2863
g8
V15668708.xml
p2864
sg10
VSTD-MAM-01-GOCSI
p2865
sg12
S'PMC2362097'
p2866
sasa(dp2867
g3
VCD000494 v. 11.0 Prostaglandins for preventing postpartum haemorrhage.rm5
p2868
sg5
(lp2869
(dp2870
g8
V21176086.xml
p2871
sg10
VSTD-Pakistan-2011
p2872
sg12
S'PMC3041931'
p2873
sasa(dp2874
g3
VCD008016 v. 3.2 Maintenance treatment with antipsychotic drugs for schizophrenia.rm5
p2875
sg5
(lp2876
(dp2877
g8
V20724402.xml
p2878
sg10
VSTD-Chen-2010
p2879
sg12
S'PMC2924475'
p2880
sa(dp2881
g8
V21927264.xml
p2882
sg10
VSTD-Channabasavanna-1987
p2883
sg12
S'PMC3172444'
p2884
sasa(dp2885
g3
VCD008926 v. 2.0 Toremifene versus tamoxifen for advanced breast cancer.rm5
p2886
sg5
(lp2887
(dp2888
g8
V9231932.xml
p2889
sg10
VSTD-Pyrhonen-1997
p2890
sg12
S'PMC2223944'
p2891
sasa(dp2892
g3
VCD006602 v. 7.0 Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children.rm5
p2893
sg5
(lp2894
(dp2895
g8
V20525274.xml
p2896
sg10
VSTD-Fernandez-2010
p2897
sg12
S'PMC2898783'
p2898
sa(dp2899
g8
V19490659.xml
p2900
sg10
VSTD-Chirico-2009
p2901
sg12
S'PMC2687544'
p2902
sa(dp2903
g8
V23919494.xml
p2904
sg10
VSTD-Bentley-2011
p2905
sg12
S'PMC3735492'
p2906
sa(dp2907
g8
V19967425.xml
p2908
sg10
VSTD-Nuijten-2010
p2909
sg12
S'PMC2816247'
p2910
sasa(dp2911
g3
VCD004794 v. 3.0 Interventions to improve water quality for preventing diarrhoea.rm5
p2912
sg5
(lp2913
(dp2914
g8
V11749745.xml
p2915
sg10
VSTD-Colford-2002
p2916
sg12
S'PMC2730258'
p2917
sasa(dp2918
g3
VCD004615 v. 5.2 Mannitol and other osmotic diuretics as adjuncts for treating cerebral malaria.rm5
p2919
sg5
(lp2920
(dp2921
g8
V17958887.xml
p2922
sg10
VSTD-Namutangula-2007
p2923
sg12
S'PMC2147028'
p2924
sasa(dp2925
g3
VCD008226 v. 2.0 Lipid lowering efficacy of atorvastatin.rm5
p2926
sg5
(lp2927
(dp2928
g8
V19265025.xml
p2929
sg10
VSTD-Rosenson-2009
p2930
sg12
S'PMC2681027'
p2931
sa(dp2932
g8
V20195400.xml
p2933
sg10
VSTD-Park-2010
p2934
sg12
S'PMC2829413'
p2935
sa(dp2936
g8
V21519514.xml
p2937
sg10
VSTD-Cho-2011
p2938
sg12
S'PMC3079135'
p2939
sa(dp2940
g8
V17184550.xml
p2941
sg10
VSTD-PULSAR--2006
p2942
sg12
S'PMC1779361'
p2943
sasa(dp2944
g3
VCD009275 v. 2.0 Different types of dietary advice for women with gestational diabetes mellitus.rm5
p2945
sg5
(lp2946
(dp2947
g8
V21900148.xml
p2948
sg10
VSTD-Louie-2011
p2949
sg12
S'PMC3198285'
p2950
sa(dp2951
g8
V19279301.xml
p2952
sg10
VSTD-Moses-2009
p2953
sg12
S'PMC2681032'
p2954
sasa(dp2955
g3
VCD007796 v. 2.2 Chinese herbal medicine for diabetic peripheral neuropathy.rm5
p2956
sg5
(lp2957
(dp2958
g8
V24058521.xml
p2959
sg10
VSTD-Hu-2005
p2960
sg12
S'PMC3776804'
p2961
sasa(dp2962
g3
VCD007913 v. 2.0 Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile n.rm5
p2963
sg5
(lp2964
(dp2965
g8
V19014494.xml
p2966
sg10
VSTD-Del-Giglio-2008
p2967
sg12
S'PMC2628928'
p2968
sasa(dp2969
g3
VCD006389 v. 3.0 Interventions to facilitate return to work in adults with adjustment disorders.rm5
p2970
sg5
(lp2971
(dp2972
g8
V17549228.xml
p2973
sg10
VSTD-Bakker-2007
p2974
sg12
S'PMC1885369'
p2975
sasa(dp2976
g3
VCD007566 v. 2.2 Exercise interventions on health-related quality of life for cancer survivors.rm5
p2977
sg5
(lp2978
(dp2979
g8
V19880433.xml
p2980
sg10
VSTD-Oh-2010
p2981
sg12
S'PMC2826100'
p2982
sasa(dp2983
g3
VCD005564 v. 6.0 Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria.rm5
p2984
sg5
(lp2985
(dp2986
g8
V15839740.xml
p2987
sg10
VSTD-Sutherland-2005
p2988
sg12
S'PMC1087200'
p2989
sasa(dp2990
g3
VCD001270 v. 6.0 Teaching critical appraisal skills in healthcare settings.rm5
p2991
sg5
(lp2992
(dp2993
g8
V15585061.xml
p2994
sg10
VSTD-Taylor-2004
p2995
sg12
S'PMC539272'
p2996
sasa(dp2997
g3
VCD003611 v. 7.0 Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.rm5
p2998
sg5
(lp2999
(dp3000
g8
V16943938.xml
p3001
sg10
VSTD-Eslami-2005
p3002
sg12
S'PMC1502073'
p3003
sa(dp3004
g8
V21358799.xml
p3005
sg10
VSTD-Chavan-2010
p3006
sg12
S'PMC3034455'
p3007
sasa(dp3008
g3
VCD006870 v. 4.0 Statins for acute coronary syndrome.rm5
p3009
sg5
(lp3010
(dp3011
g8
V20500832.xml
p3012
sg10
VSTD-FACS-2010
p3013
sg12
S'PMC2886041'
p3014
sasa(dp3015
g3
VCD002759 v. 7.0 Progressive resistance strength training for improving physical function in older adults.rm5
p3016
sg5
(lp3017
(dp3018
g8
V17134517.xml
p3019
sg10
VSTD-Sims-2006
p3020
sg12
S'PMC1698486'
p3021
sasa(dp3022
g3
VCD007877 v. 2.0 Haemostatic drugs for traumatic brain injury.rm5
p3023
sg5
(lp3024
(dp3025
g8
V17686152.xml
p3026
sg10
VSTD-Kluger-2007
p3027
sg12
S'PMC2206502'
p3028
sasa(dp3029
g3
VCD001187 v. 9.0 House dust mite control measures for asthma.rm5
p3030
sg5
(lp3031
(dp3032
g8
V12079502.xml
p3033
sg10
VSTD-Sheikh-2002
p3034
sg12
S'PMC116603'
p3035
sasa(dp3036
g3
VCD003991 v. 10.0 Vasectomy occlusion techniques for male sterilization.rm5
p3037
sg5
(lp3038
(dp3039
g8
V15056388.xml
p3040
sg10
VSTD-Sokal-2004
p3041
sg12
S'PMC406425'
p3042
sasa(dp3043
g3
VCD004958 v. 8.0 Single or double-level anterior interbody fusion techniques for cervical degenerative disc disease.rm5
p3044
sg5
(lp3045
(dp3046
g8
V19763634.xml
p3047
sg10
VSTD-Lofgren-2010
p3048
sg12
S'PMC2899760'
p3049
sasa(dp3050
g3
VCD007309 v. 5.0 Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cance.rm5
p3051
sg5
(lp3052
(dp3053
g8
V1691921.xml
p3054
sg10
VSTD-Southampton
p3055
sg12
S'PMC1971367'
p3056
sa(dp3057
g8
V1691921.xml
p3058
sg10
VSTD-RLW-8351
p3059
sg12
S'PMC1971367'
p3060
sa(dp3061
g8
V10945489.xml
p3062
sg10
VSTD-Manchester-1
p3063
sg12
S'PMC2374661'
p3064
sasa(dp3065
g3
VCD002256 v. 9.0 Treatments for symptomatic urinary tract infections during pregnancy.rm5
p3066
sg5
(lp3067
(dp3068
g8
V18476110.xml
p3069
sg10
VSTD-Charleston-1996
p3070
sg12
S'PMC2364502'
p3071
sasa(dp3072
g3
VCD008586 v. 2.0 Antiepileptic drugs for treating seizures in adults with brain tumours.rm5
p3073
sg5
(lp3074
(dp3075
g8
V19169651.xml
p3076
sg10
VSTD-Lim-2009
p3077
sg12
S'PMC2687520'
p3078
sasa(dp3079
g3
VCD002823 v. 8.2 Transcutaneous electrostimulation for osteoarthritis of the knee.rm5
p3080
sg5
(lp3081
(dp3082
g8
V18312661.xml
p3083
sg10
VSTD-Itoh-2008
p3084
sg12
S'PMC2268695'
p3085
sasa(dp3086
g3
VCD007776 v. 3.0 Preconception care for diabetic women for improving maternal and infant health.rm5
p3087
sg5
(lp3088
(dp3089
g8
V18411239.xml
p3090
sg10
VSTD-Charron_x002d_Prochownik-2008
p3091
sg12
S'PMC2453657'
p3092
sasa(dp3093
g3
VCD002310 v. 11.2 Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children.rm5
p3094
sg5
(lp3095
(dp3096
g8
V18475734.xml
p3097
sg10
VSTD-Ringdal-1996
p3098
sg12
S'PMC2365805'
p3099
sasa(dp3100
g3
VCD009361 v. 2.2 Colesevelam for type 2 diabetes mellitus.rm5
p3101
sg5
(lp3102
(dp3103
g8
V18458145.xml
p3104
sg10
VSTD-Fonseca-2008
p3105
sg12
S'PMC2494667'
p3106
sasa(dp3107
g3
VCD004547 v. 4.0 Chinese medicinal herbs for cholelithiasis.rm5
p3108
sg5
(lp3109
(dp3110
g8
V23695700.xml
p3111
sg10
VSTD-Su-2012
p3112
sg12
S'PMC3674284'
p3113
sasa(dp3114
g3
VCD004078 v. 4.0 Postoperative adjuvant chemotherapy in rectal cancer operated for cure..rm5
p3115
sg5
(lp3116
(dp3117
g8
V17375049.xml
p3118
sg10
VSTD-Sakamoto-2007-_x0028_JFMTC15_x002d_1_x0029_
p3119
sg12
S'PMC2360162'
p3120
sa(dp3121
g8
V11720425.xml
p3122
sg10
VSTD-Taal-2001-_x0028_NACCP_x0029_
p3123
sg12
S'PMC2363941'
p3124
sasa(dp3125
g3
VCD003318 v. 6.0 Strategies for integrating primary health services in low- and middle-income countries at the point .rm5
p3126
sg5
(lp3127
(dp3128
g8
V20205841.xml
p3129
sg10
VSTD-Leon-2010
p3130
sg12
S'PMC2825497'
p3131
sa(dp3132
g8
V17388666.xml
p3133
sg10
VSTD-Gregson-2007
p3134
sg12
S'PMC1831737'
p3135
sasa(dp3136
g3
VCD008776 v. 2.0 Computer-based diabetes self-management interventions for adults with type 2 diabetes mellitus.rm5
p3137
sg5
(lp3138
(dp3139
g8
V20299481.xml
p3140
sg10
VSTD-Lorig-2010
p3141
sg12
S'PMC2875437'
p3142
sa(dp3143
g8
V21788632.xml
p3144
sg10
VSTD-Quinn-2011
p3145
sg12
S'PMC3161305'
p3146
sa(dp3147
g8
V21270188.xml
p3148
sg10
VSTD-Lim-2011
p3149
sg12
S'PMC3024339'
p3150
sasa(dp3151
g3
VCD005084 v. 6.0 Interventions for tobacco cessation in the dental setting.rm5
p3152
sg5
(lp3153
(dp3154
g8
V17475005.xml
p3155
sg10
VSTD-Binnie-2007
p3156
sg12
S'PMC1871574'
p3157
sa(dp3158
g8
V19405969.xml
p3159
sg10
VSTD-Nohlert-2009
p3160
sg12
S'PMC2685131'
p3161
sasa(dp3162
g3
VCD002748 v. 9.2 Prophylactic mastectomy for the prevention of breast cancer.rm5
p3163
sg5
(lp3164
(dp3165
g8
V16052221.xml
p3166
sg10
VSTD-van-Sprundel-2005
p3167
sg12
S'PMC2361560'
p3168
sasa(dp3169
g3
VCD003992 v. 6.0 Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.rm5
p3170
sg5
(lp3171
(dp3172
g8
V12838298.xml
p3173
sg10
VSTD-Innes-2003
p3174
sg12
S'PMC2394220'
p3175
sasa(dp3176
g3
VCD007585 v. 2.0 Lymphadenectomy for the management of endometrial cancer.rm5
p3177
sg5
(lp3178
(dp3179
g8
V19070889.xml
p3180
sg10
VSTD-Kitchener-2009
p3181
sg12
S'PMC2646126'
p3182
sasa(dp3183
g3
VCD006895 v. 4.0 Probiotics for preventing acute upper respiratory tract infections.rm5
p3184
sg5
(lp3185
(dp3186
g8
V20485304.xml
p3187
sg10
VSTD-Merenstein-2010
p3188
sg12
S'PMC2906750'
p3189
sa(dp3190
g8
V21477383.xml
p3191
sg10
VSTD-West-2011
p3192
sg12
S'PMC3083335'
p3193
sasa(dp3194
g3
VCD008603 v. 3.0 Oral vaccines for preventing cholera.rm5
p3195
sg5
(lp3196
(dp3197
g8
V18523643.xml
p3198
sg10
VSTD-Mahalanabis-2008
p3199
sg12
S'PMC2396289'
p3200
sasa(dp3201
g3
VCD009671 v. 2.0 Selenium supplementation for the primary prevention of cardiovascular disease.rm5
p3202
sg5
(lp3203
(dp3204
g8
V23028897.xml
p3205
sg10
VSTD-UK-PRECISE
p3206
sg12
S'PMC3446875'
p3207
sasa(dp3208
g3
VCD003362 v. 8.0 Male circumcision for prevention of heterosexual acquisition of HIV in men.rm5
p3209
sg5
(lp3210
(dp3211
g8
V16231970.xml
p3212
sg10
VSTD-ANRS-1265
p3213
sg12
S'PMC1262556'
p3214
sasa(dp3215
g3
VCD004401 v. 9.2 Antibiotics for the prevention of acute and chronic suppurative otitis media in children.rm5
p3216
sg5
(lp3217
(dp3218
g8
V18513453.xml
p3219
sg10
VSTD-Leach-2008
p3220
sg12
S'PMC2443129'
p3221
sasa(dp3222
g3
VCD003834 v. 5.0 Lithium for schizophrenia.rm5
p3223
sg5
(lp3224
(dp3225
g8
V22058537.xml
p3226
sg10
VSTD-Dube-1981
p3227
sg12
S'PMC3012941'
p3228
sasa(dp3229
g3
VCD007694 v. 5.0 Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmet.rm5
p3230
sg5
(lp3231
(dp3232
g8
V17362472.xml
p3233
sg10
VSTD-Kuna-2007
p3234
sg12
S'PMC1920547'
p3235
sa(dp3236
g8
V20874458.xml
p3237
sg10
VSTD-Maspero-2010
p3238
sg12
S'PMC2993043'
p3239
sasa(dp3240
g3
VCD006722 v. 3.0 Psychostimulants for depression.rm5
p3241
sg5
(lp3242
(dp3243
g8
V23522244.xml
p3244
sg10
VSTD-Wheatley-1969-b
p3245
sg12
S'PMC3606375'
p3246
sa(dp3247
g8
V23522244.xml
p3248
sg10
VSTD-Wheatley-1969-a
p3249
sg12
S'PMC3606375'
p3250
sasa(dp3251
g3
VCD001886 v. 8.0 Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.rm5
p3252
sg5
(lp3253
(dp3254
g8
V17988379.xml
p3255
sg10
VSTD-Jimenez-2007
p3256
sg12
S'PMC2246206'
p3257
sa(dp3258
g8
V18361800.xml
p3259
sg10
VSTD-Apostolakis-2008
p3260
sg12
S'PMC2287179'
p3261
sasa(dp3262
g3
VCD009672 v. 2.0 Hormone therapy for sexual function in perimenopausal and postmenopausal women.rm5
p3263
sg5
(lp3264
(dp3265
g8
V19505307.xml
p3266
sg10
VSTD-Estonian-blind-trial
p3267
sg12
S'PMC2702282'
p3268
sa(dp3269
g8
V19505307.xml
p3270
sg10
VSTD-Estonian-non_x002d_blind-trial
p3271
sg12
S'PMC2702282'
p3272
sasa(dp3273
g3
VCD004323 v. 8.0 Quality of life after rectal resection for cancer with or without permanent colostomy..rm5
p3274
sg5
(lp3275
(dp3276
g8
V21835046.xml
p3277
sg10
VSTD-Peng-2011
p3278
sg12
S'PMC3177872'
p3279
sa(dp3280
g8
V10735495.xml
p3281
sg10
VSTD-Allal-2000
p3282
sg12
S'PMC2363346'
p3283
sa(dp3284
g8
V21808871.xml
p3285
sg10
VSTD-Campos_x002d_Lobato-2011
p3286
sg12
S'PMC3129949'
p3287
sasa(dp3288
g3
VCD006772 v. 4.0 Service organisation for the secondary prevention of ischaemic heart disease in primary care.rm5
p3289
sg5
(lp3290
(dp3291
g8
V19875426.xml
p3292
sg10
VSTD-SPHERE
p3293
sg12
S'PMC2770592'
p3294
sasa(dp3295
g3
VCD004366 v. 11.2 Exercise for depression.rm5
p3296
sg5
(lp3297
(dp3298
g8
V22836201.xml
p3299
sg10
VSTD-Mutrie-1988
p3300
sg12
S'PMC3505536'
p3301
sa(dp3302
g8
V17620123.xml
p3303
sg10
VSTD-Pilu-2007
p3304
sg12
S'PMC1976311'
p3305
sasa(dp3306
g3
VCD003438 v. 9.8 Interventions for increasing pedestrian and cyclist visibility for the prevention of death and injur.rm5
p3307
sg5
(lp3308
(dp3309
g8
V23263729.xml
p3310
sg10
VSTD-Kumagai-1999
p3311
sg12
S'PMC3589943'
p3312
sasa(dp3313
g3
VCD007007 v. 3.0 Screening women for intimate partner violence in healthcare settings.rm5
p3314
sg5
(lp3315
(dp3316
g8
V21182802.xml
p3317
sg10
VSTD-Kataoka-2010
p3318
sg12
S'PMC3017017'
p3319
sasa(dp3320
g3
VCD006525 v. 5.0 Collaborative care for depression and anxiety problems.rm5
p3321
sg5
(lp3322
(dp3323
g8
V22032247.xml
p3324
sg10
VSTD-Chaney-2011
p3325
sg12
S'PMC3219630'
p3326
sa(dp3327
g8
V17338822.xml
p3328
sg10
VSTD-Landis-2007
p3329
sg12
S'PMC1838423'
p3330
sa(dp3331
g8
V19832996.xml
p3332
sg10
VSTD-Richards-2012
p3333
sg12
S'PMC2770465'
p3334
sa(dp3335
g8
V20882400.xml
p3336
sg10
VSTD-Waitzkin-2011
p3337
sg12
S'PMC3051073'
p3338
sa(dp3339
g8
V20684786.xml
p3340
sg10
VSTD-Buszewicz-2010
p3341
sg12
S'PMC2923105'
p3342
sa(dp3343
g8
V20097780.xml
p3344
sg10
VSTD-Ell-2010
p3345
sg12
S'PMC2845010'
p3346
sasa(dp3347
g3
VCD001191 v. 16.4 Rivastigmine for Alzheimer's disease.rm5
p3348
sg5
(lp3349
(dp3350
g8
V23341737.xml
p3351
sg10
VSTD-Lopez_x002d_Pousa-2005
p3352
sg12
S'PMC3546803'
p3353
sasa(dp3354
g3
VCD009107 v. 4.0 Intracutaneous or subcutaneous sterile water injection compared with blinded controls for pain manag.rm5
p3355
sg5
(lp3356
(dp3357
g8
V20640118.xml
p3358
sg10
VSTD-Saxena-2009
p3359
sg12
S'PMC2900101'
p3360
sasa(dp3361
g3
VCD002243 v. 5.2 Corticosteroids for treating severe sepsis and septic shock.rm5
p3362
sg5
(lp3363
(dp3364
g8
V12133187.xml
p3365
sg10
VSTD-Yildiz-2002
p3366
sg12
S'PMC125315'
p3367
sasa(dp3368
g3
VCD005265 v. 3.3 Antibiotic prophylaxis for patients undergoing elective laparoscopic cholecystectomy.rm5
p3369
sg5
(lp3370
(dp3371
g8
V19793473.xml
p3372
sg10
VSTD-Uludag-2009
p3373
sg12
S'PMC3015970'
p3374
sasa(dp3375
g3
VCD005495 v. 5.2 Early developmental intervention programmes post-hospital discharge to prevent motor and cognitive i.rm5
p3376
sg5
(lp3377
(dp3378
g8
V19954550.xml
p3379
sg10
VSTD-Spittle-2009a
p3380
sg12
S'PMC2797495'
p3381
sasa(dp3382
g3
VCD009235 v. 5.3 Automated versus non-automated weaning for reducing the duration of mechanical ventilation for criti.rm5
p3383
sg5
(lp3384
(dp3385
g8
V19171056.xml
p3386
sg10
VSTD-Taniguchi-2009
p3387
sg12
S'PMC2688118'
p3388
sasa(dp3389
g3
VCD005535 v. 3.0 Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticost.rm5
p3390
sg5
(lp3391
(dp3392
g8
V17629923.xml
p3393
sg10
VSTD-Houghton-2007
p3394
sg12
S'PMC1971055'
p3395
sasa(dp3396
g3
VCD001247 v. 7.3 Cooling therapy for acute stroke.rm5
p3397
sg5
(lp3398
(dp3399
g8
V11918829.xml
p3400
sg10
VSTD-Dippel-2003a
p3401
sg12
S'PMC101394'
p3402
sasa(dp3403
g3
VCD001990 v. 12.0 Chemotherapy versus best supportive care for extensive small cell lung cancer.rm5
p3404
sg5
(lp3405
(dp3406
g8
V2540788.xml
p3407
sg10
VSTD-Spiro-1989
p3408
sg12
S'PMC2247136'
p3409
sasa(dp3410
g3
VCD003218 v. 9.0 Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.rm5
p3411
sg5
(lp3412
(dp3413
g8
V17285226.xml
p3414
sg10
VSTD-Wintzen-2007
p3415
sg12
S'PMC1915648'
p3416
sasa(dp3417
g3
VCD008088 v. 6.0 Anti-TNF- treatment for pelvic pain associated with endometriosis.rm5
p3418
sg5
(lp3419
(dp3420
g8
V18556683.xml
p3421
sg10
VSTD-Koninckx-2008
p3422
sg12
S'PMC2517154'
p3423
sasa(dp3424
g3
VCD005967 v. 9.3 Artesunate versus quinine for treating severe malaria.rm5
p3425
sg5
(lp3426
(dp3427
g8
V21062666.xml
p3428
sg10
VSTD-Dondorp-2010
p3429
sg12
S'PMC3033534'
p3430
sasa(dp3431
g3
VCD006378 v. 3.0 Aspirin steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's diseas.rm5
p3432
sg5
(lp3433
(dp3434
g8
V18213383.xml
p3435
sg10
VSTD-De-Jong-2008
p3436
sg12
S'PMC2194921'
p3437
sasa(dp3438
g3
VCD006876 v. 4.0 Electromechanical and robot-assisted arm training for improving generic activities of daily living .rm5
p3439
sg5
(lp3440
(dp3441
g8
V17309791.xml
p3442
sg10
VSTD-Amirabdollahian-2007
p3443
sg12
S'PMC1819386'
p3444
sa(dp3445
g8
V16790067.xml
p3446
sg10
VSTD-Kahn-2006
p3447
sg12
S'PMC1550245'
p3448
sasa(dp3449
g3
VCD008536 v. 3.3 Short and long term effects of tibolone in postmenopausal women.rm5
p3450
sg5
(lp3451
(dp3452
g8
V23926488.xml
p3453
sg10
VSTD-Ziaei-2010a
p3454
sg12
S'PMC3719303'
p3455
sasa(dp3456
g3
VCD006973 v. 3.0 Interventions for increasing ankle range of motion in patients with neuromuscular disease.rm5
p3457
sg5
(lp3458
(dp3459
g8
V18822155.xml
p3460
sg10
VSTD-Redmond-2004
p3461
sg12
S'PMC2553778'
p3462
sasa(dp3463
g3
VCD007139 v. 3.0 Alprazolam for depression.rm5
p3464
sg5
(lp3465
(dp3466
g8
V21897464.xml
p3467
sg10
VSTD-Murthy-1991
p3468
sg12
S'PMC2988295'
p3469
sasa(dp3470
g3
VCD004082 v. 11.0 Perioperative increase in global blood flow to explicit defined goals and outcomes following surgery.rm5
p3471
sg5
(lp3472
(dp3473
g8
V20698956.xml
p3474
sg10
VSTD-Jhanji-2010
p3475
sg12
S'PMC2945135'
p3476
sa(dp3477
g8
V21624138.xml
p3478
sg10
VSTD-Cecconi-2011
p3479
sg12
S'PMC3218998'
p3480
sa(dp3481
g8
V16356219.xml
p3482
sg10
VSTD-Pearse-2005
p3483
sg12
S'PMC1414018'
p3484
sa(dp3485
g8
V20156348.xml
p3486
sg10
VSTD-Mayer-2010
p3487
sg12
S'PMC2875533'
p3488
sasa(dp3489
g3
VCD007091 v. 5.0 5-alpha-reductase inhibitors for prostate cancer prevention.rm5
p3490
sg5
(lp3491
(dp3492
g8
V9703292.xml
p3493
sg10
VSTD-Cote-1998
p3494
sg12
S'PMC2063039'
p3495
sasa(dp3496
g3
VCD000214 v. 10.5 Training health professionals in smoking cessation.rm5
p3497
sg5
(lp3498
(dp3499
g8
V17372796.xml
p3500
sg10
VSTD-Unrod-2007
p3501
sg12
S'PMC1829425'
p3502
sasa(dp3503
g3
VMR000012 v. 6.2 Randomisation to protect against selection bias in healthcare trials.rm5
p3504
sg5
(lp3505
(dp3506
g8
V12213183.xml
p3507
sg10
VSTD-Clifford-2002
p3508
sg12
S'PMC126226'
p3509
sasa(dp3510
g3
VCD003236 v. 7.0 Exercise training for adults with chronic kidney disease.rm5
p3511
sg5
(lp3512
(dp3513
g8
V20003224.xml
p3514
sg10
VSTD-Leehey-2009
p3515
sg12
S'PMC2796994'
p3516
sasa(dp3517
g3
VCD007400 v. 4.0 Topical NSAIDs for chronic musculoskeletal pain in adults.rm5
p3518
sg5
(lp3519
(dp3520
g8
V16086839.xml
p3521
sg10
VSTD-Baer-2005
p3522
sg12
S'PMC1201146'
p3523
sasa(dp3524
g3
VCD003082 v. 12.0 Haloperidol versus placebo for schizophrenia.rm5
p3525
sg5
(lp3526
(dp3527
g8
V24019874.xml
p3528
sg10
VSTD-Howard-1974
p3529
sg12
S'PMC3760896'
p3530
sasa(dp3531
g3
VCD004697 v. 6.0 Prophylactic antibiotics to reduce morbidity and mortality in neonates with umbilical artery cathete.rm5
p3532
sg5
(lp3533
(dp3534
g8
V602256.xml
p3535
sg10
VSTD-Cowett-1977
p3536
sg12
S'PMC2595562'
p3537
sasa(dp3538
g3
VCD007736 v. 2.0 Educational supportive and behavioural interventions to improve usage of continuous positive airway.rm5
p3539
sg5
(lp3540
(dp3541
g8
V17513285.xml
p3542
sg10
VSTD-Stepnowsky-2007
p3543
sg12
S'PMC1874716'
p3544
sasa(dp3545
g3
VCD007961 v. 2.0 Topical microbicides for prevention of sexually transmitted infections.rm5
p3546
sg5
(lp3547
(dp3548
g8
V19023429.xml
p3549
sg10
VSTD-Halpern-2008
p3550
sg12
S'PMC2582655'
p3551
sa(dp3552
g8
V18091987.xml
p3553
sg10
VSTD-Peterson-2007
p3554
sg12
S'PMC2129116'
p3555
sa(dp3556
g8
V20851460.xml
p3557
sg10
VSTD-McCormack-2010
p3558
sg12
S'PMC2956883'
p3559
sa(dp3560
g8
V18213382.xml
p3561
sg10
VSTD-Feldblum-2008
p3562
sg12
S'PMC2190795'
p3563
sasa(dp3564
g3
VCD004769 v. 7.0 Oxygen therapy for dyspnoea in adults.rm5
p3565
sg5
(lp3566
(dp3567
g8
V14735178.xml
p3568
sg10
VSTD-Ahmedzai-2004
p3569
sg12
S'PMC2409543'
p3570
sasa(dp3571
g3
VCD003808 v. 6.0 Operative caries management in adults and children.rm5
p3572
sg5
(lp3573
(dp3574
g8
V18096042.xml
p3575
sg10
VSTD-Innes-2007
p3576
sg12
S'PMC2265270'
p3577
sasa(dp3578
g3
VCD007503 v. 3.0 Antidepressants for depression in physically ill people.rm5
p3579
sg5
(lp3580
(dp3581
g8
V24058553.xml
p3582
sg10
VSTD-Xue-2004
p3583
sg12
S'PMC3772925'
p3584
sasa(dp3585
g3
VCD004123 v. 9.2 Hyperbaric oxygen therapy for chronic wounds.rm5
p3586
sg5
(lp3587
(dp3588
g8
V20427683.xml
p3589
sg10
VSTD-Londahl-2010
p3590
sg12
S'PMC2858204'
p3591
sasa(dp3592
g3
VCD007718 v. 3.0 Telehealthcare for chronic obstructive pulmonary disease.rm5
p3593
sg5
(lp3594
(dp3595
g8
V18417444.xml
p3596
sg10
VSTD-Nguyen-2008
p3597
sg12
S'PMC2483918'
p3598
sasa(dp3599
g3
VCD004626 v. 10.7 First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high.rm5
p3600
sg5
(lp3601
(dp3602
g8
V22022003.xml
p3603
sg10
VSTD-N0265041749
p3604
sg12
S'PMC3195130'
p3605
sasa(dp3606
g3
VCD004374 v. 3.0 Short term urinary catheter policies following urogenital surgery in adults.rm5
p3607
sg5
(lp3608
(dp3609
g8
V22778750.xml
p3610
sg10
VSTD-Wyman-1987
p3611
sg12
S'PMC3384962'
p3612
sasa(dp3613
g3
VCD003175 v. 6.0 Adjuvant chemotherapy for endometrial cancer after hysterectomy.rm5
p3614
sg5
(lp3615
(dp3616
g8
V16868539.xml
p3617
sg10
VSTD-GICOG
p3618
sg12
S'PMC2360651'
p3619
sasa(dp3620
g3
VCD003222 v. 5.0 Transcutaneous electrical nerve stimulation (TENS) for chronic pain.rm5
p3621
sg5
(lp3622
(dp3623
g8
V16897618.xml
p3624
sg10
VSTD-Oosterhof-2006
p3625
sg12
S'PMC3476076'
p3626
sasa(dp3627
g3
VCD004333 v. 6.0 Helmets for preventing injury in motorcycle riders.rm5
p3628
sg5
(lp3629
(dp3630
g8
V23259013.xml
p3631
sg10
VSTD-Goldstein-1986
p3632
sg12
S'PMC3516240'
p3633
sasa(dp3634
g3
VCD000980 v. 16.0 Vitamin C for preventing and treating the common cold.rm5
p3635
sg5
(lp3636
(dp3637
g8
V23902583.xml
p3638
sg10
VSTD-Briggs-1984
p3639
sg12
S'PMC3765382'
p3640
sasa(dp3641
g3
VCD001446 v. 14.0 Corticosteroids for Guillain-Barr syndrome.rm5
p3642
sg5
(lp3643
(dp3644
g8
V17426908.xml
p3645
sg10
VSTD-Van-Koningsveld-2004
p3646
sg12
S'PMC2778673'
p3647
sasa(dp3648
g3
VCD004116 v. 6.0 Herbal medicines for treatment of irritable bowel syndrome.rm5
p3649
sg5
(lp3650
(dp3651
g8
V21202743.xml
p3652
sg10
VSTD-Ye-LJ-2000
p3653
sg12
S'PMC2961892'
p3654
sa(dp3655
g8
V17375186.xml
p3656
sg10
VSTD-Gu-XX-1999
p3657
sg12
S'PMC1810433'
p3658
sa(dp3659
g8
V23788040.xml
p3660
sg10
VSTD-Xu-XP-2002
p3661
sg12
S'PMC3702287'
p3662
sasa(dp3663
g3
VCD004011 v. 5.0 Strategies for the removal of short-term indwelling urethral catheters in adults.rm5
p3664
sg5
(lp3665
(dp3666
g8
V22778750.xml
p3667
sg10
VSTD-Wyman-1987
p3668
sg12
S'PMC3384962'
p3669
sasa(dp3670
g3
VCD001287 v. 10.6 Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.rm5
p3671
sg5
(lp3672
(dp3673
g8
V19624838.xml
p3674
sg10
VSTD-Worth-2009
p3675
sg12
S'PMC2720945'
p3676
sasa(dp3677
g3
VCD007881 v. 3.0 Interventions for cough in cancer.rm5
p3678
sg5
(lp3679
(dp3680
g8
V8688342.xml
p3681
sg10
VSTD-Moroni-1996
p3682
sg12
S'PMC2074576'
p3683
sasa(dp3684
g3
VCD007798 v. 3.0 Clinically-indicated replacement versus routine replacement of peripheral venous catheters.rm5
p3685
sg5
(lp3686
(dp3687
g8
V18614482.xml
p3688
sg10
VSTD-Webster-2008
p3689
sg12
S'PMC2483870'
p3690
sa(dp3691
g8
V20831782.xml
p3692
sg10
VSTD-Rickard-2010
p3693
sg12
S'PMC2944158'
p3694
sasa(dp3695
g3
VCD003048 v. 6.0 Probiotics for treating acute infectious diarrhoea.rm5
p3696
sg5
(lp3697
(dp3698
g8
V17287932.xml
p3699
sg10
VSTD-Henker-2007a
p3700
sg12
S'PMC1802727'
p3701
sa(dp3702
g8
V17760859.xml
p3703
sg10
VSTD-Frigerio-1986
p3704
sg12
S'PMC2171037'
p3705
sasa(dp3706
g3
VCD002892 v. 7.0 Preventing occupational stress in healthcare workers.rm5
p3707
sg5
(lp3708
(dp3709
g8
V14710215.xml
p3710
sg10
VSTD-Delvaux-2004
p3711
sg12
S'PMC2395320'
p3712
sasa(dp3713
g3
VCD002808 v. 6.0 Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary.rm5
p3714
sg5
(lp3715
(dp3716
g8
V22427771.xml
p3717
sg10
VSTD-Tehraninejad-2010
p3718
sg12
S'PMC3302709'
p3719
sasa(dp3720
g3
VCD009611 v. 3.0 Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.rm5
p3721
sg5
(lp3722
(dp3723
g8
V17634183.xml
p3724
sg10
VSTD-Turpeinen-2008
p3725
sg12
S'PMC2532957'
p3726
sasa(dp3727
g3
VCD000515 v. 6.2 Percutaneous transluminal balloon angioplasty and stenting for carotid artery stenosis.rm5
p3728
sg5
(lp3729
(dp3730
g8
V20189239.xml
p3731
sg10
VSTD-ICSS-2010
p3732
sg12
S'PMC2849002'
p3733
sasa(dp3734
g3
VCD004260 v. 8.0 Continuous passive motion following total knee arthroplasty in people with arthritis.rm5
p3735
sg5
(lp3736
(dp3737
g8
V18442423.xml
p3738
sg10
VSTD-Lenssen-2008
p3739
sg12
S'PMC2386789'
p3740
sa(dp3741
g8
V16504087.xml
p3742
sg10
VSTD-Lenssen-2003
p3743
sg12
S'PMC1403777'
p3744
sasa(dp3745
g3
VCD006633 v. 5.0 Clozapine versus other atypical antipsychotics for schizophrenia.rm5
p3746
sg5
(lp3747
(dp3748
g8
V23869281.xml
p3749
sg10
VSTD-Li--2003
p3750
sg12
S'PMC3707322'
p3751
sasa(dp3752
g3
VCD005992 v. 4.0 Legislative smoking bans for reducing secondhand smoke exposure smoking prevalence and tobacco cons.rm5
p3753
sg5
(lp3754
(dp3755
g8
V19165321.xml
p3756
sg10
VSTD-Fern_x00e1_ndez-2009
p3757
sg12
S'PMC2621339'
p3758
sa(dp3759
g8
V17760974.xml
p3760
sg10
VSTD-Gal_x00e1_n-2007
p3761
sg12
S'PMC2034550'
p3762
sasa(dp3763
g3
VCD001069 v. 7.0 Sucrose for analgesia in newborn infants undergoing painful procedures.rm5
p3764
sg5
(lp3765
(dp3766
g8
V19448377.xml
p3767
sg10
VSTD-Alsaedi-2009
p3768
sg12
S'PMC2813645'
p3769
sa(dp3770
g8
V20817247.xml
p3771
sg10
VSTD-Slater-2010
p3772
sg12
S'PMC2958259'
p3773
sasa(dp3774
g3
VCD009285 v. 4.0 Tiotropium versus placebo for chronic obstructive pulmonary disease.rm5
p3775
sg5
(lp3776
(dp3777
g8
V18686739.xml
p3778
sg10
VSTD-Tonnel-2008
p3779
sg12
S'PMC2629970'
p3780
sa(dp3781
g8
V20714373.xml
p3782
sg10
VSTD-Bateman-2010b
p3783
sg12
S'PMC2921687'
p3784
sa(dp3785
g8
V17605774.xml
p3786
sg10
VSTD-Freeman-2007
p3787
sg12
S'PMC1913915'
p3788
sa(dp3789
g8
V21503263.xml
p3790
sg10
VSTD-Trooster-2011
p3791
sg12
S'PMC3078679'
p3792
sa(dp3793
g8
V21103404.xml
p3794
sg10
VSTD-Cooper-2010
p3795
sg12
S'PMC2981152'
p3796
sasa(dp3797
g3
VCD008054 v. 2.2 Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.rm5
p3798
sg5
(lp3799
(dp3800
g8
V14511396.xml
p3801
sg10
VSTD-Guyot-2003
p3802
sg12
S'PMC222910'
p3803
sasa(dp3804
g3
VCD003423 v. 4.2 Antihistamines andor decongestants for otitis media with effusion (OME) in children.rm5
p3805
sg5
(lp3806
(dp3807
g8
V19434268.xml
p3808
sg10
VSTD-Choung-2008
p3809
sg12
S'PMC2671765'
p3810
sasa(dp3811
g3
VCD008216 v. 3.0 Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for non-rhabdomy.rm5
p3812
sg5
(lp3813
(dp3814
g8
V14520438.xml
p3815
sg10
VSTD-Bertuzzi-2003
p3816
sg12
S'PMC2394317'
p3817
sasa(dp3818
g3
VCD005457 v. 7.0 Carbetocin for preventing postpartum haemorrhage.rm5
p3819
sg5
(lp3820
(dp3821
g8
V17176279.xml
p3822
sg10
VSTD-Leung-2006
p3823
sg12
S'PMC1804104'
p3824
sasa(dp3825
g3
VCD008250 v. 2.0 Breathing exercises for chronic obstructive pulmonary disease.rm5
p3826
sg5
(lp3827
(dp3828
g8
V20418993.xml
p3829
sg10
VSTD-Katiyar-2006
p3830
sg12
S'PMC2856361'
p3831
sasa(dp3832
g3
VCD001544 v. 8.0 Mechanical bowel preparation for elective colorectal surgery.rm5
p3833
sg5
(lp3834
(dp3835
g8
V20433721.xml
p3836
sg10
VSTD-Scabini-2010
p3837
sg12
S'PMC2873340'
p3838
sasa(dp3839
g3
VCD007754 v. 3.0 Community-based intervention packages for reducing maternal and neonatal morbidity and mortality and.rm5
p3840
sg5
(lp3841
(dp3842
g8
V17591348.xml
p3843
sg10
VSTD-Syed-2006
p3844
sg12
S'PMC3001155'
p3845
sa(dp3846
g8
V23826502.xml
p3847
sg10
VSTD-Bhutta-2010
p3848
sg12
S'PMC3700035'
p3849
sa(dp3850
g8
V17591349.xml
p3851
sg10
VSTD-Bari-2006
p3852
sg12
S'PMC3001156'
p3853
sasa(dp3854
g3
VCD000422 v. 8.0 Vaccines for preventing pneumococcal infection in adults.rm5
p3855
sg5
(lp3856
(dp3857
g8
V20211953.xml
p3858
sg10
VSTD-Maruyama-2010
p3859
sg12
S'PMC2834887'
p3860
sasa(dp3861
g3
VCD000528 v. 8.4 Drugs for treating Schistosoma mansoni infection.rm5
p3862
sg5
(lp3863
(dp3864
g8
V19296834.xml
p3865
sg10
VSTD-Tweyongyere-2009-UGA
p3866
sg12
S'PMC2666740'
p3867
sa(dp3868
g8
V21695161.xml
p3869
sg10
VSTD-Olliaro-2011-TZA
p3870
sg12
S'PMC3114749'
p3871
sa(dp3872
g8
V21695161.xml
p3873
sg10
VSTD-Olliaro-2011-MRT
p3874
sg12
S'PMC3114749'
p3875
sa(dp3876
g8
V21695161.xml
p3877
sg10
VSTD-Olliaro-2011-BRA
p3878
sg12
S'PMC3114749'
p3879
sasa(dp3880
g3
VCD009514 v. 1.0 Relaxation techniques for pain management in labour.rm5
p3881
sg5
(lp3882
(dp3883
g8
V19538406.xml
p3884
sg10
VSTD-Bergstrom-2009
p3885
sg12
S'PMC2759981'
p3886
sasa(dp3887
g3
VCD004108 v. 9.0 Nedocromil sodium for chronic asthma in children.rm5
p3888
sg5
(lp3889
(dp3890
g8
V18475604.xml
p3891
sg10
VSTD-Fiocchi-1994
p3892
sg12
S'PMC2365600'
p3893
sasa(dp3894
g3
VCD004015 v. 6.3 Lay health workers in primary and community health care for maternal and child health and the manage.rm5
p3895
sg5
(lp3896
(dp3897
g8
V18364043.xml
p3898
sg10
VSTD-Kouyate-2008
p3899
sg12
S'PMC2287184'
p3900
sa(dp3901
g8
V19181730.xml
p3902
sg10
VSTD-MacArthur-2009
p3903
sg12
S'PMC2636685'
p3904
sa(dp3905
g8
V17591349.xml
p3906
sg10
VSTD-Bari-2006
p3907
sg12
S'PMC3001156'
p3908
sa(dp3909
g8
V19147637.xml
p3910
sg10
VSTD-Dennis-2009
p3911
sg12
S'PMC2628301'
p3912
sa(dp3913
g8
V18686554.xml
p3914
sg10
VSTD-Zaman-2008
p3915
sg12
S'PMC2740673'
p3916
sasa(dp3917
g3
VCD001090 v. 10.5 Intravenous immunoglobulin for treating sepsis severe sepsis and septic shock.rm5
p3918
sg5
(lp3919
(dp3920
g8
V12512504.xml
p3921
sg10
VSTD-Karatzas-2002
p3922
sg12
S'PMC153443'
p3923
sa(dp3924
g8
V12225613.xml
p3925
sg10
VSTD-Tugrul-2002
p3926
sg12
S'PMC125317'
p3927
sasa(dp3928
g3
VCD001293 v. 13.0 School-based programmes for preventing smoking.rm5
p3929
sg5
(lp3930
(dp3931
g8
V18468543.xml
p3932
sg10
VSTD-Campbell-2008
p3933
sg12
S'PMC2387195'
p3934
sa(dp3935
g8
V19440519.xml
p3936
sg10
VSTD-Johnson-2009
p3937
sg12
S'PMC2681204'
p3938
sasa(dp3939
g3
VCD000054 v. 10.0 Interventions for treating genital chlamydia trachomatis infection in pregnancy.rm5
p3940
sg5
(lp3941
(dp3942
g8
V18476121.xml
p3943
sg10
VSTD-Edwards-1996
p3944
sg12
S'PMC2364515'
p3945
sa(dp3946
g8
V18476128.xml
p3947
sg10
VSTD-Martin-1997
p3948
sg12
S'PMC2364533'
p3949
sa(dp3950
g8
V18476049.xml
p3951
sg10
VSTD-Rosenn-1995
p3952
sg12
S'PMC2364446'
p3953
sa(dp3954
g8
V18475393.xml
p3955
sg10
VSTD-Turrentine-1995
p3956
sg12
S'PMC2364394'
p3957
sasa(dp3958
g3
VCD006099 v. 6.0 Wound drains following thyroid surgery.rm5
p3959
sg5
(lp3960
(dp3961
g8
V15946379.xml
p3962
sg10
VSTD-Khanna-2005
p3963
sg12
S'PMC1156915'
p3964
sasa(dp3965
g3
VMR000010 v. 6.0 Grey literature in meta-analyses of randomized trials of health care interventions.rm5
p3966
sg5
(lp3967
(dp3968
g8
V23645909.xml
p3969
sg10
VSTD-Hopewell-2004
p3970
sg12
S'PMC3646177'
p3971
sasa(dp3972
g3
VCD008492 v. 3.0 Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.rm5
p3973
sg5
(lp3974
(dp3975
g8
V20832366.xml
p3976
sg10
VSTD-Smithuis-2010-MMR
p3977
sg12
S'PMC2947715'
p3978
sa(dp3979
g8
V20409302.xml
p3980
sg10
VSTD-Awab-2010-AFG
p3981
sg12
S'PMC2864284'
p3982
sa(dp3983
g8
V16179089.xml
p3984
sg10
VSTD-Hutagalung-2005-THA
p3985
sg12
S'PMC1261533'
p3986
sa(dp3987
g8
V21267072.xml
p3988
sg10
VSTD-Poravuth-2010-ASIA
p3989
sg12
S'PMC3022577'
p3990
sasa(dp3991
g3
VCD005231 v. 5.0 Interventions to reduce harm from continued tobacco use.rm5
p3992
sg5
(lp3993
(dp3994
g8
V19943947.xml
p3995
sg10
VSTD-Kralikova-2009
p3996
sg12
S'PMC2792228'
p3997
sasa(dp3998
g3
VCD004307 v. 10.0 Competitions and incentives for smoking cessation.rm5
p3999
sg5
(lp4000
(dp4001
g8
V23626740.xml
p4002
sg10
VSTD-Paxton-1980
p4003
sg12
S'PMC3633932'
p4004
sasa(dp4005
g3
VCD004376 v. 5.0 Exercise for osteoarthritis of the knee.rm5
p4006
sg5
(lp4007
(dp4008
g8
V15924620.xml
p4009
sg10
VSTD-Thorstensson-2005
p4010
sg12
S'PMC1187893'
p4011
sasa(dp4012
g3
VCD006655 v. 4.0 Laparoscopy versus laparotomy for the management of early stage endometrial cancer.rm5
p4013
sg5
(lp4014
(dp4015
g8
V16381364.xml
p4016
sg10
VSTD-Zorlu-2005
p4017
sg12
S'PMC3015649'
p4018
sasa(dp4019
g3
VCD008039 v. 4.0 Ibuprofen with or without an antiemetic for acute migraine headaches in adults.rm5
p4020
sg5
(lp4021
(dp4022
g8
V17563841.xml
p4023
sg10
VSTD-Misra-2007
p4024
sg12
S'PMC3476139'
p4025
sasa(dp4026
g3
VCD007315 v. 2.0 Perioperative glycaemic control for diabetic patients undergoing surgery.rm5
p4027
sg5
(lp4028
(dp4029
g8
V18799004.xml
p4030
sg10
VSTD-De-La-Rosa-2008
p4031
sg12
S'PMC2592751'
p4032
sa(dp4033
g8
V19142552.xml
p4034
sg10
VSTD-Chan-2008
p4035
sg12
S'PMC2671976'
p4036
sasa(dp4037
g3
VCD006782 v. 4.0 Interventions for preventing hamstring injuries.rm5
p4038
sg5
(lp4039
(dp4040
g8
V21967753.xml
p4041
sg10
VSTD-Hoskins-2008
p4042
sg12
S'PMC3204266'
p4043
sasa(dp4044
g3
VCD008651 v. 3.0 Stavudine or zidovudine in three-drug combination therapy for initial treatment of HIV infection in .rm5
p4045
sg5
(lp4046
(dp4047
g8
V19081791.xml
p4048
sg10
VSTD-Li-2008
p4049
sg12
S'PMC2597744'
p4050
sasa(dp4051
g3
VCD005292 v. 5.2 Herbal preparations for uterine fibroids.rm5
p4052
sg5
(lp4053
(dp4054
g8
V23813869.xml
p4055
sg10
VSTD-Liu-LY-2010
p4056
sg12
S'PMC3759346'
p4057
sa(dp4058
g8
V21201460.xml
p4059
sg10
VSTD-Zhu-FH-2006
p4060
sg12
S'PMC2960419'
p4061
sasa(dp4062
g3
VCD002200 v. 5.0 Follow-up strategies for patients treated for non-metastatic colorectal cancer.rm5
p4063
sg5
(lp4064
(dp4065
g8
V16622437.xml
p4066
sg10
VSTD-Wattchow-2006
p4067
sg12
S'PMC2361245'
p4068
sasa(dp4069
g3
VCD002967 v. 10.0 Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.rm5
p4070
sg5
(lp4071
(dp4072
g8
V19688338.xml
p4073
sg10
VSTD-Russell_x002d_Jones-2009
p4074
sg12
S'PMC2744824'
p4075
sa(dp4076
g8
V17403121.xml
p4077
sg10
VSTD-Home-2007
p4078
sg12
S'PMC1974817'
p4079
sa(dp4080
g8
V19289857.xml
p4081
sg10
VSTD-Zinman-2009
p4082
sg12
S'PMC2699702'
p4083
sa(dp4084
g8
V19114612.xml
p4085
sg10
VSTD-List-2009
p4086
sg12
S'PMC2660449'
p4087
sa(dp4088
g8
V19366970.xml
p4089
sg10
VSTD-Nauck-2009b
p4090
sg12
S'PMC2699710'
p4091
sa(dp4092
g8
V18931095.xml
p4093
sg10
VSTD-Nauck-2009a
p4094
sg12
S'PMC2606836'
p4095
sasa(dp4096
g3
VCD004690 v. 6.0 Cognitive behavioural therapy for anxiety disorders in children and adolescents.rm5
p4097
sg5
(lp4098
(dp4099
g8
V21356037.xml
p4100
sg10
VSTD-Melfsen-2011
p4101
sg12
S'PMC3058082'
p4102
sasa(dp4103
g3
VCD000146 v. 19.3 Nicotine replacement therapy for smoking cessation.rm5
p4104
sg5
(lp4105
(dp4106
g8
V22323576.xml
p4107
sg10
VSTD-T_x00f8_nnesen-2012
p4108
sg12
S'PMC3432241'
p4109
sasa(dp4110
g3
VCD006383 v. 3.2 Insulin detemir versus insulin glargine for type 2 diabetes mellitus.rm5
p4111
sg5
(lp4112
(dp4113
g8
V18204830.xml
p4114
sg10
VSTD-Rosenstock-2008
p4115
sg12
S'PMC2235909'
p4116
sa(dp4117
g8
V20200301.xml
p4118
sg10
VSTD-Swinnen-2010a
p4119
sg12
S'PMC2875419'
p4120
sasa(dp4121
g3
VCD007335 v. 3.0 Interventions to improve question formulation in professional practice and self-directed learning.rm5
p4122
sg5
(lp4123
(dp4124
g8
V11716797.xml
p4125
sg10
VSTD-Villanueva-2001
p4126
sg12
S'PMC59901'
p4127
sasa(dp4128
g3
VCD006612 v. 4.0 Homocysteine-lowering interventions for preventing cardiovascular events.rm5
p4129
sg5
(lp4130
(dp4131
g8
V21115589.xml
p4132
sg10
VSTD-SU.FOL.OM3-2010
p4133
sg12
S'PMC2993045'
p4134
sasa(dp4135
g3
VCD006474 v. 4.0 Prebiotics in infants for prevention of allergy.rm5
p4136
sg5
(lp4137
(dp4138
g8
V18947426.xml
p4139
sg10
VSTD-Westerbeek-2010
p4140
sg12
S'PMC2579424'
p4141
sasa(dp4142
g3
VCD006616 v. 3.2 N-acetylcysteine for sepsis and systemic inflammatory response in adults.rm5
p4143
sg5
(lp4144
(dp4145
g8
V15312215.xml
p4146
sg10
VSTD-Emet-2004
p4147
sg12
S'PMC522835'
p4148
sasa(dp4149
g3
VCD006219 v. 5.25 Interventions for preventing weight gain after smoking cessation.rm5
p4150
sg5
(lp4151
(dp4152
g8
V18263663.xml
p4153
sg10
VSTD-_x0032_-VA-Aubin-2008
p4154
sg12
S'PMC2569194'
p4155
sasa(dp4156
g3
VCD004250 v. 8.7 Exercises for mechanical neck disorders.rm5
p4157
sg5
(lp4158
(dp4159
g8
V19812130.xml
p4160
sg10
VSTD-Kuijper-2009
p4161
sg12
S'PMC2758937'
p4162
sa(dp4163
g8
V21303529.xml
p4164
sg10
VSTD-Martel-2011
p4165
sg12
S'PMC3045999'
p4166
sasa(dp4167
g3
VCD007287 v. 2.0 Antigen-specific active immunotherapy for ovarian cancer.rm5
p4168
sg5
(lp4169
(dp4170
g8
V19216794.xml
p4171
sg10
VSTD-Str_x00f6_hlein-2009
p4172
sg12
S'PMC2644666'
p4173
sasa(dp4174
g3
VCD002140 v. 7.0 Concurrent chemoradiotherapy in non-small cell lung cancer.rm5
p4175
sg5
(lp4176
(dp4177
g8
V16641904.xml
p4178
sg10
VSTD-Manegold-2003
p4179
sg12
S'PMC2361263'
p4180
sasa(dp4181
g3
VCD003908 v. 8.0 Rehabilitation interventions for foot drop in neuromuscular disease.rm5
p4182
sg5
(lp4183
(dp4184
g8
V17361345.xml
p4185
sg10
VSTD-van-der-Kooi-2007
p4186
sg12
S'PMC2779375'
p4187
sasa(dp4188
g3
VCD001220 v. 8.2 Population-based biomedical sexually transmitted infection control interventions for reducing HIV in.rm5
p4189
sg5
(lp4190
(dp4191
g8
V17388666.xml
p4192
sg10
VSTD-Gregson-2007
p4193
sg12
S'PMC1831737'
p4194
sasa(dp4195
g3
VCD008381 v. 2.2 Psychological and pharmacological interventions for depression in patients with diabetes mellitus an.rm5
p4196
sg5
(lp4197
(dp4198
g8
V19729522.xml
p4199
sg10
VSTD-Echeverry-2009
p4200
sg12
S'PMC2782968'
p4201
sa(dp4202
g8
V17570858.xml
p4203
sg10
VSTD-Paile_x002d_Hyv_x00e4_rinen-2007
p4204
sg12
S'PMC1914073'
p4205
sa(dp4206
g8
V12747810.xml
p4207
sg10
VSTD-Paile_x002d_Hyv_x00e4_rinen-2003
p4208
sg12
S'PMC165418'
p4209
sa(dp4210
g8
V24058553.xml
p4211
sg10
VSTD-Xue-2004
p4212
sg12
S'PMC3772925'
p4213
sa(dp4214
g8
V21216855.xml
p4215
sg10
VSTD-van-Bastelaar-2011
p4216
sg12
S'PMC3024341'
p4217
sasa(dp4218
g3
VCD004125 v. 6.0 Drugs for preventing postoperative nausea and vomiting.rm5
p4219
sg5
(lp4220
(dp4221
g8
V1853495.xml
p4222
sg10
VSTD-Campbell-1991
p4223
sg12
S'PMC2448633'
p4224
sa(dp4225
g8
V9876753.xml
p4226
sg10
VSTD-Dabbous-1998
p4227
sg12
S'PMC3015295'
p4228
sasa(dp4229
g3
VCD000256 v. 10.0 Artemisinin derivatives for treating uncomplicated malaria.rm5
p4230
sg5
(lp4231
(dp4232
g8
V23818874.xml
p4233
sg10
VSTD-ThanMYA91
p4234
sg12
S'PMC3688502'
p4235
sa(dp4236
g8
V23818874.xml
p4237
sg10
VSTD-ThanMYA97
p4238
sg12
S'PMC3688502'
p4239
sa(dp4240
g8
V23818874.xml
p4241
sg10
VSTD-ThanMYA93b
p4242
sg12
S'PMC3688502'
p4243
sa(dp4244
g8
V23818874.xml
p4245
sg10
VSTD-ThanMYA93c
p4246
sg12
S'PMC3688502'
p4247
sa(dp4248
g8
V23818874.xml
p4249
sg10
VSTD-ThanMYA93a
p4250
sg12
S'PMC3688502'
p4251
sa(dp4252
g8
V23818874.xml
p4253
sg10
VSTD-ThanMYA96a
p4254
sg12
S'PMC3688502'
p4255
sa(dp4256
g8
V23818874.xml
p4257
sg10
VSTD-ThanMYA94a
p4258
sg12
S'PMC3688502'
p4259
sa(dp4260
g8
V23818874.xml
p4261
sg10
VSTD-ThanMYA90_x002d_91
p4262
sg12
S'PMC3688502'
p4263
sasa(dp4264
g3
VCD000941 v. 13.0 Vaginal misoprostol for cervical ripening and induction of labour.rm5
p4265
sg5
(lp4266
(dp4267
g8
V15450119.xml
p4268
sg10
VSTD-_x0030_13-Papanikolaou-2004
p4269
sg12
S'PMC524504'
p4270
sasa(dp4271
g3
VCD004421 v. 8.0 Taxanes for adjuvant treatment of early breast cancer.rm5
p4272
sg5
(lp4273
(dp4274
g8
V19819914.xml
p4275
sg10
VSTD-FinHer
p4276
sg12
S'PMC2860103'
p4277
sasa(dp4278
g3
VCD003410 v. 20.2 Heroin maintenance for chronic heroin-dependent individuals.rm5
p4279
sg5
(lp4280
(dp4281
g8
V17002810.xml
p4282
sg10
VSTD-RIOTT-2010
p4283
sg12
S'PMC1613238'
p4284
sasa(dp4285
g3
VCD000006 v. 8.0 Absorbable suture materials for primary repair of episiotomy and second degree tears.rm5
p4286
sg5
(lp4287
(dp4288
g8
V10881642.xml
p4289
sg10
VSTD-McElhinney-2000
p4290
sg12
S'PMC2449154'
p4291
sasa(dp4292
g3
VCD002137 v. 8.2 Reduced or modified dietary fat for preventing cardiovascular disease.rm5
p4293
sg5
(lp4294
(dp4295
g8
V19542011.xml
p4296
sg10
VSTD-Strychar-2009
p4297
sg12
S'PMC2732152'
p4298
sasa(dp4299
g3
VCD000947 v. 8.0 Continuous and interrupted suturing techniques for repair of episiotomy or second-degree tears.rm5
p4300
sg5
(lp4301
(dp4302
g8
V24059980.xml
p4303
sg10
VSTD-Zafar-2008
p4304
sg12
S'PMC3734022'
p4305
sasa(dp4306
g3
VMR000023 v. 4.2 When and how to update systematic reviews.rm5
p4307
sg5
(lp4308
(dp4309
g8
V12877755.xml
p4310
sg10
VSTD-Barrowman-2003
p4311
sg12
S'PMC212708'
p4312
sa(dp4313
g8
V22415239.xml
p4314
sg10
VSTD-Weller-1998
p4315
sg12
S'PMC3314787'
p4316
sasa(dp4317
g3
VCD003869 v. 10.0 Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.rm5
p4318
sg5
(lp4319
(dp4320
g8
V19127261.xml
p4321
sg10
VSTD-Neuhaus-2009
p4322
sg12
S'PMC2634726'
p4323
sasa(dp4324
g3
VCD002295 v. 9.0 Exercise interventions for smoking cessation.rm5
p4325
sg5
(lp4326
(dp4327
g8
V19017582.xml
p4328
sg10
VSTD-McKay-2008
p4329
sg12
S'PMC2630830'
p4330
sasa(dp4331
g3
VCD006250 v. 4.0 Bisphosphonates for advanced prostate cancer.rm5
p4332
sg5
(lp4333
(dp4334
g8
V9328156.xml
p4335
sg10
VSTD-Kylmala-1997
p4336
sg12
S'PMC2228066'
p4337
sasa(dp4338
g3
VCD005455 v. 4.0 Choice of instruments for assisted vaginal delivery.rm5
p4339
sg5
(lp4340
(dp4341
g8
V22685661.xml
p4342
sg10
VSTD-Mustafa-2002
p4343
sg12
S'PMC3366228'
p4344
sasa(dp4345
g3
VCD007071 v. 4.0 In-service training for health professionals to improve care of the seriously ill newborn or child i.rm5
p4346
sg5
(lp4347
(dp4348
g8
V18270586.xml
p4349
sg10
VSTD-Opiyo-2008
p4350
sg12
S'PMC2229665'
p4351
sasa(dp4352
g3
VCD007107 v. 2.4 Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in ca.rm5
p4353
sg5
(lp4354
(dp4355
g8
V11720426.xml
p4356
sg10
VSTD-Sculier-2001
p4357
sg12
S'PMC2363948'
p4358
sasa(dp4359
g3
VCD006663 v. 7.0 Enzyme replacement therapy for Anderson-Fabry disease.rm5
p4360
sg5
(lp4361
(dp4362
g8
V17622343.xml
p4363
sg10
VSTD-Vedder-2007
p4364
sg12
S'PMC1913555'
p4365
sasa(dp4366
g3
VCD006185 v. 5.0 Electromechanical-assisted training for walking after stroke.rm5
p4367
sg5
(lp4368
(dp4369
g8
V19523207.xml
p4370
sg10
VSTD-Westlake-2009
p4371
sg12
S'PMC2708184'
p4372
sasa(dp4373
g3
VCD005460 v. 6.0 Traditional birth attendant training for improving health behaviours and pregnancy outcomes.rm5
p4374
sg5
(lp4375
(dp4376
g8
V21292711.xml
p4377
sg10
VSTD-Gill-2011
p4378
sg12
S'PMC3032994'
p4379
sasa(dp4380
g3
VCD003916 v. 7.1 Adjuvant radiotherapy for stage I endometrial cancer.rm5
p4381
sg5
(lp4382
(dp4383
g8
V19070891.xml
p4384
sg10
VSTD-ASTEC_x002f_EN.5
p4385
sg12
S'PMC2646125'
p4386
sasa(dp4387
g3
VCD002946 v. 8.0 Glucosamine therapy for treating osteoarthritis.rm5
p4388
sg5
(lp4389
(dp4390
g8
V17974032.xml
p4391
sg10
VSTD-Mehta-2007
p4392
sg12
S'PMC2131759'
p4393
sasa(dp4394
g3
VCD007897 v. 2.2 Remediating buildings damaged by dampness and mould for preventing or reducing respiratory tract sym.rm5
p4395
sg5
(lp4396
(dp4397
g8
V17035145.xml
p4398
sg10
VSTD-Kercsmar-2006
p4399
sg12
S'PMC1626393'
p4400
sasa(dp4401
g3
VCD002006 v. 10.0 Position in the second stage of labour for women without epidural anaesthesia.rm5
p4402
sg5
(lp4403
(dp4404
g8
V23492921.xml
p4405
sg10
VSTD-Bhardwaj-1994
p4406
sg12
S'PMC3590536'
p4407
sasa(dp4408
g3
VCD001224 v. 5.0 Voluntary counseling and testing (VCT) for changing HIV-related risk behavior in developing countrie.rm5
p4409
sg5
(lp4410
(dp4411
g8
V19623481.xml
p4412
sg10
VSTD-Cremin-2010
p4413
sg12
S'PMC2865634'
p4414
sasa(dp4415
g3
VCD006282 v. 4.0 Drug treatment for spinal muscular atrophy types II and III.rm5
p4416
sg5
(lp4417
(dp4418
g8
V20808854.xml
p4419
sg10
VSTD-Swoboda-2010
p4420
sg12
S'PMC2924376'
p4421
sasa(dp4422
g3
VCD007277 v. 3.0 Abatacept for rheumatoid arthritis.rm5
p4423
sg5
(lp4424
(dp4425
g8
V18055472.xml
p4426
sg10
VSTD-Schiff-2008
p4427
sg12
S'PMC2564802'
p4428
sasa(dp4429
g3
VCD000059 v. 12.0 Clozapine versus typical neuroleptic medication for schizophrenia.rm5
p4430
sg5
(lp4431
(dp4432
g8
V23984190.xml
p4433
sg10
VSTD-Xia-2002-_x0028_CPZ_x0029_
p4434
sg12
S'PMC3745831'
p4435
sasa(dp4436
g3
VCD004525 v. 6.51 Etanercept for the treatment of rheumatoid arthritis.rm5
p4437
sg5
(lp4438
(dp4439
g8
V18794178.xml
p4440
sg10
VSTD-Combe-2006
p4441
sg12
S'PMC2689524'
p4442
sasa(dp4443
g3
VCD008449 v. 2.0 Mirror therapy for improving motor function after stroke.rm5
p4444
sg5
(lp4445
(dp4446
g8
V21515905.xml
p4447
sg10
VSTD-Ietswaart-2011
p4448
sg12
S'PMC3097892'
p4449
sa(dp4450
g8
V22506139.xml
p4451
sg10
VSTD-Yun-2010
p4452
sg12
S'PMC3309215'
p4453
sasa(dp4454
g3
VCD005956 v. 3.0 Interventions to improve adherence to exercise for chronic musculoskeletal pain in adults.rm5
p4455
sg5
(lp4456
(dp4457
g8
V17907147.xml
p4458
sg10
VSTD-Hurley-2007
p4459
sg12
S'PMC2673355'
p4460
sa(dp4461
g8
V16734904.xml
p4462
sg10
VSTD-Nour-2006
p4463
sg12
S'PMC1525193'
p4464
sa(dp4465
g8
V15285783.xml
p4466
sg10
VSTD-Ersek-2004
p4467
sg12
S'PMC509247'
p4468
sa(dp4469
g8
V16426449.xml
p4470
sg10
VSTD-Smeets-2006
p4471
sg12
S'PMC1382224'
p4472
sasa(dp4473
g3
VCD003030 v. 6.5 Continuing education meetings and workshops effects on professional practice and health care outcom.rm5
p4474
sg5
(lp4475
(dp4476
g8
V12694632.xml
p4477
sg10
VSTD-Forsetlund-2003
p4478
sg12
S'PMC153535'
p4479
sasa(dp4480
g3
VCD010292 v. 3.0 Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome.rm5
p4481
sg5
(lp4482
(dp4483
g8
V20428412.xml
p4484
sg10
VSTD-Chappell-2008
p4485
sg12
S'PMC2840539'
p4486
sasa(dp4487
g3
VCD002795 v. 8.0 Pharmacotherapy for post traumatic stress disorder (PTSD).rm5
p4488
sg5
(lp4489
(dp4490
g8
V21407853.xml
p4491
sg10
VSTD-Pfizer588
p4492
sg12
S'PMC2955947'
p4493
sa(dp4494
g8
V21407853.xml
p4495
sg10
VSTD-Pfizer589
p4496
sg12
S'PMC2955947'
p4497
sasa(dp4498
g3
VCD008152 v. 2.4 Primaquine for reducing Plasmodium falciparum transmission.rm5
p4499
sg5
(lp4500
(dp4501
g8
V20832366.xml
p4502
sg10
VSTD-Smithuis-2010
p4503
sg12
S'PMC2947715'
p4504
sa(dp4505
g8
V22303437.xml
p4506
sg10
VSTD-Kolaczinski-2012
p4507
sg12
S'PMC3269419'
p4508
sa(dp4509
g8
V18074034.xml
p4510
sg10
VSTD-El_x002d_Sayed-2007
p4511
sg12
S'PMC2111052'
p4512
sa(dp4513
g8
V17105658.xml
p4514
sg10
VSTD-Ledermann-2006
p4515
sg12
S'PMC1665467'
p4516
sa(dp4517
g8
V17925871.xml
p4518
sg10
VSTD-Shekalaghe-2007
p4519
sg12
S'PMC1995753'
p4520
sasa(dp4521
g3
VCD001735 v. 17.4 Support surfaces for pressure ulcer prevention.rm5
p4522
sg5
(lp4523
(dp4524
g8
V20687915.xml
p4525
sg10
VSTD-Mistiaen-2009
p4526
sg12
S'PMC2924330'
p4527
sasa(dp4528
g3
VCD000493 v. 8.0 Interventions for treating cholestasis in pregnancy.rm5
p4529
sg5
(lp4530
(dp4531
g8
V22695903.xml
p4532
sg10
VSTD-PITCH-2012
p4533
sg12
S'PMC3420230'
p4534
sasa(dp4535
g3
VCD001922 v. 6.0 Physical methods for preventing deep vein thrombosis in stroke.rm5
p4536
sg5
(lp4537
(dp4538
g8
V19477503.xml
p4539
sg10
VSTD-CLOTS-2009
p4540
sg12
S'PMC2692021'
p4541
sasa(dp4542
g3
VCD004744 v. 6.0 Rivastigmine for vascular cognitive impairment.rm5
p4543
sg5
(lp4544
(dp4545
g8
V19300631.xml
p4546
sg10
VSTD-Mok-2007
p4547
sg12
S'PMC2656338'
p4548
sasa(dp4549
g3
VCD009187 v. 2.0 Interventions for recruiting smokers into cessation programmes.rm5
p4550
sg5
(lp4551
(dp4552
g8
V22768793.xml
p4553
sg10
VSTD-Carlini-2012
p4554
sg12
S'PMC3438078'
p4555
sa(dp4556
g8
V16954124.xml
p4557
sg10
VSTD-McClure-2006
p4558
sg12
S'PMC2018826'
p4559
sasa(dp4560
g3
VCD008286 v. 3.0 Combined pharmacotherapy and behavioural interventions for smoking cessation.rm5
p4561
sg5
(lp4562
(dp4563
g8
V17475005.xml
p4564
sg10
VSTD-Binnie-2007
p4565
sg12
S'PMC1871574'
p4566
sa(dp4567
g8
V22853197.xml
p4568
sg10
VSTD-Brandstein-2011
p4569
sg12
S'PMC3453521'
p4570
sasa(dp4571
g3
VCD006133 v. 5.0 Steroidal contraceptives effect on carbohydrate metabolism in women without diabetes mellitus.rm5
p4572
sg5
(lp4573
(dp4574
g8
V22066891.xml
p4575
sg10
VSTD-_x00c5_gren-2011
p4576
sg12
S'PMC3233272'
p4577
sasa(dp4578
g3
VCD008618 v. 2.0 Exercise for improving outcomes after osteoporotic vertebral fracture.rm5
p4579
sg5
(lp4580
(dp4581
g8
V20163739.xml
p4582
sg10
VSTD-Bennell-2010
p4583
sg12
S'PMC2830179'
p4584
sasa(dp4585
g3
VCD003188 v. 15.3 Bisphosphonates in multiple myeloma a network meta-analysis.rm5
p4586
sg5
(lp4587
(dp4588
g8
V21131037.xml
p4589
sg10
VSTD-Morgan-2010
p4590
sg12
S'PMC3639680'
p4591
sasa(dp4592
g3
VMR000028 v. 2.4 How effects on health equity are assessed in systematic reviews of interventions.rm5
p4593
sg5
(lp4594
(dp4595
g8
V20825660.xml
p4596
sg10
VSTD-Jepson-2010
p4597
sg12
S'PMC2944371'
p4598
sa(dp4599
g8
V19692738.xml
p4600
sg10
VSTD-Bambra-2010
p4601
sg12
S'PMC2921286'
p4602
sa(dp4603
g8
V19426469.xml
p4604
sg10
VSTD-Darmstadt-2009
p4605
sg12
S'PMC2679412'
p4606
sa(dp4607
g8
V18505545.xml
p4608
sg10
VSTD-Main-2008
p4609
sg12
S'PMC2412872'
p4610
sa(dp4611
g8
V19426466.xml
p4612
sg10
VSTD-Yakoob-2009
p4613
sg12
S'PMC2679409'
p4614
sa(dp4615
g8
V19426467.xml
p4616
sg10
VSTD-Menezes-2009
p4617
sg12
S'PMC2679410'
p4618
sa(dp4619
g8
V19426468.xml
p4620
sg10
VSTD-Haws-2009
p4621
sg12
S'PMC2679411'
p4622
sa(dp4623
g8
V19828063.xml
p4624
sg10
VSTD-Shea-2009
p4625
sg12
S'PMC3226237'
p4626
sa(dp4627
g8
V19426470.xml
p4628
sg10
VSTD-Bhutta-2009
p4629
sg12
S'PMC2679413'
p4630
sa(dp4631
g8
V20233384.xml
p4632
sg10
VSTD-Barros-2010
p4633
sg12
S'PMC2841444'
p4634
sasa(dp4635
g3
VCD008402 v. 2.0 Foot orthoses for patellofemoral pain in adults.rm5
p4636
sg5
(lp4637
(dp4638
g8
V18952682.xml
p4639
sg10
VSTD-Collins-2008a
p4640
sg12
S'PMC2572211'
p4641
sasa(dp4642
g3
VCD007483 v. 3.0 Artemisinin-based combination therapy for treating uncomplicated malaria.rm5
p4643
sg5
(lp4644
(dp4645
g8
V18545692.xml
p4646
sg10
VSTD-Yeka-2007-UGA
p4647
sg12
S'PMC2405936'
p4648
sa(dp4649
g8
V18620577.xml
p4650
sg10
VSTD-Adjei-2006-GHA
p4651
sg12
S'PMC2478668'
p4652
sa(dp4653
g8
V17125496.xml
p4654
sg10
VSTD-Van-den-Broek-2004-ZAR
p4655
sg12
S'PMC1697822'
p4656
sa(dp4657
g8
V16033307.xml
p4658
sg10
VSTD-Yeka-2004-UGA
p4659
sg12
S'PMC1181876'
p4660
sa(dp4661
g8
V17570848.xml
p4662
sg10
VSTD-Faye-2003-SEN
p4663
sg12
S'PMC1919387'
p4664
sa(dp4665
g8
V17971864.xml
p4666
sg10
VSTD-Grande-2005-PER
p4667
sg12
S'PMC2040506'
p4668
sa(dp4669
g8
V17631681.xml
p4670
sg10
VSTD-Mukhtar-2005-SDN
p4671
sg12
S'PMC1940006'
p4672
sa(dp4673
g8
V19099594.xml
p4674
sg10
VSTD-Kobbe-2007-GHA
p4675
sg12
S'PMC2625364'
p4676
sa(dp4677
g8
V17525792.xml
p4678
sg10
VSTD-Kamya-2006-UGA
p4679
sg12
S'PMC1876597'
p4680
sa(dp4681
g8
V19017387.xml
p4682
sg10
VSTD-Mens-2007-KEN
p4683
sg12
S'PMC2600646'
p4684
sa(dp4685
g8
V17477865.xml
p4686
sg10
VSTD-Bonnet-2004-GIN
p4687
sg12
S'PMC1868032'
p4688
sa(dp4689
g8
V16871329.xml
p4690
sg10
VSTD-Bukirwa-2005-UGA
p4691
sg12
S'PMC1488893'
p4692
sa(dp4693
g8
V16179089.xml
p4694
sg10
VSTD-Hutagalung-2002-THA
p4695
sg12
S'PMC1261533'
p4696
sa(dp4697
g8
V17519010.xml
p4698
sg10
VSTD-Menard-2006-MDG
p4699
sg12
S'PMC1887535'
p4700
sa(dp4701
g8
V18575626.xml
p4702
sg10
VSTD-Owusu_x002d_Agyei-2006-GHA
p4703
sg12
S'PMC2430614'
p4704
sa(dp4705
g8
V19128455.xml
p4706
sg10
VSTD-Kayentao-2006-MLI
p4707
sg12
S'PMC2631542'
p4708
sasa(dp4709
g3
VCD004921 v. 5.0 Chinese medicinal herbs to treat the side-effects of chemotherapy in breast cancer patients.rm5
p4710
sg5
(lp4711
(dp4712
g8
V22937790.xml
p4713
sg10
VSTD-Fang-1995
p4714
sg12
S'PMC3487803'
p4715
sasa(dp4716
g3
VCD001977 v. 8.0 Acupuncture for peripheral joint osteoarthritis.rm5
p4717
sg5
(lp4718
(dp4719
g8
V11914160.xml
p4720
sg10
VSTD-Sangdee-2002-_x002a_
p4721
sg12
S'PMC102323'
p4722
sa(dp4723
g8
V11914160.xml
p4724
sg10
VSTD-Sangdee-2002-_x002a__x002a_
p4725
sg12
S'PMC102323'
p4726
sasa(dp4727
g3
VCD007775 v. 2.0 Pharmacological therapies for maintenance treatments of opium dependence.rm5
p4728
sg5
(lp4729
(dp4730
g8
V14624703.xml
p4731
sg10
VSTD-Assadi-2003
p4732
sg12
S'PMC293465'
p4733
sasa(dp4734
g3
VCD006794 v. 5.0 Early amniotomy and early oxytocin for prevention of or therapy for delay in first stage spontaneo.rm5
p4735
sg5
(lp4736
(dp4737
g8
V21054896.xml
p4738
sg10
VSTD-Nachum-2010
p4739
sg12
S'PMC2988803'
p4740
sasa(dp4741
g3
VCD010398 v. 1.2 The effect of pharmacist-provided non-dispensing services on patient outcomes health service utilis.rm5
p4742
sg5
(lp4743
(dp4744
g8
V19902034.xml
p4745
sg10
VSTD-Arun-2008
p4746
sg12
S'PMC2772000'
p4747
sa(dp4748
g8
V17892588.xml
p4749
sg10
VSTD-Zwarenstein-2007
p4750
sg12
S'PMC2200659'
p4751
sasa(dp4752
g3
VCD004186 v. 10.0 Amitriptyline for depression.rm5
p4753
sg5
(lp4754
(dp4755
g8
V22058460.xml
p4756
sg10
VSTD-Quadri-1980
p4757
sg12
S'PMC3013310'
p4758
sasa(dp4759
g3
VCD003412 v. 8.0 Interventions for basal cell carcinoma of the skin.rm5
p4760
sg5
(lp4761
(dp4762
g8
V9218740.xml
p4763
sg10
VSTD-Avril-1997
p4764
sg12
S'PMC2223779'
p4765
sasa(dp4766
g3
VCD000331 v. 10.2 Epidural versus non-epidural or no analgesia in labour.rm5
p4767
sg5
(lp4768
(dp4769
g8
V17176461.xml
p4770
sg10
VSTD-Nafisi-2006
p4771
sg12
S'PMC1764008'
p4772
sasa(dp4773
g3
VCD003380 v. 12.1 Psychological and educational interventions for preventing depression in children and adolescents.rm5
p4774
sg5
(lp4775
(dp4776
g8
V20181120.xml
p4777
sg10
VSTD-Zehnder-2010
p4778
sg12
S'PMC2841102'
p4779
sasa(dp4780
g3
VCD000230 v. 7.7 Zinc supplementation for improving pregnancy and infant outcome.rm5
p4781
sg5
(lp4782
(dp4783
g8
V19902797.xml
p4784
sg10
VSTD-Ghana-2009
p4785
sg12
S'PMC2928084'
p4786
sasa(dp4787
g3
VCD003327 v. 5.0 Surgical versus endoscopic treatment of bile duct stones.rm5
p4788
sg5
(lp4789
(dp4790
g8
V8725454.xml
p4791
sg10
VSTD-Kapoor-1996
p4792
sg12
S'PMC2443081'
p4793
sasa(dp4794
g3
VCD005427 v. 6.0 Combined chiropractic interventions for low-back pain.rm5
p4795
sg5
(lp4796
(dp4797
g8
V20184717.xml
p4798
sg10
VSTD-Br_x00f8_nfort-1989
p4799
sg12
S'PMC2841070'
p4800
sasa(dp4801
g3
VCD005207 v. 9.0 Colony stimulating factors (including erythropoietin granulocyte colony stimulating factor and anal.rm5
p4802
sg5
(lp4803
(dp4804
g8
V21269484.xml
p4805
sg10
VSTD-Yip-2011
p4806
sg12
S'PMC3221969'
p4807
sa(dp4808
g8
V22007348.xml
p4809
sg10
VSTD-Prasad-2011
p4810
sg12
S'PMC3191816'
p4811
sasa(dp4812
g3
VCD007814 v. 2.0 Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer.rm5
p4813
sg5
(lp4814
(dp4815
g8
V11870500.xml
p4816
sg10
VSTD-Matsumoto-2002
p4817
sg12
S'PMC2375187'
p4818
sasa(dp4819
g3
VCD003139 v. 10.0 High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional c.rm5
p4820
sg5
(lp4821
(dp4822
g8
V11720455.xml
p4823
sg10
VSTD-MCG-2001
p4824
sg12
S'PMC2375253'
p4825
sasa(dp4826
g3
VCD003243 v. 6.0 Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adults.rm5
p4827
sg5
(lp4828
(dp4829
g8
V18469091.xml
p4830
sg10
VSTD-LOTUS-Trial-2008
p4831
sg12
S'PMC2565581'
p4832
sasa(dp4833
g3
VCD000012 v. 10.0 Alternative versus conventional institutional settings for birth.rm5
p4834
sg5
(lp4835
(dp4836
g8
V22035427.xml
p4837
sg10
VSTD-Begley-2009
p4838
sg12
S'PMC3226589'
p4839
sa(dp4840
g8
V21749629.xml
p4841
sg10
VSTD-Bernitz-2011
p4842
sg12
S'PMC3187863'
p4843
sasa(dp4844
g3
VCD001067 v. 9.0 Antibiotic regimens for endometritis after delivery.rm5
p4845
sg5
(lp4846
(dp4847
g8
V12839630.xml
p4848
sg10
VSTD-Scalambrino-1989
p4849
sg12
S'PMC1852268'
p4850
sa(dp4851
g8
V18476152.xml
p4852
sg10
VSTD-Chatwani-1997
p4853
sg12
S'PMC2364549'
p4854
sa(dp4855
g8
V18475417.xml
p4856
sg10
VSTD-Chatwani-1995
p4857
sg12
S'PMC2364413'
p4858
sa(dp4859
g8
V12839630.xml
p4860
sg10
VSTD-Roy-2003
p4861
sg12
S'PMC1852268'
p4862
sasa(dp4863
g3
VCD002014 v. 8.0 Behavioural treatment for chronic low-back pain.rm5
p4864
sg5
(lp4865
(dp4866
g8
V18663487.xml
p4867
sg10
VSTD-van-der-Roer-2008
p4868
sg12
S'PMC2527421'
p4869
sa(dp4870
g8
V23537369.xml
p4871
sg10
VSTD-Strong-1998
p4872
sg12
S'PMC3617092'
p4873
sa(dp4874
g8
V16426449.xml
p4875
sg10
VSTD-Smeets-2006
p4876
sg12
S'PMC1382224'
p4877
sasa(dp4878
g3
VCD006132 v. 5.2 Interventions for improving adherence to ocular hypotensive therapy.rm5
p4879
sg5
(lp4880
(dp4881
g8
V22419858.xml
p4882
sg10
VSTD-Nakakura-2012
p4883
sg12
S'PMC3299559'
p4884
sasa(dp4885
g3
VCD003619 v. 6.0 Weight reduction for non-alcoholic fatty liver disease.rm5
p4886
sg5
(lp4887
(dp4888
g8
V20664019.xml
p4889
sg10
VSTD-Lazo-2010
p4890
sg12
S'PMC2945152'
p4891
sasa(dp4892
g3
VCD008530 v. 2.0 Antibiotic therapy for preventing infections in patients with acute stroke.rm5
p4893
sg5
(lp4894
(dp4895
g8
V18478129.xml
p4896
sg10
VSTD-Harms-2008
p4897
sg12
S'PMC2373885'
p4898
sasa(dp4899
g3
VCD007496 v. 2.0 Male circumcision for prevention of homosexual acquisition of HIV in men.rm5
p4900
sg5
(lp4901
(dp4902
g8
V18628946.xml
p4903
sg10
VSTD-Begley-2008
p4904
sg12
S'PMC2443289'
p4905
sa(dp4906
g8
V20595141.xml
p4907
sg10
VSTD-McDaid-2010
p4908
sg12
S'PMC3010905'
p4909
sa(dp4910
g8
V17848992.xml
p4911
sg10
VSTD-Mor-2007-_x0028_HIV_x002d_pos_x0029_
p4912
sg12
S'PMC1955830'
p4913
sa(dp4914
g8
V17848992.xml
p4915
sg10
VSTD-Mor-2007
p4916
sg12
S'PMC1955830'
p4917
sa(dp4918
g8
V17848992.xml
p4919
sg10
VSTD-Mor-2007-_x0028_HIV_x002d_neg_x0029_
p4920
sg12
S'PMC1955830'
p4921
sa(dp4922
g8
V19662523.xml
p4923
sg10
VSTD-Lane-2011
p4924
sg12
S'PMC2888758'
p4925
sasa(dp4926
g3
VCD008122 v. 4.0 Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries.rm5
p4927
sg5
(lp4928
(dp4929
g8
V18834523.xml
p4930
sg10
VSTD-Abeku-2008a
p4931
sg12
S'PMC2571107'
p4932
sa(dp4933
g8
V18834523.xml
p4934
sg10
VSTD-Abeku-2008b
p4935
sg12
S'PMC2571107'
p4936
sa(dp4937
g8
V18959777.xml
p4938
sg10
VSTD-Kyabayinze-2008
p4939
sg12
S'PMC2584069'
p4940
sa(dp4941
g8
V19399156.xml
p4942
sg10
VSTD-Msellem-2009
p4943
sg12
S'PMC2667629'
p4944
sa(dp4945
g8
V18620560.xml
p4946
sg10
VSTD-Bharti-2008
p4947
sg12
S'PMC2478667'
p4948
sasa(dp4949
g3
VCD007028 v. 3.2 Mailuoning for acute ischaemic stroke.rm5
p4950
sg5
(lp4951
(dp4952
g8
V23272146.xml
p4953
sg10
VSTD-Zhang-2004
p4954
sg12
S'PMC3522714'
p4955
sasa(dp4956
g3
VCD007076 v. 5.0 Pregabalin for acute and chronic pain in adults.rm5
p4957
sg5
(lp4958
(dp4959
g8
V18796160.xml
p4960
sg10
VSTD-Arezzo-2008
p4961
sg12
S'PMC2565674'
p4962
sasa(dp4963
g3
VCD005429 v. 5.0 Which anticholinergic drug for overactive bladder symptoms in adults.rm5
p4964
sg5
(lp4965
(dp4966
g8
V19143854.xml
p4967
sg10
VSTD-Choo-2008
p4968
sg12
S'PMC2680337'
p4969
sasa(dp4970
g3
VCD006423 v. 4.0 Glucagon-like peptide analogues for type 2 diabetes mellitus.rm5
p4971
sg5
(lp4972
(dp4973
g8
V19317822.xml
p4974
sg10
VSTD-L-_x002d_-LEAD-1-Marre-2009
p4975
sg12
S'PMC2871176'
p4976
sa(dp4977
g8
V20722676.xml
p4978
sg10
VSTD-Lixi-_x002d_-Ratner-2010
p4979
sg12
S'PMC3068287'
p4980
sa(dp4981
g8
V19366970.xml
p4982
sg10
VSTD-T-_x002d_-Nauck-2009
p4983
sg12
S'PMC2699710'
p4984
sa(dp4985
g8
V19592625.xml
p4986
sg10
VSTD-A-_x002d_-Rosenstock-2009
p4987
sg12
S'PMC2752910'
p4988
sa(dp4989
g8
V18931095.xml
p4990
sg10
VSTD-L-_x002d_-LEAD-2-Nauck-2009
p4991
sg12
S'PMC2606836'
p4992
sa(dp4993
g8
V19688338.xml
p4994
sg10
VSTD-L-_x002d_-LEAD-5-Russell_x002d_J-2009
p4995
sg12
S'PMC2744824'
p4996
sa(dp4997
g8
V19289857.xml
p4998
sg10
VSTD-L-_x002d_-LEAD-4-Zinman-2009
p4999
sg12
S'PMC2699702'
p5000
sa(dp5001
g8
V20536952.xml
p5002
sg10
VSTD-T_x002d_-Ratner-2010
p5003
sg12
S'PMC2948428'
p5004
sasa(dp5005
g3
VCD002308 v. 8.18 Early use of inhaled corticosteroids in the emergency department treatment of acute asthma.rm5
p5006
sg5
(lp5007
(dp5008
g8
V16433920.xml
p5009
sg10
VSTD-Bateman-2006
p5010
sg12
S'PMC1386666'
p5011
sasa(dp5012
g3
VCD006583 v. 5.0 Laparoscopic entry techniques.rm5
p5013
sg5
(lp5014
(dp5015
g8
V10772522.xml
p5016
sg10
VSTD-Feste-2000
p5017
sg12
S'PMC3015351'
p5018
sa(dp5019
g8
V17761080.xml
p5020
sg10
VSTD-Venkatesh-2007
p5021
sg12
S'PMC3015718'
p5022
sasa(dp5023
g3
VCD007672 v. 2.3 Interventions to improve continuity of care in the follow-up of patients with cancer.rm5
p5024
sg5
(lp5025
(dp5026
g8
V15238983.xml
p5027
sg10
VSTD-Wells-2004
p5028
sg12
S'PMC2364768'
p5029
sa(dp5030
g8
V19107130.xml
p5031
sg10
VSTD-King-2009
p5032
sg12
S'PMC2634705'
p5033
sa(dp5034
g8
V16622437.xml
p5035
sg10
VSTD-Wattchow-2006
p5036
sg12
S'PMC2361245'
p5037
sa(dp5038
g8
V12232756.xml
p5039
sg10
VSTD-Hanks-2002
p5040
sg12
S'PMC2364271'
p5041
sasa(dp5042
g3
VCD007498 v. 3.5 Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.rm5
p5043
sg5
(lp5044
(dp5045
g8
V19493352.xml
p5046
sg10
VSTD-Hochreiter-2009
p5047
sg12
S'PMC2717450'
p5048
sasa(dp5049
g3
VCD004565 v. 3.0 Interventions before consultations for helping patients address their information needs.rm5
p5050
sg5
(lp5051
(dp5052
g8
V11720460.xml
p5053
sg10
VSTD-Brown-2001
p5054
sg12
S'PMC2375236'
p5055
sa(dp5056
g8
V10390003.xml
p5057
sg10
VSTD-Brown-1999
p5058
sg12
S'PMC2363012'
p5059
sasa(dp5060
g3
VCD006519 v. 3.0 Polymer-based oral rehydration solution for treating acute watery diarrhoea.rm5
p5061
sg5
(lp5062
(dp5063
g8
V18270575.xml
p5064
sg10
VSTD-Ramakrishna-2008
p5065
sg12
S'PMC2217593'
p5066
sasa(dp5067
g3
VCD008101 v. 3.0 Continuous glucose monitoring systems for type 1 diabetes mellitus.rm5
p5068
sg5
(lp5069
(dp5070
g8
V20696865.xml
p5071
sg10
VSTD-Juvenile-2009
p5072
sg12
S'PMC2945155'
p5073
sa(dp5074
g8
V19767384.xml
p5075
sg10
VSTD-Raccah-2009
p5076
sg12
S'PMC2782985'
p5077
sa(dp5078
g8
V21335621.xml
p5079
sg10
VSTD-Battelino-2011
p5080
sg12
S'PMC3064030'
p5081
sasa(dp5082
g3
VCD003709 v. 5.0 Vasopressors for hypotensive shock.rm5
p5083
sg5
(lp5084
(dp5085
g8
V16542484.xml
p5086
sg10
VSTD-Luckner-2006
p5087
sg12
S'PMC1550871'
p5088
sa(dp5089
g8
V19017409.xml
p5090
sg10
VSTD-Morelli-2008b
p5091
sg12
S'PMC2646303'
p5092
sa(dp5093
g8
V16507156.xml
p5094
sg10
VSTD-Seguin-2006
p5095
sg12
S'PMC1550826'
p5096
sa(dp5097
g8
V19664253.xml
p5098
sg10
VSTD-Morelli-2009
p5099
sg12
S'PMC2750187'
p5100
sasa(dp5101
g3
VCD003367 v. 9.0 Antitumour antibiotic containing regimens for metastatic breast cancer.rm5
p5102
sg5
(lp5103
(dp5104
g8
V8431375.xml
p5105
sg10
VSTD-Fraser-1993
p5106
sg12
S'PMC1968186'
p5107
sa(dp5108
g8
V10496359.xml
p5109
sg10
VSTD-Harper_x002d_Wynne-1999
p5110
sg12
S'PMC2362871'
p5111
sasa(dp5112
g3
VCD007179 v. 3.0 Antibiotics for treating human brucellosis.rm5
p5113
sg5
(lp5114
(dp5115
g8
V15214959.xml
p5116
sg10
VSTD-Karabay-2004
p5117
sg12
S'PMC459220'
p5118
sasa(dp5119
g3
VCD001134 v. 9.0 Psychosocial and psychological interventions for preventing postpartum depression.rm5
p5120
sg5
(lp5121
(dp5122
g8
V16483383.xml
p5123
sg10
VSTD-Lumley-2006
p5124
sg12
S'PMC1479326'
p5125
sa(dp5126
g8
V19147637.xml
p5127
sg10
VSTD-Dennis-2009
p5128
sg12
S'PMC2628301'
p5129
sasa(dp5130
g3
VCD007844 v. 3.0 Behavioral interventions to promote condom use among women living with HIV.rm5
p5131
sg5
(lp5132
(dp5133
g8
V18431475.xml
p5134
sg10
VSTD-Gilbert-2008
p5135
sg12
S'PMC2292251'
p5136
sasa(dp5137
g3
VCD000076 v. 11.0 Electroconvulsive therapy for schizophrenia.rm5
p5138
sg5
(lp5139
(dp5140
g8
V21206808.xml
p5141
sg10
VSTD-Girish-2003
p5142
sg12
S'PMC2951534'
p5143
sa(dp5144
g8
V21927109.xml
p5145
sg10
VSTD-Agarwal-1985
p5146
sg12
S'PMC3011123'
p5147
sa(dp5148
g8
V22058556.xml
p5149
sg10
VSTD-Bagadia-1981
p5150
sg12
S'PMC3012902'
p5151
sa(dp5152
g8
V22058544.xml
p5153
sg10
VSTD-Janakiramiah-1981
p5154
sg12
S'PMC3012948'
p5155
sasa(dp5156
g3
VCD007189 v. 4.9 Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals.rm5
p5157
sg5
(lp5158
(dp5159
g8
V17525796.xml
p5160
sg10
VSTD-Peterson-2007
p5161
sg12
S'PMC1876601'
p5162
sasa(dp5163
g3
VCD002252 v. 8.0 Antihypertensive drug therapy for mild to moderate hypertension during pregnancy.rm5
p5164
sg5
(lp5165
(dp5166
g8
V23560009.xml
p5167
sg10
VSTD-Brazil-2000a
p5168
sg12
S'PMC3611911'
p5169
sasa(dp5170
g3
VCD006047 v. 5.4 Household interventions for preventing domestic lead exposure in children.rm5
p5171
sg5
(lp5172
(dp5173
g8
V14644671.xml
p5174
sg10
VSTD-Jordan-2003
p5175
sg12
S'PMC1241771'
p5176
sasa(dp5177
g3
VCD000978 v. 13.0 Interventions for preventing oral mucositis for patients with cancer receiving treatment.rm5
p5178
sg5
(lp5179
(dp5180
g8
V8688343.xml
p5181
sg10
VSTD-Symonds-1996
p5182
sg12
S'PMC2074575'
p5183
sa(dp5184
g8
V12671696.xml
p5185
sg10
VSTD-Stokman-2003
p5186
sg12
S'PMC2376383'
p5187
sa(dp5188
g8
V7917930.xml
p5189
sg10
VSTD-Jebb-1994
p5190
sg12
S'PMC2033386'
p5191
sa(dp5192
g8
V3390377.xml
p5193
sg10
VSTD-Mills-1988
p5194
sg12
S'PMC2246575'
p5195
sa(dp5196
g8
V11161394.xml
p5197
sg10
VSTD-Hartmann-2001
p5198
sg12
S'PMC2363753'
p5199
sasa(dp5200
g3
VCD003860 v. 8.4 Fraction size in radiation treatment for breast conservation in early breast cancer.rm5
p5201
sg5
(lp5202
(dp5203
g8
V18356109.xml
p5204
sg10
VSTD-START-A-2008
p5205
sg12
S'PMC2323709'
p5206
sasa(dp5207
g3
VCD008328 v. 2.8 Airway clearance techniques for chronic obstructive pulmonary disease.rm5
p5208
sg5
(lp5209
(dp5210
g8
V16137351.xml
p5211
sg10
VSTD-Vargas-2005
p5212
sg12
S'PMC1269449'
p5213
sasa(dp5214
g3
VCD009419 v. 2.0 Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease.rm5
p5215
sg5
(lp5216
(dp5217
g8
V21552662.xml
p5218
sg10
VSTD-N_x00e1_polis-2011
p5219
sg12
S'PMC3071998'
p5220
sasa(dp5221
g3
VCD005595 v. 3.0 Rehabilitation for ankle fractures in adults.rm5
p5222
sg5
(lp5223
(dp5224
g8
V19781053.xml
p5225
sg10
VSTD-Nilsson-2009
p5226
sg12
S'PMC2760502'
p5227
sasa(dp5228
g3
VCD006911 v. 6.0 Music interventions for improving psychological and physical outcomes in cancer patients.rm5
p5229
sg5
(lp5230
(dp5231
g8
V23741635.xml
p5232
sg10
VSTD-Ferrer-2005
p5233
sg12
S'PMC3666262'
p5234
sasa(dp5235
g3
VCD004974 v. 9.0 Immunostimulants for preventing respiratory tract infection in children.rm5
p5236
sg5
(lp5237
(dp5238
g8
V18831749.xml
p5239
sg10
VSTD-Wahl-2008
p5240
sg12
S'PMC2573879'
p5241
sasa(dp5242
g3
VCD004425 v. 10.0 Combined oral contraceptive pills for treatment of acne.rm5
p5243
sg5
(lp5244
(dp5245
g8
V21995590.xml
p5246
sg10
VSTD-Mansour-2011
p5247
sg12
S'PMC3233274'
p5248
sasa(dp5249
g3
VCD008465 v. 2.0 Exercise interventions on health-related quality of life for people with cancer during active treatm.rm5
p5250
sg5
(lp5251
(dp5252
g8
V18581595.xml
p5253
sg10
VSTD-Hwang-2008
p5254
sg12
S'PMC2615347'
p5255
sa(dp5256
g8
V20842268.xml
p5257
sg10
VSTD-Vadiraja-2009b
p5258
sg12
S'PMC2933732'
p5259
sa(dp5260
g8
V19826172.xml
p5261
sg10
VSTD-Adamsen-2009
p5262
sg12
S'PMC2762035'
p5263
sa(dp5264
g8
V19880433.xml
p5265
sg10
VSTD-Oh-2010
p5266
sg12
S'PMC2826100'
p5267
sasa(dp5268
g3
VCD008160 v. 3.0 Workplace interventions for neck pain in workers.rm5
p5269
sg5
(lp5270
(dp5271
g8
V17260162.xml
p5272
sg10
VSTD-Voerman-2007
p5273
sg12
S'PMC1915628'
p5274
sasa(dp5275
g3
VCD005211 v. 6.0 Exercise interventions for upper-limb dysfunction due to breast cancer treatment.rm5
p5276
sg5
(lp5277
(dp5278
g8
V18581595.xml
p5279
sg10
VSTD-Hwang-2008
p5280
sg12
S'PMC2615347'
p5281
sasa(dp5282
g3
VCD003711 v. 7.5 Herbal medicines for viral myocarditis.rm5
p5283
sg5
(lp5284
(dp5285
g8
V18723572.xml
p5286
sg10
VSTD-Pan-XS-2010
p5287
sg12
S'PMC2553588'
p5288
sasa(dp5289
g3
VCD005473 v. 3.0 Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders.rm5
p5290
sg5
(lp5291
(dp5292
g8
V15667657.xml
p5293
sg10
VSTD-Carey-2005
p5294
sg12
S'PMC547907'
p5295
sasa(dp5296
g3
VCD007078 v. 6.0 Internet-based interventions for smoking cessation.rm5
p5297
sg5
(lp5298
(dp5299
g8
V19033146.xml
p5300
sg10
VSTD-Rabius-2008
p5301
sg12
S'PMC2630842'
p5302
sa(dp5303
g8
V19097974.xml
p5304
sg10
VSTD-Stoddard-2008
p5305
sg12
S'PMC2630832'
p5306
sa(dp5307
g8
V15829474.xml
p5308
sg10
VSTD-Etter-2005
p5309
sg12
S'PMC1550632'
p5310
sa(dp5311
g8
V19017582.xml
p5312
sg10
VSTD-McKay-2008
p5313
sg12
S'PMC2630830'
p5314
sa(dp5315
g8
V19087949.xml
p5316
sg10
VSTD-Brendryen-2008a
p5317
sg12
S'PMC2630841'
p5318
sasa(dp5319
g3
VCD008305 v. 3.3 Chinese herbal medicines for hypercholesterolemia.rm5
p5320
sg5
(lp5321
(dp5322
g8
V23555827.xml
p5323
sg10
VSTD-Ding-1999
p5324
sg12
S'PMC3608539'
p5325
sasa(dp5326
g3
VCD000085 v. 5.0 Extra-abdominal versus intra-abdominal repair of the uterine incision at caesarean section.rm5
p5327
sg5
(lp5328
(dp5329
g8
V18476211.xml
p5330
sg10
VSTD-Magann-_x0028_M_x0029_-1993b
p5331
sg12
S'PMC2364670'
p5332
sa(dp5333
g8
V18476211.xml
p5334
sg10
VSTD-Magann-_x0028_S_x0029_-1993b
p5335
sg12
S'PMC2364670'
p5336
sasa(dp5337
g3
VCD000028 v. 14.0 Pharmacotherapy for hypertension in the elderly.rm5
p5338
sg5
(lp5339
(dp5340
g8
V22530180.xml
p5341
sg10
VSTD-Carter-1970
p5342
sg12
S'PMC3327043'
p5343
sasa(dp5344
g3
VCD006145 v. 6.0 Exercise for the management of cancer-related fatigue in adults.rm5
p5345
sg5
(lp5346
(dp5347
g8
V18581595.xml
p5348
sg10
VSTD-Hwang-2008
p5349
sg12
S'PMC2615347'
p5350
sa(dp5351
g8
V19826172.xml
p5352
sg10
VSTD-Adamsen-2009
p5353
sg12
S'PMC2762035'
p5354
sa(dp5355
g8
V19880433.xml
p5356
sg10
VSTD-Oh-2010
p5357
sg12
S'PMC2826100'
p5358
sasa(dp5359
g3
VCD004703 v. 6.0 Transabdominal pre-peritoneal (TAPP) vs totally extraperitoneal (TEP) laparoscopic techniques for in.rm5
p5360
sg5
(lp5361
(dp5362
g8
V10917122.xml
p5363
sg10
VSTD-Lepere-2000
p5364
sg12
S'PMC3015374'
p5365
sasa(dp5366
g3
VCD003766 v. 11.2 Continuous support for women during childbirth.rm5
p5367
sg5
(lp5368
(dp5369
g8
V17612408.xml
p5370
sg10
VSTD-Bruggemann-2007
p5371
sg12
S'PMC1936417'
p5372
sasa(dp5373
g3
VCD003445 v. 8.0 Supportive care for patients with gastrointestinal cancer.rm5
p5374
sg5
(lp5375
(dp5376
g8
V7819058.xml
p5377
sg10
VSTD-Cascinu-1995
p5378
sg12
S'PMC2033463'
p5379
sasa(dp5380
g3
VCD005004 v. 4.0 Green tea (Camellia sinensis) for the prevention of cancer.rm5
p5381
sg5
(lp5382
(dp5383
g8
V16804523.xml
p5384
sg10
VSTD-Kikuchi-2006
p5385
sg12
S'PMC2360636'
p5386
sa(dp5387
g8
V12177800.xml
p5388
sg10
VSTD-Hoshiyama-2002
p5389
sg12
S'PMC2364221'
p5390
sa(dp5391
g8
V15054454.xml
p5392
sg10
VSTD-Suzuki-2004
p5393
sg12
S'PMC2409667'
p5394
sa(dp5395
g8
V10584890.xml
p5396
sg10
VSTD-Key-1999
p5397
sg12
S'PMC2374337'
p5398
sa(dp5399
g8
V18766189.xml
p5400
sg10
VSTD-Li-2008
p5401
sg12
S'PMC2567088'
p5402
sasa(dp5403
g3
VCD007275 v. 2.0 Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours.rm5
p5404
sg5
(lp5405
(dp5406
g8
V18261131.xml
p5407
sg10
VSTD-Wright-2008
p5408
sg12
S'PMC2440307'
p5409
sasa(dp5410
g3
VCD001973 v. 9.0 Interventions for treating oral mucositis for patients with cancer receiving treatment.rm5
p5411
sg5
(lp5412
(dp5413
g8
V22615593.xml
p5414
sg10
VSTD-Baharvand-2010
p5415
sg12
S'PMC3232086'
p5416
sasa(dp5417
g3
VCD006842 v. 3.0 Oscillating devices for airway clearance in people with cystic fibrosis.rm5
p5418
sg5
(lp5419
(dp5420
g8
V19703826.xml
p5421
sg10
VSTD-Osman-2010
p5422
sg12
S'PMC2922723'
p5423
sasa(dp5424
g3
VCD005481 v. 4.4 Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS.rm5
p5425
sg5
(lp5426
(dp5427
g8
V19358725.xml
p5428
sg10
VSTD-Kumar-2009
p5429
sg12
S'PMC2672933'
p5430
sasa.